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Abstract
This thesis researches the economics of type 2 diabetes in middle-income coun-
tries (MICs). Given the high prevalence of type 2 diabetes in MICs, in-depth
country specific analysis is key for understanding the economic consequences of
type 2 diabetes. The thesis consists of four studies with the unifying theme of
improving the understanding of the causal impact of diabetes on economic out-
comes. Study (1) provides an updated overview, critically assesses and identifies
gaps in the current literature on the economic costs of type 2 diabetes using
a systematic review approach; study (2) investigates the effects of self-reported
diabetes on employment probabilities in Mexico, using cross-sectional data and
making use of a commonly used instrumental variable approach; study (3) re-
visits and extends these results via the use of a fixed effects panel data analy-
sis, also considering a broader range of outcomes, including wages and working
hours. Further, it makes use of cross-sectional biomarker data that allow for the
investigation of undiagnosed diabetes. Study (4) researches the effect of a dia-
betes diagnosis on employment as well as behavioural risk factors in China, using
longitudinal data and applying an alternative identification strategy, marginal
structural models estimation, while comparing these results with fixed effects es-
timation results. The thesis identifies a considerable economic burden of diabetes
in middle-income countries and uncovers several inequities affecting women, the
poor and the uninsured. Biomarker results indicate that the adverse effects are
limited to those aware of their diabetes. Finally, women are also found to achieve
fewer positive changes of their behavioural risk factors after a diabetes diagnosis
than men, offering a potential explanation for their more adverse employment
outcomes compared to men. To reduce the economic burden, the groups most
affected by the identified inequities should be targeted. Further, the underlying
reasons for the found sex differences need to be identified.
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Background to the thesis
Diabetes, and especially type 2 diabetes, has seen an unprecedented rise in preva-
lence globally and especially in low- and middle-income countries (LMICs), where
rates reached and often surpassed those of high-income countries (HICs), such as
the USA, UK or Germany (Hu, 2011; NCD Risk Factor Collaboration, 2016).
Today, two-thirds of the over 400 million people with diabetes live in LMICs (In-
ternational Diabetes Federation, 2014) and, in particular, in China, India, Brazil,
Indonesia, Pakistan, Russia, Egypt and Mexico (NCD Risk Factor Collaboration,
2016). In 2015, diabetes has been responsible for over 5 million deaths and people
with diabetes are estimated to die 6 years earlier due to the disease and increas-
ingly before the age of 60 (International Diabetes Federation, 2015; Seshasai et
al., 2011). This increase in prevalence is due to a shift in age structure towards
older populations and is further spurred by rapid changes in levels of physical
activity, nutrition and other lifestyle related factors (Hu, 2011; NCD Risk Factor
Collaboration, 2016).
In LMICs, the rise of non-communicable diseases (NCDs) has in many cases led
to a double disease burden, where health systems have to deal with high rates of
infectious as well as non-communicable diseases (Jamison et al., 2013). Given the
scarce resources in these countries (Mills, 2014), the increasing number of people
with diabetes and at risk of the disease are putting an additional burden on these
systems (Chan et al., 2016; Wareham et al., 2016). However, despite the epidemic
levels diabetes has reached in LMICs, research on its economic consequences has
remained sparse for these countries and mostly limited to HICs. More research is
needed to identify how diabetes is affecting individuals in LMICs, and the groups
most adversely affected. This could help raise awareness of policy makers of the
size and of the potential inequities of the disease burden, and help to design
strategies to reduce these inequities.
Currently healthcare systems in LMICs are likely further increasing inequities
by providing better care and coverage for those in formal employment and eco-
nomically better off (Di Cesare et al., 2013; Mills, 2014). For Peru, a recent
study identified several barriers to care for people with diabetes, that are likely
highly relevant for other middle-income countries (MICs) as well. They included
a generally low political commitment to improve access to and the quality of di-
abetes care, little qualified personnel to treat diabetes at the primary care level,
high out-of-pocket expenditures, partly related to the seeking of specialized dia-
betes care in the private sector, and few resources in the healthcare budget being
allocated to non-communicable-diseases treatment despite its high mortality bur-
den (Cardenas et al., 2016). Further, it appears that a diabetes diagnosis often
happens too late to prevent first complications, with a first diagnosis frequently
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being made after a patient has been admitted to a hospital emergency department
due to diabetes related complications (Cardenas et al., 2016). Similar observa-
tions have been made for other LMICs (Beran, 2015; World Health Organization,
2014).
Types of diabetes
Diabetes is a term used to describe various conditions characterised by elevated
blood glucose levels. These either occur because the pancreas is not able to
produce sufficient insulin, or due to insulin resistance, where the body is not
able to use the produced insulin effectively (World Health Organization, 2016).
The different conditions themselves have distinct origins, especially the two most
common types called type 1 diabetes and type 2 diabetes.
• Type 1 diabetes is an autoimmune disease with an important genetic
component and whose triggers still remain largely elusive. It emerges when
the insulin producing cells on the pancreas are attacked and destroyed by
the immune system and insulin has to be provided exogenously. About
10% of all global diabetes cases are type 1 diabetes and it is particularly
prevalent in Northern European countries, such as Finland, though it gen-
erally exhibits much geographic variation. Its onset is mainly during the
first 30 years of life. Symptoms tend to appear rather quickly and can be
quite severe, leading to a relatively rapid diagnosis or death if insulin is not
given or available. People with type 1 diabetes will need to inject insulin
to control their blood glucose levels for their entire life following diagnosis
(Tuomilehto, 2013).
• Type 2 diabetes results from the body’s ineffective use of insulin and
accounts for about 90% of all diabetes cases (World Health Organization,
2016). Albeit there is a considerable genetic component to the development
of type 2 diabetes, there are many known risk factors that favour the de-
velopment of type 2 diabetes, such as overweight and obesity, an unhealthy
diet, physical inactivity and smoking, among others (American Diabetes
Association, 2014; World Health Organization, 2016). Interestingly, the
risk to develop type 2 diabetes varies also by ethnicity, with South-East
Asian populations developing diabetes at lower body mass index (BMI)
levels than populations of European decent (Ramachandran et al., 2010).
Type 2 diabetes often remains undetected for several years due to its more
gradual development compared with type 1 diabetes (American Diabetes
Association, 2014). Therefore, even in HICs and especially in LMICs, a
proportion of at least 1/4 of the population with type 2 diabetes is unaware
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of the condition (Beagley et al., 2014).
The onset of type 2 diabetes also appears to be increasingly earlier in life.
This has been observed mainly in ethnic minorities in HIC, such as Mexicans
and Asians, while data are limited for LMICs (Fazeli Farsani et al., 2013). Also,
the increasing numbers of obesity in child- and early adulthood are leading to
the earlier onset of type 2 diabetes (Chen et al., 2011). Hence, type 2 diabetes
increasingly affects people in the middle of their productive lifespan, extending
the time they have to live with the disease and the probability of developing
debilitating complications.
Diabetes complications
The most common complication for all types of diabetes, and often already
present at diagnosis, is retinopathy (35% at diagnosis), being responsible for
2.6% of blindness globally. Further, up to 50% of cases of end stage renal disease
are a direct result of diabetes, especially in countries where access to dialysis is
restricted. People with diabetes also have a 2–3 times higher risk to experience
cardiovascular disease compared to people without diabetes. A further compli-
cation is amputation of lower limps due to impaired wound healing, being 10–20
higher for people with diabetes. In addition to these microvascular complications,
diabetes has its greatest health impact as a risk factor for cardiovascular disease
and stroke (World Health Organization, 2016). There is also a growing literature
suggesting a—potentially bidirectional—relationship between diabetes and de-
pression (Dooren et al., 2013; Nouwen et al., 2010; Roy et al., 2012). In addition,
there seems to be a link between diabetes and the development of certain types of
cancer, (Nead et al., 2015; Tsilidis et al., 2015), as well as an array of other infec-
tious diseases, intentional self-harm and degenerative disorders diseases (Seshasai
et al., 2011).
Diabetes prevention
Diabetes complications are a result of consistently elevated blood glucose levels,
and are aggravated if blood pressure is high as well, as is often the case. Hence
many complications could be prevented if recommended treatment goals were
achieved. However, limited resources and access to healthcare make it difficult
to properly treat type 2 diabetes in LMICs (Villalpando et al., 2010), and even
in HICs a large part of the population with diabetes does not achieve treatment
goals to prevent complications (Diabetes UK, 2012).
Primary prevention of diabetes or at least a delayed onset are further major
goals of diabetes research and could be achieved by reducing the prevalence of the
19
known risk factors such as obesity, an unhealthy diet and sedentary behaviour
(World Health Organization, 2016). However, so far most approaches to prevent
type 2 diabetes have not had the desired effect and may not always be realistic in
very resource constrained settings (White, 2016). In particular efforts to reduce
the biggest type 2 diabetes risk factors of obesity and overweight have been
unsuccessful (Roberto et al., 2015).
The need for further economic research on diabetes
To design effective interventions and to make qualified decisions about the use of
primary and secondary prevention strategies of diabetes, researchers and policy
makers need information about the current burden of diabetes, both in terms
of health and economically. Information on all aspects of economic costs and,
optimally, the quality of the estimates has to be available. In particular, in
LMICs equity issues are likely to be of importance if the burden of diabetes
varies by socioeconomic groups, ethnicity or sex, potentially widening existing
socioeconomic inequities. However, at the start of this thesis, little was known
about the economic impact of diabetes in developing countries. There had, to my
knowledge, not been a comprehensive systematic review of studies assessing the
costs related to diabetes, both in terms of direct and indirect costs. One (non-
systematic) review existed (Ettaro et al., 2004), including cost-of-illness (COI)
studies published until the year 2001. Completely absent in that review were
studies from LMICs. Further, considerable time had passed since that review
and the methodological quality of research published since then needed to be
assessed and areas of future research had to be identified. Also missing was a
comprehensive overview of studies using quantitative methods to estimate the
impact of diabetes on labour market outcomes, such as employment and wages.
Objectives of the thesis
The thesis focuses on three main research questions related to the economics of
diabetes in MICs.
1. What is the worldwide evidence on the economic burden of type 2 diabetes,
both in terms of COI and the labour market effects of diabetes?
2. What is the impact of diabetes on labour market outcomes in MICs?
3. How does a diabetes diagnosis affect behavioural risk factors?
These three research questions are answered in Chapters 2, 3, 4 and 5 and
several sub-themes are explored. These include potential inequities of the eco-
nomic burden of diabetes, time trends in the impact of diabetes on labour market
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outcomes and behavioural risk factors, heterogeneities in the impact of diabetes
between those aware and those unaware of the condition, and the robustness of
the estimates to different estimation techniques and geographic settings.
The economic burden of diabetes across the globe
Chapter 2: The Economic Costs of Type 2 Diabetes: A Global Systematic Review
provides a first comprehensive global picture of the economic burden of type 2
diabetes, including both COI studies and studies on the labour market effects of
diabetes from both HICs and LMICs. The aim was to provide information on
the economic costs of diabetes for as many countries as possible. Another goal
was the identification of research areas, both in terms of methodology and topic,
where evidence was lacking and/or current methodologies could be improved
upon. This was intended to guide the subsequent chapters of this thesis as well
as other researchers interested in the economics of diabetes. Chapter 2 thereby
answers research question one.
The labour market impact of type 2 diabetes
The review identified the labour market impact of diabetes in LMICs as a topic
that had not received much attention. Apart from the lack of evidence from de-
veloping countries, there was also scope for methodological improvements com-
pared to the existing HIC evidence. Further, information on the effects on sub-
populations, i.e. comparisons between rich and poor and the formal and informal
labour market were non-existent.
However, in order to carry out such an analysis, appropriate data needed to
be identified. To this end, a search for suitable household data from LMICs was
carried out, using general as well as specialized search engines, such as the World
Bank Central Microdata Catalog http://microdata.worldbank.org/, the De-
mographic and Health Survey Database http://dhsprogram.com/data/, the
Global Health Data Exchange Database http://ghdx.healthdata.org/, and
the International Household Survey Network Catalog http://catalog.ihsn.
org/index.php/catalog. The aim was to identify datasets containing informa-
tion on self-reported or measured diabetes. Specialized websites providing an
overview on household survey data in developing countries were also scoped to
identify relevant data (such as http://ipl.econ.duke.edu/dthomas/dev_data/
index.html and https://sites.google.com/site/medevecon/development-economics/
devecondata/micro for household survey from developing countries, and an
overview on datasets containing biomarker information provided by The Biomarker
Network at http://gero.usc.edu/CBPH/network/resources/studies/). An
overview of the identified surveys is provided in Table A1 in the appendix.
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Given the availability of data and the extent of diabetes in MICs compared
to low-income countries (LICs), a decision was made to focus on MICs for the
remainder of the thesis and, in particular, on Mexico and China. The main rea-
son was the availability of suitable data provided by the Mexican Family Life
Survey (MxFLS) and China Health and Nutrition Survey (CHNS). First, the
MxFLS was used to investigate the impact of diabetes on labour market out-
comes in Mexico, as the data provided information on important covariates, in-
cluding parental diabetes, not available in other surveys. Further, Mexico is a
country with particularly high obesity and diabetes rates making it an interesting
case to study. Chapter 3 therefore investigates the causal effect of diabetes on
employment probabilities in Mexico, providing answers to research question two.
Identification of the causal effect of diabetes on labour market outcomes
As is eluded to in Chapter 3, identifying a causal relationship of diabetes with
labour market outcomes is being complicated by the possibility of unobserved
time-variant and -invariant heterogeneity. In Chapter 3, an instrumental vari-
able (IV) approach was used, as a first step of analysis, to address this research
question. However, as is often the case with IVs, the identification strategy
is imperfect and it remains open to debate whether the used instrument fully
satisfies the exclusion restriction, even if formal econometric testing suggests it
does, leaving the possibility of biased estimates. Several other strategies po-
tentially exist to identify the true effect of diabetes on labour market outcomes
using quasi-experimental econometric approaches (Antonakis et al., 2012). For
example, a natural experiment—that would affect people’s diabetes risk while at
the same time have no direct effect on labour market outcomes such as employ-
ment probabilities or wages—may be used. However, a setting with exogenously
introduced variation is notoriously difficult to find (moreover, it may provide
information only for a very—often geographically or economically—specific pop-
ulation that has been exposed to this natural experiment). Another strategy to
improve inference is the use of panel data and in particular the fixed effects (FE)
estimation, which does not depend on exogenously introduced variation. Rely-
ing only on within-individual variation, the strategy allows to fully account for
time-invariant factors that may affect diabetes and labour market outcomes si-
multaneously. This is likely of importance in the case of diabetes and economic
outcomes, where the use of IVs has been motivated by the possibility that un-
observed character trades—generally thought to be stable over time—,such as
motivation as well as early life experiences, may be confounding the relationships
(Seuring et al., 2015b).
Therefore, part one of Chapter 4 takes advantage of a recent addition of data to
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the MxFLS to apply a FE estimation approach, testing if the effects of diabetes on
employment probabilities found in Chapter 3 are robust to using this alternative
identification strategy. Further, it extends the number of investigated outcomes
to three, adding wages and working hours.
Do the effects of diabetes change over time?
Diabetes is a lifelong disease whose debilitating complications generally appear
after several years of elevated blood glucose levels (World Health Organization,
2016). So far, little is known about the exact time after diagnosis that diabetes
starts exhibiting potential adverse effects on labour market outcomes. However,
in order to design strategies to mitigate the economic impact of diabetes this
would be important to know as it would help in finding the most efficient point
in time to intervene. If effects occur immediately after diagnosis, it may be
because severe complications are already present at the point of diagnosis, leaving
little possibilities to prevent the economic burden. This would suggest that much
could be prevented by an earlier diagnosis and appropriate treatment and lifestyle
changes. It could further indicate a potential effect of the diagnosis itself, for
example on psychological health, causing reductions in employment probabilities
or wages. However, if effects appear only years after the diagnosis, severe diabetes
complications that have developed due to sub-optimal blood glucose management
may be causing the reductions in productivity. This could hint at a possibility to
mitigate the negative economic consequences of diabetes by secondary prevention
through better diabetes management even without an earlier diagnosis. The
systematic review in Chapter 2 showed a lack of evidence in this area. Only
one study by Minor (2013) investigated the long term consequences of diabetes,
finding non-linear effects in a USA population. Apart from the need for additional
evidence, also several possibilities for methodological improvements exist. Part
two of Chapter 4 therefore assesses the impact of the time since diagnosis on
labour market outcomes, using both linear and non-linear specifications in a FE
framework.
Measurement of diabetes in household surveys
There are two possibilities of measuring diabetes in household surveys: (1) asking
participants about their diabetes status or (2) identifying people with diabetes us-
ing biometric tests, such as fasting blood glucose or glycated hemoglobin (HbA1c)
levels. Using self-reported information likely leads to the exclusion of a consid-
erable part of the population with diabetes that has not yet received a diagnosis
by a healthcare professional (Beagley et al., 2014). Using biomarker information,
also previously undiagnosed cases can be identified. Blood glucose measurements
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provide information on glucose levels at the time of the blood draw but it is not
possible to infer on glucose levels over time. They are also sensitive to food con-
sumption and may lead to false positives if taken in a non-fasted state. HbA1c
levels provide an indication of the average blood glucose levels over the preceding
three months and are not sensitive to the glucose level at the time of the blood
draw (World Health Organization, 2011). They are, however, sensitive to an
array of disorders such as haemoglobinopathies, anaemias, and disorders associ-
ated with accelerated red cell turnover (World Health Organization, 2011). The
cut-off points for diabetes detection for blood glucose measurement and HbA1c
measurement are 126 mg/dl and 6.5%, respectively (World Health Organization,
2006, 2011).
Unfortunately, and largely due to data limitations, previous research had to rely
mainly on self-reported diabetes information. It has therefore remained unclear
if the effects found also extended to the population with diabetes unaware of
its condition. Part 3 of Chapter 4 uses a relatively large sample of biomarker
data with HbA1c measurements, made available in wave 3 of the MxFLS that
was released in 2015, to investigate the extent of the undiagnosed population in
Mexico and the association of diabetes with labour market outcomes for the entire
and undiagnosed population with diabetes. This part also addresses the question
if current disease severity, as proxied by HbA1c levels, is related to labour market
outcomes.
Overall, the three parts of Chapter 4 provide extensive additional evidence to
answer research question two, by providing evidence of the effect of diabetes on
employment probabilities using an alternative estimation strategy compared to
Chapter 3, extending the investigated outcomes to wages and working hours and
providing evidence on the effects of diabetes duration. Finally, it investigates
heterogeneities in the effects of diabetes for the entire population with diabetes,
i.e. those aware as well as those unaware of their condition.
Diabetes, behavioural risk factors and employment status
Previous research on the impact of diabetes on employment has assumed a non-
dynamic relationship between diabetes and employment probabilities, with dia-
betes affecting employment but employment not affecting diabetes. This, how-
ever, may be a too restrictive assumption, for example if employment status
affects behavioural risk factors such as smoking, alcohol consumption or weight
that can affect the likelihood of developing diabetes. However, simply accounting
for these risk behaviours in a non-dynamic framework may also lead to biased es-
timates as it is likely that these risk factors themselves are affected by a diabetes
diagnosis as people try to live healthier to prevent further diabetes complications
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or through the effects of medications. This also makes it impossible to account for
the potential effect of obesity on labour market outcomes when trying to identify
the causal effect of diabetes in such a framework.
These behavioural risk factors also themselves represent an important outcome
to investigate, given that there is evidence that the adverse impact of diabetes
could be at least partly prevented by changes in lifestyle and appropriate treat-
ment (Wareham et al., 2016). This would require a diagnosis of diabetes, in order
to create awareness of the disease. As Chapter 4 has shown for Mexico, a large
part of the population with diabetes is unaware of its condition, whether in HICs
or developing countries (Beagley et al., 2014). But even once a diagnosis has been
made, appropriate changes towards a healthier lifestyle and medical treatment are
required to prevent complications and are only possible if the type of information
about ways to achieve this is accessible to and understood by the person with di-
abetes. This information is typically provided by a healthcare professional at the
time of diagnosis and thereafter. Relatively little is known about the extent to
which people with diabetes are making such changes after a diagnosis, especially
in MICs, where healthcare access and health literacy is likely more limited than
in HICs (Mills, 2014).
Research study three in Chapter 5 investigates the effect of a diabetes diag-
nosis on both employment probabilities and health behaviours in China, using
six waves of very detailed panel data from the CHNS. China, like Mexico, is a
country where diabetes rates have increased dramatically over the last decades,
now affecting about 100 million people or close to 10% of the adult population
(NCD Risk Factor Collaboration, 2016), with many remaining unaware of hav-
ing the condition (Wang et al., 2015). In a first step to take into account the
potential interrelatedness of diabetes, employment status and behavioural risk
factors, the study uses marginal structural models (MSMs), which are able to
account for time-variant confounding. This strategy allows adjusting for the fact
that behavioural risk factors and also employment status could be causes as well
as effects of diabetes, which cannot be distinguished with traditional econometric
methods, such as ordinary least squares (OLS) or FE. To further investigate
the potential sources of bias and robustness of the results also a FE and random
effects (RE) approach are used. This chapter intends to answer research question
three by providing evidence on the effect of a diabetes diagnosis on behavioural
risk factors and by taking into account the potential relationship with employ-
ment as well. It thereby also provides further evidence to answer research question
two, using a different estimation strategy and information from a different coun-
try, and also suggests that future research should try to model employment and
health behaviours simultaneously to uncover the underlying pathways through
which they may affect each other.
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Thesis methods and structure
This research uses systematic review and advanced quantitative methods to an-
swer the research questions that together form this thesis.
A series of four independent research studies form this thesis. Chapters 2 and 3
have already been published as journal articles and Chapter 4 has been published
as a discussion paper and has been submitted to an international peer reviewed
journal the time of completion of the thesis. Chapter 5 will be submitted within
the next months. This is outlined in more detail in the publication and statement
of ownership section. Each study addresses different research questions, but has
the investigation of the labour market impact of diabetes as a unifying theme.
Taken together the studies progressively complement each other, providing a
better understanding of the economic impact of diabetes in MICs. Each study is
presented in a separate chapter. For Chapters 3, 4 and 5, a pre-amble precedes the
actual study to contextualize the respective findings with the preceding chapter
and the entire thesis.
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2 The economic costs of type 2
diabetes: a global systematic
review
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Abstract
There has been a widely documented and recognized increase in diabetes
prevalence not only in high-income countries (HICs) but also in low- and
middle-income countries (LMICs), over recent decades. It is less clear what
is the economic burden associated with diabetes, especially in LMICs. We
provide a systematic review of the global evidence on the costs of type II
diabetes. Our review seeks to update and considerably expand the previous
major review of the costs of diabetes by capturing the evidence on overall,
direct and indirect costs of type II diabetes worldwide that was published
since 2001. In addition we include a body of economic evidence that has
hitherto been distinct from the cost-of-illness (COI) work, i.e. studies on
the labour market impact of diabetes. PubMed, EMBASE, EconLit and
IBSS were searched (without language restrictions) for studies assessing the
economic burden of type 2 diabetes published from January 2001 to Octo-
ber 2014. Costs reported in the included studies were converted to inter-
national dollars ($) adjusted for 2011 values. Alongside the narrative syn-
thesis and methodological review of the studies we conduct an exploratory
linear regression analysis, examining the factors behind the considerable
heterogeneity in existing cost estimates between and within countries. We
identified 86 COI and 22 labour market studies. COI studies varied con-
siderably in both methods and cost estimates, with most studies not using
a control group, though the use of either regression analysis or matching
has increased. Direct costs were generally found to be higher than indirect
costs. Direct costs ranged from $242 for a study on out-of-pocket (OOP)
expenditures in Mexico to $11917 for a study on the cost of diabetes in the
USA, while indirect costs ranged from $45 for Pakistan to $16914 for the
Bahamas. In LMICs—in much contrast to HICs—substantial part of the
cost burden arose to patients from OOP treatment costs. Our regression
analysis revealed that direct diabetes costs are closely and positive associ-
ated with a country’s gross domestic product (GDP) per capita, and that
the USA stood out as having particularly high costs, even after control-
ling for GDP per capita. Studies on the labour market impact of diabetes
were almost exclusively confined to HICs and found strong adverse effects,
particularly for male employment probabilities. Many of these studies also
took into account the possible endogeneity of diabetes, which was not the
case for COI studies. The reviewed studies indicate a large economic bur-
den of diabetes, most directly affecting patients in LMICs. The magnitude
of the cost estimates differs considerably between and within countries,
calling for the contextualization of the study results. There remains large
scope for adding to the evidence base on labour market effects of diabetes
in LMICs. Further, there is a need for future COI studies to incorporate
more advanced statistical methods in their analysis to account for possible
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biases in the estimated costs.
Introduction
Diabetes is a chronic disease that has spread widely, not only in high-income but
also in many LMICs over the last decades. The most recent data from the Inter-
national Diabetes Federation indicate that diabetes affected 382 million people
worldwide in 2013, a number that is expected to grow to 592 million by 2035.
The estimated global prevalence in 2013 amounts to 8.3% among people aged
20–79 years, with the world’s most populous countries India and China reaching
prevalence rates between 9% and 10%, corresponding to 65 and 100 million in
absolute numbers, respectively. Particularly high prevalence rates are found in
Mexico (12.6%) and Egypt (16.8%), surpassing the rates of most HICs, including
the USA (9.2%) and Germany (8.2%) (International Diabetes Federation, 2014).
Taken together, in 2013 about two-thirds of all individuals with diabetes lived
in LMICs (International Diabetes Federation, 2014). The rising prevalence of
diabetes in LMICs appears to be fuelled by rapid urbanization, nutrition transi-
tion and increasingly sedentary lifestyles (Hu, 2011). The most prevalent form of
diabetes by far is type 2 diabetes, affecting about 90% of people with diabetes
while the remaining 10% mainly have type 1 diabetes or gestational diabetes
(International Diabetes Federation, 2014).
Due to its adverse effect on people’s health, diabetes also imposes an economic
burden on individuals and households affected as well as on healthcare systems.
The economic burden of diabetes was confirmed by a review of COI studies on
diabetes mellitus, published in 2004, covering the literature up to the year 2000.
The authors concluded that the direct and indirect economic burden of diabetes
was “large”, and that costs had increased over time. However, the review also
noted that significant variation in costing methodologies made it near impossible
to directly compare the cost estimates. However, the studies reviewed by Ettaro
et al. (2004) were almost exclusively focused on the USA, with a small part
coming from European HICs and none from LMICs. The aim of this study is
therefore to systematically review the literature on the economic costs of diabetes
published since 2001 (i.e. the first year not covered by the Ettaro et al. (2004)
review), as we expect a considerable number of new studies also from LMICs. In
addition to the COI studies we review the literature on labour market outcomes,
with a specific interest in the methodological challenges involved. In doing so we
substantively update and expand the scope of the Ettaro et al. (2004) review,
allowing us to revisit its findings regarding the evidence base about the economic
burden of type 2 diabetes globally.
COI studies generally assess the direct and indirect costs of a particular illness,
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where the former represent the opportunity cost of resources used for treatment.
The indirect costs measure the value of resources lost due the illness, most com-
monly those caused by losses in productivity due to mortality and morbidity as
measured in lost earnings (Segel, 2006). In addition, another approach also fo-
cuses on estimating the impact of diabetes on labour market outcomes. However,
rather than trying to estimate the monetary losses that arise from a decrease
in productivity, these studies typically compare labour market outcomes (e.g.
employment probabilities, earnings or lost work days) between people with and
without diabetes, while accounting for differences in age, education and other
demographic and socioeconomic variables, that might arise between both groups
and that could affect labour market outcomes as well as the chances of developing
diabetes. The aim of studies in this field is to obtain a clearer picture of how
diabetes causally affects these labour market outcomes, without necessarily mon-
etizing the results. Because of the different methodologies and data requirements,
these studies tend to differ considerably from traditional COI studies, which is
why we reviewed them separately. To the best of our knowledge this is the first
review that systematically assesses the studies in this particular field.
Methods
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines were used as a basis for the overall study approach (Moher et al., 2009).
Search strategy
The electronic search was based on the following search terms: "Diabetes Mel-
litus"[Mesh] AND ("Costs and Cost Analysis"[Mesh] OR "Cost of Illness"[Mesh]
OR "Employment"[Mesh] OR "labour Market"[All fields] OR "Labour Market"[All
fields] OR "Productivity"OR "Willingness to pay"[All fields]). The above search
was run in PubMed and was then adapted for searches in EMBASE, EconLit and
the International Bibliography of the Social Sciences (IBSS). The search was car-
ried out from October 2012 to October 2014 and restricted to studies published
between January 2001 and October 2014, as the earlier review had covered COI
studies until 2000 (Ettaro et al., 2004). No language restrictions were applied.
The references were downloaded in RIS format where possible and then trans-
ferred to Mendeley. Authors were contacted for further information if clarification
was needed after the full text analysis.
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Inclusion and exclusion criteria
Studies were eligible if a monetary estimate of the direct and/or indirect costs of
diabetes was presented in the results section or if studies provided an estimate
of the impact of diabetes on labour market outcomes (employment probabilities,
labour income, wages and lost work days). We did not exclude studies with a
small sample size as this might have discriminated against studies in LMICs.
Studies on types of diabetes explicitly different from type 2 diabetes were ex-
cluded. However, we included studies that did not explicitly mention the type of
diabetes, given that type 2 diabetes accounts for about 90% of all diabetes cases.
Studies exclusively assessing the costs of diabetes complications or the costs of
management strategies were excluded as were studies estimating the costs for
specific groups with diabetes (e.g. costs for people with poorly controlled dia-
betes), since we were interested in the costs incurred to populations comprising
the whole spectrum of people with type 2 diabetes. Editorials, reviews and stud-
ies for which the full text could not be retrieved or only an abstract was available
were also excluded.
Data extraction and analysis
Data extraction was carried out by two investigators (TS and OA). After du-
plicates were removed, titles and abstracts were scanned by one researcher (TS)
to identify studies suitable for a full text review. The process was checked by a
second researcher (OA) on a random subsample of 2000 studies of the retrieved
references. The full text was subsequently retrieved for the identified studies and
they were reviewed by two researchers (TS and OA), with disagreements resolved
by discussion. Finally, 109 studies were identified (see Figure 1) that fulfilled
the inclusion criteria and data extraction was carried out using a pre-defined
extraction table. Primary outcomes were the total costs, the direct costs, and
the indirect costs of type 2 diabetes and the respective per capita estimates of
these outcomes, as well as the impact of type 2 diabetes on employment prob-
abilities, income, wages and lost work days. Secondary outcomes comprised the
methodology used to assess the monetary costs of type 2 diabetes, the range of
cost factors included in the analysis, as well as the methodology used to assess
the labour market impact of diabetes. Further extracted information included
the year of publication, year of data collection, the time horizon, the country or
region studied, the data source, sample size and age as well as information on
whether the study distinguished between types of diabetes.
We present the COI study results in per capita values to facilitate comparability
across countries. For studies presenting overall population level estimates rather
than per capita costs information, we calculated those costs, whenever possible,
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Figure 1: PRISMA flowchart.
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using the diabetes prevalence mentioned in the respective study. If no total cost
estimate was presented but information on direct and indirect costs was available,
then direct and indirect costs were added up to produce a total cost estimate.
We converted costs into purchasing-power-parity (PPP) adjusted US$ estimates,
also referred to as international dollars and henceforth denoted with the $ sign,
in order to further increase comparability. Since some studies did not present the
data in the country’s local currency but in US$ or some other major currency, we
used the exchange rate given in the article to convert the estimates back into the
local currency. If no exchange rate was provided in the study itself, we used the
average exchange rate1 for the reported year. The PPP adjusted estimates for
the year 2011 were then calculated using the Campbell and Cochrane Economics
Methods Group Evidence for Policy and Practice Information and Coordination
Centre (CCEMG-EEPPI Centre) cost converter (Shemilt et al., 2010). For all
additional analyses carried out in the following sections only studies for which a
mean cost estimate was presented or could be calculated, were included. Further,
in the case of a study presenting estimates for more than 1 year, only the estimate
for the most recent year was used for the analysis. For studies presenting both
incremental and total cost estimates, only the incremental cost estimate was taken
into account.
Studies were further classified into two groups according to the level of eco-
nomic development of the investigated country—(1) high-income and (2) LMICs
(LMICs)—according to the historical World Bank income group classification of
the respective country in the year that data collection for the respective study
had taken place (World Bank, n.d.). Where necessary due to space constraints we
used abbreviations for country names, as detailed in Table A2 in the appendix.
In order to explore the factors involved in the variation of direct costs reported
in COI studies, we first plotted the direct per capita costs in relation to the
gross-domestic-product (GDP) per capita of the respective country and provided
an estimate of the relationship using linear regression. We then conducted an
exploratory regression analysis, with the annual direct cost per patient as the
dependent variable to investigate what other factors might explain the variation
in direct cost estimates. The set of independent variables comprised (1) the esti-
mation approach in each study, (2) the year of data used, (3) GDP per capita of
the studied country in international dollars, (4) an indicator of whether the study
was conducted in the USA, (5) an indicator of whether the study was deemed to
be nationally representative, and (6) a variable indicating whether the study had
explicitly taken diabetes-related complications into account. The year of the data
used was considered because the development of social security systems and treat-
1Midpoint exchange rate according to OANDA historical exchange rates—[http://www.
oanda.com/currency/historical-rates/]
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ment methods may affect how the direct costs evolve over time. We categorized
this variable into groups: studies using data from before 1995, 1995 to 1999, 2000
to 2004, 2005–2009 and 2010–2004. The dummy variable for studies on the USA
was included to account for the generally higher healthcare expenditures in the
USA compared with other HICs with similar per capita income levels (Laugesen
et al., 2011). Accounting for national representativeness should control for any
effects that might be driven by those studies that estimate costs for sub-national,
regional- or city-level population samples. Including an estimator for diabetes
complications should account for the possible underestimation of diabetes costs
in studies excluding complications. We exclude country estimates extracted from
multi-country studies in our preferred specification, as their inclusion would lead
to an over-statement of the cost effect of the estimation method employed in the
given multi-country study.
Results
Due to the differences in methodologies, we first present the findings on the iden-
tified COI studies and subsequently turn to studies on labour market outcomes.
Cost-of-illness studies on type 2 diabetes
Number of studies
We identified a total of 86 relevant COI studies (see Table A3 in the appendix for
a detailed description of the included studies), of which 62 focused on HICs, 23
on LMICs, and one multi-country study covered both HICs and LMICs. Studies
in LMICs increased over time, with the majority of the LMIC studies being
published between 2007 and 2014. Six of the selected studies were multi-country
studies, of which two (Kirigia et al., 2009; Smith-Spangler et al., 2012) did not
provide detailed cost estimates for every country in the study and one did not
provide a year for the estimated costs, so that we could not calculate estimates
in international dollars (Boutayeb et al., 2014). Therefore, we could not include
these particular studies in our country-specific analysis.
Regional distribution
In terms of geographic regions, most studies were carried out on countries in Latin
America and the Caribbean (n=38) and Europe (n=37), followed by the USA and
Canada (n=26), East Asia and Pacific (n=11), the Middle East and North Africa
(n=5), South Asia (n=4), Sub-Saharan Africa (n=4) and Australia (n=1). The
number of countries studied is higher than the number of articles reviewed due to
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four multi-country studies (Abdulkadri et al., 2009; Barceló et al., 2003; Boutayeb
et al., 2014; Jönsson, 2002), estimating costs for multiple countries. The USA
was the most studied country (n=19), followed by Canada (n=7) and Germany
(n=5). Mexico (n=6) and China (n=4) were the most frequently studied LMICs.
Data sources
Especially in LMICs, self-administered surveys represented a popular method to
retrieve data on the cost of diabetes. These were mostly limited regionally, i.e. to
a city or hospital, and usually only representative of these regional populations
with diabetes but not of a national population. In HICs, databases of insurance
and healthcare providers were the main source of information in most studies.
These data tended to be representative either at a national or at some sub-
national level. As a result, the size of the samples in HICs was mostly between
1,000 and several million. By contrast, studies in low- and lower-middle-income
countries were generally characterized by smaller sample sizes, ranging from 35
(Suleiman et al., 2006) to about 2,433 (Yang et al., 2012) in the studies reviewed
here.
Variation in costing approaches
As discussed in more detail in Text Box 1, a range of costing approaches are used
in the COI literature. Figure 2 shows that the most common costing method for
the direct costs of diabetes in HICs was the sum-all medical approach for people
with diabetes without using control groups (Arredondo et al., 2007; Arredondo
et al., 2005; Arredondo et al., 2011b, 2004; Barceló et al., 2003; Bjegovic et al.,
2007; Boutayeb et al., 2014; Brandle et al., 2003; Camilo González et al., 2009;
Chi et al., 2011; Condliffe et al., 2014; Horak, 2009; Jönsson, 2002; Kirigia et al.,
2009; Lau et al., 2011; Lee et al., 2006; Lucioni et al., 2003; Maciejewski et al.,
2004; Martin et al., 2007; Morsanutto et al., 2006; Nakamura et al., 2008; Nolan
et al., 2006; Ohinmaa et al., 2004; Oliva et al., 2004; Peele et al., 2002; Pohar
et al., 2007b; Redekop et al., 2002; Ringborg et al., 2008; Zhou et al., 2005).
The disease-attributable costing approach (Abdulkadri et al., 2009; Ballesta
et al., 2006; Bastida et al., 2002a; Buescher et al., 2010; Dall et al., 2003; Davis
et al., 2006; Honkasalo et al., 2014; Johnson et al., 2006; Lin et al., 2004; Mata
et al., 2002; Rodríguez Bolaños et al., 2010; Simpson et al., 2003; Solli et al.,
2010; Suleiman et al., 2006; Tunceli et al., 2010) and the attributable-fraction
approach were also used widely, though mainly in the USA (Bolin et al., 2009;
Dall et al., 2008; Dall et al., 2010; Dawson et al., 2002; Honeycutt et al., 2009;
Leśniowska et al., 2014; Schmitt-Koopmann et al., 2004).
The incremental cost approach was applied primarily in studies on HICs (Birn-
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baum et al., 2003; Bruno et al., 2012; Chodick et al., 2005; Durden et al., 2009;
Esteghamati et al., 2009; Honeycutt et al., 2009; Köster et al., 2006, 2011; Köster
et al., 2012; Linden et al., 2009; Marchesini et al., 2011; Norlund et al., 2001;
O’Connell et al., 2012; Pohar et al., 2007a; Ramsey et al., 2002; Ricordeau et al.,
2003; Rodbard et al., 2010; Smith-Spangler et al., 2012; Trogdon et al., 2008;
Tunceli et al., 2010; Wirhn et al., 2008; Yang et al., 2012).
For LMICs, the survey approach was the most used (Biorac et al., 2009; Chan
et al., 2007; Chatterjee et al., 2011; Druss et al., 2001; Elrayah-Eliadarous et
al., 2010; Javanbakht et al., 2011; Khowaja et al., 2007; Al-Maskari et al., 2010;
Ramachandran et al., 2007; Tharkar et al., 2010; Wang et al., 2009a, 2010, 2009b).
By contrast, almost all indirect cost assessments followed the same methodol-
ogy, i.e. the human capital approach. This approach considers all forgone labour
earnings of a patient or caregiver that are attributable to diabetes. A minor-
ity of three studies (Chang, 2010; Gyldmark et al., 2001; Tharkar et al., 2010),
estimated the indirect costs using the WTP approach, which tries to measure
how much individuals would be willing to pay to reduce the risk of an illness
(Segel, 2006), here diabetes (or certain complications associated with it). One of
the studies included WTP estimates in addition to the direct and indirect costs
measured by the human capital approach (Tharkar et al., 2010), but did not in-
clude the WTP estimate in the overall cost estimate, while the other two studies
estimated exclusively the WTP (Chang, 2010; Gyldmark et al., 2001).
Study perspective
Studies also varied in their perspective, again compromising direct comparability
of the cost estimates across studies. Overall, most studies either took a societal
(n=32) or healthcare system perspective (n=48). The former generally takes
into account the direct and indirect monetary costs that arise to society, including
costs to the healthcare system, costs due to lost productivity and sometimes OOP
costs (Segel, 2006). The latter was especially common in HICs where many studies
assessed the cost of diabetes to private or public health insurances. In LMICs,
studies often took the patient perspective (n=5), estimating OOP expenditures
and in some cases productivity losses, directly arising to the diabetes patient.
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Figure 2: Number of COI studies, by costing approach and income group.
High−income Low− and middle−income
20
19 19
3
2
8
3 3
10
0
5
1
0
1
5
2
0
S
u
m
−
A
ll 
M
e
d
ic
a
l
S
u
m
−
D
ia
g
n
o
s
is
 S
p
e
c
if
ic
R
B
/m
a
tc
h
in
g
S
u
rv
e
y
W
T
P
S
u
m
−
A
ll 
M
e
d
ic
a
l
S
u
m
−
D
ia
g
n
o
s
is
 S
p
e
c
if
ic
R
B
/m
a
tc
h
in
g
S
u
rv
e
y
W
T
P
Study approach
N
u
m
b
e
r 
o
f 
s
tu
d
ie
s
Notes For LMICs no willingness to pay (WTP) study is counted, because the only study
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Text box 1 COI methodologies
Methodologies for COI studies can broadly be categorized into two main categories:(1) estimat-
ing the total disease costs and (2) estimating the incremental costs (Akobundu et al., 2006).
Studies can then be divided further according to the specific approach used for estimation. Our
categorization builds on that by Akobundu et al. (2006) in their review of COI methodologies.
1. Total disease costs
a) Sum-All Medical: captures all medical expenditures of a person diagnosed with
diabetes, irrespective of the relation of the expenditures with diabetes.
b) Sum-Diagnosis Specific: includes the costs that are related to diabetes. This can be
done by using a disease-attributable costing approach, using administrative claims
databases to identify the cost of diabetes by respective International Statistical
Classification of Diseases and Related Health Problems (ICD) codes that link the
expenditures to a primary or secondary diagnosis of diabetes as the reason for the
healthcare utilization. Alternatively, a similar technique used at the population
level is the attributable-fraction approach, where the relative contribution of, e.g.
diabetes, to the risk of developing another disease (e.g. renopathy or cardiovascular
disease) is used to determine how much of the costs of this disease can be attributed
to diabetes.
c) Survey approach: while not specifically mentioned by Akobundu et al. (2006), for
this review we create a separate category capturing studies using surveys of people
with diabetes. This category differs from the two approaches a) and b) above in
that estimations rely solely on the individual, reported experience of people with
diabetes, without use of any diagnostic data at an aggregate level. The survey
approach was also used as a separate category in the earlier review on diabetes
COI studies by Ettaro et al. (2004).
2. Incremental disease costs
There are two main approaches for the estimation of incremental medical costs:
a) Regression approach: a statistical technique which can account for observable dif-
ferences between the group with diabetes and the control group (i.e. those without
diabetes) to find—ideally—the independent effect of diabetes on healthcare costs.
The differences typically accounted for are age, region and gender.
b) Matching approach: uses a control group to directly compare those with diabetes
to those without diabetes after matching each person of the ’treatment’ group to
a ’similar’ person of the control group, using various categories like age, region
and gender to—again—find the independent effect of diabetes on healthcare cost
(Akobundu et al., 2006).
All of the above approaches can be used in prevalence or an incidence based study. In the former
case the costs of diabetes are estimated for a certain point in time, typically one year, while the
latter approach estimates costs over a person’s lifetime or several years, always starting with
the point at which the disease is diagnosed. Both approaches may also be combined in studies
estimating the future cost burden of type 2 diabetes by first taking a prevalence approach to
calculate current costs and then using predictions about future diabetes incidence rates to arrive
at an estimate of diabetes costs at a certain point in the future.
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Costing components
Of the 75 studies that reported the cost components they used to estimate direct
costs, 72 took into account outpatient hospital visits, 70 inpatient hospital visits,
63 physician visits, 58 drug costs, 51 laboratory costs for diagnostic tests and
check-ups, 37 equipment costs and 21 non-medical and transportation costs. A
total of 46 studies had at least included the costs of hospital, outpatient and
physician visits as well as drugs (see Table A4 for a detailed description of cost
components used in each study).
Cost estimates of diabetes using a prevalence approach
Two basic epidemiological approaches exist for the estimation of COI, and they
are not directly comparable. The incidence approach follows people with diabetes,
usually starting with their diagnosis at a common base year, estimating yearly
costs for a sample of people at the same disease stage, finally giving an estimate
of diabetes costs over a certain time period, such as from diagnosis to death or
over a distinct period of, for example, 10 years. This approach can also document
how costs of diabetes change and develop over the progression of the disease (Larg
et al., 2011). By contrast, the prevalence approach estimates the costs of diabetes
for a cross-section of people with diabetes at a certain point in time, normally a
year, who are at different stages of the disease. It is most suitable for assessing
the total economic burden of diabetes at a certain point in time. Due to this
difference in time periods and the data used, the estimates of prevalence-based
studies are not directly comparable with those of incidence-based studies. Hence,
we present the cost estimates, starting with the prevalence approach.
Table 2 shows the range of direct cost estimates by estimation approach and
income status. As can be observed, direct cost estimates varied widely, both be-
tween and within the different estimation approaches. Cost estimates for direct
costs, irrespective of the costing method applied and the cost components in-
cluded, ranged from $242 for Mexico (Arredondo et al., 2005) in 2010 to $11,917
for the USA (Condliffe et al., 2014) in 2007. Also, studies from LMICs generally
indicated smaller direct costs than studies from HICs.
For indirect costs, studies using the human capital approach estimated costs
ranging from $45 for Pakistan (Khowaja et al., 2007) in 2006 to $16,914 for the
Bahamas (Barceló et al., 2003) in 2000. Three studies estimated indirect costs
by using the WTP approach and found costs ranging from $191 in a study on the
WTP for a health insurance for type 2 diabetes in Denmark in 1993 (Gyldmark
et al., 2001), a WTP $4,004 per year for a cure of type 2 diabetes (Chang, 2010)
in Taiwan and an annual payment of $4,737 to halt disease progression/prevent
future complications of diabetes in India (Tharkar et al., 2010).
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Societal costs of type 2 diabetes, which are estimated by studies combining
direct and indirect costs, ranged from $544 in a study on the economic costs of
diabetes in Iran (Esteghamati et al., 2009) in 2001 to $18,224 for the Bahamas
(Barceló et al., 2003) in 2000.
In order to improve the cross-country comparability of the costs of diabetes
we plotted the results from studies providing a direct per capita cost estimate
against the GDP per capita estimate of the respective country (we limited this
comparison to studies using samples representative of their entire population).
Figure 3 confirms the expectation that costs do increase with economic wealth:
GDP per capita explains about one-third of the variation in cost estimates (see
r2 in Figure 3). Also, studies on the USA seem to estimate costs consistently
higher than would be expected on the basis of its GDP per capita.
The USA, however, spend consistently more than what would be expected on
the basis of its GDP per capita. Again, the wide variation in estimated costs
for many countries underscores the point that the studies need to be contextual-
ized and may not be directly comparable per se. On the whole—though by no
means always—the matching and regression as well as the sum-diagnosis specific
approaches appear to produce lower cost estimates than especially the total cost
results, particularly so for HICs. In an inevitably crude attempt to quantita-
tively explore the driving factors behind the heterogeneity in cost estimates, we
estimated a simple linear regression model with per capita direct costs as the
dependent variable; explanatory variables included GDP per capita, the estima-
tion approach employed by the study, the number of included cost components,
a dummy for studies carried out in the USA, the year of data collection, the
representativeness of the study and if the study included diabetes complications
as explanatory variables. The results, displayed in Table 2, show a strong re-
lationship between GDP per capita and expenditures for diabetes, with every
additional international dollar in per capita GDP translating into an average in-
crease in direct diabetes expenditures of about $0.04. The estimation approach
is not found to matter significantly, nor is the year of study. Estimates from
USA studies put the costs at over $3,000 higher (on average) than studies from
other countries, indicating that costs in the USA may indeed be unusually high.
The number of costing components and the inclusion of complications likely also
explain some of the variance in estimates, although they are just below and above
the 10% significance level, respectively. Overall, the included independent vari-
ables explain about 56% of the variation in direct cost estimates. In a sensitivity
analysis, we included the results from multi-country studies providing country
estimates in the regression analysis. The only major difference to the presented
analysis is that the inclusion of complications as well as the number of included
cost components were now significant at the 1% and 5% significance level, re-
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Table 1: Summary of direct costs by estimation approach and income status in
international dollars $ (2011) for prevalence-based studies.
High-income countries Low- and middle-income countries
Sum-
all
med-
ical
costs
Sum-
diagnosis
spe-
cific
RB /
match-
ing
own
sur-
vey
Sum-
all
med-
ical
costs
Sum-
diagnosis
spe-
cific
RB /
match-
ing
own
sur-
vey
Min 1117 907 264 1495 242 662 443 456
Max 11917 9346 8306 5585 4129 4672 1136 3401
N 25a 19a 18 3 27a 5a 2 10
Notes a Includes country estimates from multi-country studies; RB Regression based
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spectively. The effect size and significance of the other estimates did not change
considerably.
The sensitivity of the cost results to the estimation approach was also examined
by two studies that investigated the effect of different estimation techniques in
diabetes COI studies. Honeycutt et al. (2009) compared the use of a regression-
based and an attributable-fraction approach and found that the cost estimate of
the former exceeded the latter by 43%. Tunceli et al. (2010) compared the match-
ing and the diabetes (disease)-attributable costs approach and found a 14–29%
higher cost estimate using matching, depending on the assumptions used. Both
studies concluded that an incremental cost approach results in a higher, and likely
more exact, estimate of the direct costs of diabetes than disease-attributable ap-
proaches. The authors attributed this to the fact that a regression or matching
approach can assign costs to diabetes that cannot be linked to diabetes other-
wise. Those approaches are therefore in a position to account for all costs of
co-morbidities caused by diabetes, while this is not automatically the case with
the other approaches.
Direct and indirect costs of diabetes
Comparing the relative importance of direct and indirect costs across countries
may provide some information regarding the underlying drivers of costs due to
diabetes in different countries. For instance, a higher ratio of direct to indirect
costs may indicate that the higher direct expenditures have led to better treat-
ment and less complications and thereby have reduced the productivity losses due
to diabetes. We therefore plotted direct against indirect costs from studies that
provided both estimates and drew a 45°line depicting the equal share of direct
and indirect costs (see Figure 4). Studies above the line found higher direct costs
compared to indirect costs and studies below the line found higher indirect costs
compared to direct costs.
Most studies found a larger share for direct costs in comparison with indirect
costs. This is especially true for HICs, where only a study on Sweden (Bolin et al.,
2009) found a larger share for indirect costs. For LMICs, a study on Colombia
(Camilo González et al., 2009) found considerably higher indirect costs, as did
the multi-country study of Barceló et al. (2003) and a study on various countries
in the African region (Kirigia et al., 2009), which both found higher indirect costs
for almost every country in the study and also on average for the entire region,
represented as the mean overall study estimate in Figure 4. Both studies used
similar approaches to estimate costs, and indirect cost estimates were likely so
high because evidence from only a few countries within the region was used as a
basis for estimating indirect costs for every other country in the respective study.
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Figure 3: GDP to direct costs ratio by estimation approach.
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Table 2: Relationship between direct costs and study characteristics (robust linear
regression).
Estimate Std. Error
Constant 2133 1773.922
GDP per capita ($) 0.045∗∗ 0.017
Estimation Approach
Sum-All medical (Ref.)
Sum-Diagnosis Specific −413.880 528.766
RB/matching −719.868 526.896
Survey −689.806 671.020
At least four costing components 702.966∗ 403.968
USA study 3111.067∗∗∗ 533.534
Year of study
<1995 (Ref.)
1995-1999 −1744.799 1632.498
2000-2004 −816.647 1586.966
2005-2009 −1021.685 1592.595
2010-2014 −2744.739 1839.689
Study representative −598.670 409.070
Complications 666.803 414.727
R-squared adj. 0.559
N 70
Notes Standard errors in parenthesis. Ref. reference category. ∗ p < 0.10, ∗∗
p < 0.05, ∗∗∗ p < 0.01.
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Further, the studies took the countries’ per capita gross national product as a
proxy for earnings, which might have led to an over-estimation of the indirect
costs (Kirigia et al., 2009).
Overall, no clear pattern emerges that would indicate that in LMICs indirect
costs would be higher than direct costs due to their less extensive healthcare sys-
tems, or that HICs would be able to prevent indirect costs as a result of their
higher healthcare spending. For instance, while some studies indicated that
middle-income countries (MICs), such as Colombia and Mexico, have higher in-
direct costs, studies on China, Pakistan and, again, Mexico showed the opposite.
Difficulties in measuring costs could be one of the main reasons for the hetero-
geneity in results even for the same country and may make a comparison of direct
and indirect costs difficult. In particular in LMICs, direct healthcare expenditures
may be low due to limited availability and access to healthcare, hence direct costs
would be higher if more treatment options were available. Indirect costs may also
be incorrectly measured, for example the use of the human capital approach—
which estimates the potential instead of the actual lost production, e.g. assuming
that a sick individual cannot be replaced by a previously unemployed individual,
even though in reality production losses may only be temporary until the em-
ployer has found a replacement—may lead to an overestimation of the losses in
productivity (Segel, 2006).
Studies using the incidence approach
The four studies that used an incidence approach (see Table 3) estimated the
cost of diabetes either over a person’s lifetime (Birnbaum et al., 2003; Camilo
González et al., 2009) or over a certain period after diagnosis (Johnson et al.,
2006; Martin et al., 2007). Camilo González et al. (2009) modelled the lifetime
(direct and indirect) costs of a typical diabetes patient in Colombia, arriving at a
mean cost estimate of $54,000. The second study providing lifetime estimates by
Birnbaum et al. (2003), estimated incremental lifetime healthcare costs for USA
females with diabetes of $283,000.
Two studies followed patients over a limited time period and found different
patterns in the development of type 2 diabetes-attributable healthcare costs. In
Germany costs increased from $1634 in the first year after diagnosis to $4881 in
the seventh year (Martin et al., 2007). In Canada, Johnson et al. (2006) found
the highest costs in the year of diagnosis with $7635, up from $2755 the year prior
to diagnosis. In the year after diagnosis costs decreased to $4273 and then only
increased slightly to $4618 in year ten. In Germany and Canada, costs related
to complications or hospital visits were the most important components and in
Germany increased steadily over time. In Canada costs related to prescriptions
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Figure 4: Direct and indirect cost relation in studies estimating total costs of type
2 diabetes.
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increased the most.
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Table 3: Incidence studies on the costs of diabetes
Ref. Country Time horizon Population Approach Results
Johnson et al.
(2006)
Canada 1992–2001 Incidence T2D patients from
Saskatchewan Health’s admin-
istrative database in Canada
Sum-all medi-
cal
Highest total healthcare
costs at year of diagnosis
with CAN$7343 ($7635),
then increased from a low of
CAN$3880 ($4034) 3 years
after diagnosis to CAN$4441
10 years thereafter ($4618).
Camilo
González et
al. (2009)
Colombia 32 years Hypothetical average
Columbian T2D patient
Sum-all medi-
cal
Total lifetime costs (32 year pe-
riod) of average diabetes pa-
tient, including direct and in-
direct costs, 57.565 million
Colombian pesos ($54,351).
Martin et al.
(2007)
Germany 1995–2003 Newly diagnosed T2D patients
from randomly drawn practices
across Germany
Sum-all medi-
cal
EUR 1,288 ($1635) for the first
treatment year after diabetes
diagnosis and increased to EUR
3845 ($4880) in the seventh
year.
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Table 3: Incidence studies on the costs of diabetes
Ref. Country Time horizon Population Approach Results
Birnbaum et al.
(2003)
United States 1997–1998 Women employed by nation-
wide operating company and
hypothetical women above age
64 receiving Medicare
RB / matching $282973 incremental lifetime
direct healthcare costs, us-
ing incidence-based, steady-
state methodology.
T2D type 2 diabetes
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Country level costs prediction studies
Four studies projected costs of diabetes over a certain period of time (Davis et
al., 2006; Lau et al., 2011; Ohinmaa et al., 2004; Wang et al., 2009b), making
assumptions about the future development of diabetes prevalence and population
ageing (see Table 4). For Canada, a 1.7-fold increase from 2000 to 2016 (Ohinmaa
et al., 2004) and a 2.4-fold increase from 2008 to 2035 in diabetes healthcare
costs was estimated (Lau et al., 2011). Taking a healthcare system perspective,
both studies found that the estimated increase would be mostly driven by an
ageing population. For Australia, Davis et al. (2006) estimated a 2.5- to 3.4-fold
increase in diabetes attributable healthcare costs from 2000 to 2051, depending
on the underlying assumptions about population ageing and diabetes prevalence
rates. For China, Wang et al. (2009b) extrapolated total costs of diabetes from
the year 2007 to 2030, estimating the costs of diabetes to increase 1.8-fold, solely
accounting for the expected increase in prevalence.
The impact of diabetes on employment probabilities and
productivity
Besides studies that determined the cost of diabetes by costing related expendi-
tures, another body of research has investigated—using econometric techniques—
the impact of diabetes on ’productivity’, a term used here to comprise outcomes
including employment probabilities and lost work days and income or earnings.
A recent study systematically reviewed evidence on the impact of diabetes on the
ability to work, focusing on studies assessing the impact of diabetes on early re-
tirement, lost work hours, absenteeism and presenteeism (Breton et al., 2013). We
focused particularly on studies exploring the impact of diabetes on employment
probabilities and earnings—both issues that were not covered in the mentioned
review—and we took a more detailed look at the empirical challenges posed by the
issue of endogeneity (see page 215 in the Appendix for a more detailed discussion
of endogeneity).
Tables 5 and 6 synthesize the relevant information from the 23 identified stud-
ies on the effect of diabetes on employment and other labour market outcomes.
Almost all studies were conducted on HICs, mainly the USA (n=13) and Euro-
pean countries (n=4). Only one study focused on a LMIC investigating the effect
of diabetes on labour income in China.
Employment probabilities
Most studies examined the impact of diabetes on employment probability (n=17),
applying a range of econometric techniques. These have evolved over time, and
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Table 4: Country level costs prediction studies
Ref. Country Population Approach Time
horizon
Results
Davis et
al. (2006)
Australia Australian
popula-
tion
Sum
diagnosis
Specific
2000–
2051
If age and sex spe-
cific prevalence re-
mains unchanged a
2.5-fold increase; if
age and sex spe-
cific prevalence al-
lowed to change as
well a 3.4-fold in-
crease.
Ohinmaa
et al.
(2004)
Canada Canadian
popula-
tion
Sum-all
medical
costs
2000–
2016
1.7-fold increase.
Lau et al.
(2011)
Canada Four
Alberta
Health
and
Wellness
databases
Sum-all
medical
costs
2008–
2035
2.4-fold increase.
Wang
et al.
(2009b)
China In pa-
tients
and out-
patients
in 20
hospitals
Own sur-
vey
2007
and 2030
(projec-
tion)
Increase from $73
billion in 2007
to $132 billion
in 2030 (1.8 fold
increase).
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more recent studies took into account the possibility that diabetes might be
endogenous: it is conceivable that especially personal traits such as motivation
and drive could influence the propensity to develop type 2 diabetes as well as
a persons’ job market opportunities. Further, being employed or unemployed
could also lead to changes in lifestyles, due to changes in income, stress or leisure
time, that could themselves affect the chances of developing diabetes (Brown
et al., 2005b). Of the studies that tried to account for this problem (Brown
et al., 2005b; Harris, 2009; Latif, 2009; Lin, 2011; Minor, 2011; Zhang et al.,
2009), the majority used an instrumental variable (IV) technique. This approach
allows for the consistent estimation of the effect of diabetes on employment if a
variable can be found that is causally related to diabetes without affecting the
employment probabilities through any other unobserved pathway apart from its
effect on diabetes (see Text Box 1). In the case of type 2 diabetes, all studies used
the family history of diabetes as an IV to exploit the fact that the development
of type 2 diabetes is much more likely for individuals whose biological parents
have also had diabetes. It is argued that, while controlling for education, age and
other observable demographic and socioeconomic factors (e.g. wealth, regional
and ethnic differences and the number of children in the household), having a
family member with diabetes should not affect the person’s employment status
or other labour market outcomes, while strongly predicting the onset of type 2
diabetes.
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Table 5: Studies estimating the relationship between diabetes and employment (2001 – 2014)
Ref Survey year Country Age Effect on employment
Males Females
Harris (2009) 1999-2000 Australia >24 Exogenous: 10.8 percentage
points reduction to be in labour
force; endogenous: 7.1 percent-
age points reduction and test
indicates endogeneity.
Exogenous: 10 percentage
points to be in labour force;
endogenous: Nine percentage
points reduction and test
indicates endogeneity
Zhang et al.
(2009)
2001, 2004-2005 Australia 18-64 50-64: 11.5 percentage points
less likely to be in labour force;
18-49: 3.9 percentage points
less likely, all effects increase
when other chronic diseases are
present.
No significant effect for diabetes
alone; significant negative ef-
fect if other chronic diseases are
present.
Latif (2009) 1998 Canada 15-64 Exogenous: 19 percentage
points less likely to be em-
ployed; endogenous: not
significant and positive and
test indicates endogeneity.
Exogenous: 17 percentage
points less likely to be em-
ployed, endogenous: not
significant and positive and
test indicates exogeneity.
Kraut et al.
(2001)
1983-1990 Canada 18-64 With complications 2 times less likely to be in labour force; no
significant effect on employment for those in labour force.a
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Table 5: Studies estimating the relationship between diabetes and employment (2001 – 2014)
Ref Survey year Country Age Effect on employment
Males Females
Norlund et al.
(2001)
1992-1993 Sweden >24 14.2 percentage points higher retirement rate (22.9 compared to
8.7).a
Alavinia et al.
(2008)
2004 Sweden, Den-
mark, Nether-
lands, Ger-
many, Austria,
Switzerland,
France, Italy,
Spain, Greece
50-65 For whole dataset: no effect of diabetes on being unemployed, but
increased odds ratio of 1.33 on being retired. No information on
effects by country.a
Lin (2011) 2005 Taiwan 45-64 Exogenous: 9 percentage points
less likely to be employed; en-
dogenous: 19 percentage points
less likely to be employed; test
on whole sample indicates endo-
geneity.
Exogenous: 11 percentage
points less likely to be em-
ployed, endogenous: not
significant and negative.
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Table 5: Studies estimating the relationship between diabetes and employment (2001 – 2014)
Ref Survey year Country Age Effect on employment
Males Females
Brown et al.
(2005b)
USA >44 Exogenous: 7.4 percentage
points less likely to be em-
ployed; endogenous: 10.6 per-
centage points less likely but
test indicates exogeneity.
Exogenous: 7.5 percentage
points less likely to be em-
ployed; Endogenous: no signifi-
cant effect found and test indi-
cates endogeneity.
Minor (2011) 2006 USA >19 at diagno-
sis
Exogenous: 25.2 percentage
points less likely to be em-
ployed, endogenous: 45.1 per-
centage points less likely to be
employed.
Vijan et al.
(2004)
1992-2000 USA 51-61 More likely to be retired in 1992 (adjusted OR 1.3). Over 8 years
follow up spent 0.14 incremental years in retirement.a
Bastida et al.
(2002a)
1996-1997 USA >44 7.5 percentage points less likely
to be employed.
No significant effect on employ-
ment probabilities found.
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Table 5: Studies estimating the relationship between diabetes and employment (2001 – 2014)
Ref Survey year Country Age Effect on employment
Males Females
Brown et al.
(2011)
2008 USA 35-64 Diabetes negatively related
to employment (5 percentage
points reduction); better di-
abetes management (HbA1c)
positively affects employment
probabilities; HbA1c lowering
of 10% increases employment
probability by 0.44 percentage
points.
No significant effect on employ-
ment probabilities found.
Tunceli et al.
(2005)
1992,1994 USA 51-61 9 percentage points less likely
to work without complications
controlled for, with complica-
tions controlled for 7.1 percent-
age points less likely.
5.9 percentage points less likely
to work without complications
controlled for, with complica-
tions controlled for 4.4 percent-
age points less likely but not
significant.
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Table 5: Studies estimating the relationship between diabetes and employment (2001 – 2014)
Ref Survey year Country Age Effect on employment
Males Females
Tunceli et al.
(2009)
1997-2005 USA 20-44 and 45-64 20-44: proportion with work limitations 3.1% higher; 45-64: pro-
portion not working is 8.1% higher; the proportion work disabled
is 3.4% higher; proportion with work limitations is 5.7% higher
(all compared to similar age group without diabetes).a
Valdmanis et
al. (2001)
1990-1995 USA Unemployment rate for persons with diabetes was 16% compared
with 3% among matched comparison group.a
Ng et al. (2001) 1989 USA >29 at diagno-
sis
3.6% less likely of being employed (exogenous), 12% for those with
complications.a
Minor (2013) 1979-2010 USA >14 Average reduction of employ-
ment probability of 28 percent-
age points; strongest employ-
ment penalty in first 5 years af-
ter diagnosis.
Average reduction of employ-
ment probability of 36 percent-
age points; strongest employ-
ment penalty in first 15 years
after diagnosis.
a No gender differentiation in study
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Because IV estimation has worse asymptotic properties than single equation
regression results when endogeneity is not an issue, studies tested for the existence
of endogeneity to determine which results to rely on for inference (Brown et
al., 2005b; Latif, 2009; Lin, 2011; Minor, 2011). Interestingly, the reviewed
studies found diabetes to be endogenous for either males (Latif, 2009) or females
(Brown et al., 2005b; Minor, 2011), but never for both. Further, the use of an
IV sometimes increased the estimated effect (Lin, 2011; Minor, 2011) whereas in
other cases the effect turned insignificant (Brown et al., 2005b; Latif, 2009). As
a result, no unambiguous conclusions can be drawn as to how endogeneity affects
diabetes and whether or not it causes biased estimates. Most of the relevant
studies also explored whether accounting for body mass index (BMI) or other
diabetes-related chronic conditions would substantially alter the result and found
this not to be the case (Brown et al., 2005b; Latif, 2009; Minor, 2013).
Overall, studies more commonly found a significant adverse impact of diabetes
on males, ranging from no effect in Canada (Latif, 2009) to a 19 percentage point
reduction in Taiwan (Lin, 2011). Conversely, no effect was found for women in
Taiwan (Lin, 2011), Australia (Zhang et al., 2009) or for Mexican Americans in
Texas (Brown et al., 2005b). However, a 45% decrease in employment probabili-
ties was observed for women in the USA (Minor, 2011). Extending the scope and
looking at how diabetes duration affected labour market outcomes, using pooled
longitudinal data from the USA, one study found that the main adverse effect on
employment probabilities materialized within the first 5 years after diagnosis for
men and 11–15 years after diagnosis for women (Minor, 2013).
Productivity
For earnings, no effect was found for Mexican-American men in Texas (Bastida
et al., 2002a), while the highest loss was found for women in the USA ($21,392
per year) (Minor, 2011). Again looking at diabetes duration, a wage penalty
was only found for USA men 6–10 years after diagnosis, reducing their wage by
about 18 percentage points (Minor, 2013). The only study on a non-HIC, China,
tried to tease out the psychological effect of a diabetes diagnosis on subsequent
labour income, finding a reduction of 22% in income for males, but not for females.
Further, those with an HbA1c between 8–10% experienced the most severe income
penalty (29%). The study further showed that the adverse effect of a diabetes
diagnosis was concentrated among the poorest third of the study population (Liu
et al., 2014). Another study investigated the effect on earning losses for caregivers
of people with diabetes in the United Kingdom (UK), finding a reduction of
$2,609 per year, while the person with diabetes experienced a loss of $1,744 per
year (Holmes et al., 2003). For income, a reduction of $6,250 per year was found
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for older USA adults who had been followed between the years 1992 and 2000
(Rivera et al., 2004). In terms of lost workdays and work hours due to diabetes,
the effects ranged from no impact on lost work days on older people (Rivera et
al., 2004) and females in the USA (Minor, 2011) to 3.2 lost work days in a USA
population within a 2-week period if complications were present (Ng et al., 2001).
In terms of the methodology used, these studies tended to rarely account for
endogeneity, and they mostly used standard regression or matching methods to
estimate the impact of diabetes. Three studies (Bastida et al., 2002a; Brown et
al., 2011; Minor, 2011) corrected for the possibility of a sample selection bias, to
account for systematic differences between the working population and the overall
population. Only one study additionally applied IV methods and found diabetes
to be endogenous, so that its effects on earnings were dramatically understated
using naive regression results (Minor, 2011). For working hours and days missed
due to illness, the same study found no indication of endogeneity. Only one study
applied an approach other than IV to account for endogeneity, using a difference-
in-difference model and exploiting a recent diagnosis of diabetes, which was the
result of the collection of biomarkers in the survey used, as a natural experiment
to measure how income developed between those who were newly diagnosed and
those without diabetes in the years following diagnosis (Liu et al., 2014).
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Table 6: Studies estimating the relationship between diabetes and other productivity outcomes (2001 – 2014)
Ref. Survey year Country Age Effect on other productivity outcomes
Males Females
Kraut et al.
(2001)
1983–1990 Canada 18–64 Effect on earnings only when
complications are present: re-
duced to 72% of total income of
controls.a
Liu et al. (2014) 2009, 2011 China not given 16.3% decrease in annual income; strongest effect for those in lower
income quintiles.a
Herquelot et al.
(2011)
1989–2007 France Male 40–50, fe-
males 35–50 in
1989
1.7 HR to transition from employed to disabled, 1.6 HR to be
retired, 7.3 HR to be dead; between age 35 and 60 each person
with diabetes lost 1.1 years of time in workforce.a
Leijten et al.
(2014)
2010–2013 Netherlands 45–64 Diabetes reduced work ability measured using Work Ability Index
(WAI) by 2%. No significant effect on productivity was found.a
Norlund et al.
(2001)
1992–1993 Sweden >24 9.4 more sick days.a
Holmes et al.
(2003)
1999 UK <65 GBP 869 lost earnings per year with diabetes; GBP 1300 for carers
of people with diabetes.a
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Table 6: Studies estimating the relationship between diabetes and other productivity outcomes (2001 – 2014)
Ref. Survey year Country Age Effect on other productivity outcomes
Males Females
Minor (2011) 2006 USA >19 at diagno-
sis
Exogenous: $2865 loss in earn-
ings per year, Endogenous:
$19655; Exogenous: 2 working
hours less per week, no signifi-
cant effect on missed workdays
per year, endogenous: no signif-
icant effect on working hours or
workdays missed.
Vijan et al.
(2004)
1992–2000 USA 51–61 Lost income of $50004 from 1992–2000 per capita or $6250 per
year, for whole USA population of same age $85.6 billion or $10.7
billion per year; people with diabetes more likely to have taken
sick days in 1992 (adjusted OR 1.3).a
Collins et al.
(2005)
2002 USA working age No significant effect on work days.a
Bastida et al.
(2002a)
1996–1997 USA >44 No significant effect on earn-
ings.
Women with diabetes earn 84%
less.
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Table 6: Studies estimating the relationship between diabetes and other productivity outcomes (2001 – 2014)
Ref. Survey year Country Age Effect on other productivity outcomes
Males Females
Brown et al.
(2011)
2008 USA 35–64 Wages reduced by 0.74% due
to diabetes; for every 10% re-
duction in HbA1c wages rise by
0.62%. HbA1c >8 was related
to decreasing wages.
No significant effect of diabetes
on female earnings; no effect
of blood sugar management for
women, HbA1c levels just below
6 to just above 7 were related to
lower wages.
Lenneman et al.
(2011)
2005–2009 USA >16 Lost earnings per year of $2146.a
Tunceli et al.
(2005)
1992, 1994 USA 51–61 No significant effect on number
of work days.
2.5 more lost workdays per year.
Valdmanis et
al. (2001)
1990–1995 USA 71% of the persons with diabetes had an annual income of less
than $20000 compared with 59% of the matched respondents.a
Ng et al. (2001) 1989 USA >29 at diagno-
sis
No significant effect on work
days for T2D, for those with
complications 3.2 days lost
within two weeks
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Table 6: Studies estimating the relationship between diabetes and other productivity outcomes (2001 – 2014)
Ref. Survey year Country Age Effect on other productivity outcomes
Males Females
Brown et al.
(2005a)
NA USA >45 For every dollar of labour income lost by adults with diabetes, a
further income reduction of $0.48 occurs in the community. Total
output reduction for upper bound estimate is $300 million for the
local economy.a
Minor (2013) 1979–2010 USA >14 No general effect of type 2 dia-
betes on wages; some evidence
of wage penalty of about 18%
6–10 years after diagnosis
No strong evidence found for
wage penalty for females
Notes T2D type 2 diabetes a No gender differentiation in study
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Discussion
The objectives of this systematic review were to identify new evidence on the
economic impact of type 2 diabetes that emerged since 2001 and extend the
scope of the review by including studies on the labour market impact of diabetes.
We identified studies from a great variety of countries, with large differences in
cost estimates across and within countries.
General findings and developments since the 2004 review of
diabetes COI studies
An obvious development since the last review is the emergence of COI studies on
LMICs. The economic burden related to diabetes found in these studies indicated
a strong direct impact on those affected by diabetes. This is reflected in the
substantial burden of OOP treatment costs incurred by patients (Arredondo et
al., 2007; Chatterjee et al., 2011; Elrayah-Eliadarous et al., 2010; Esteghamati
et al., 2009; Khowaja et al., 2007; Ramachandran et al., 2007; Smith-Spangler
et al., 2012; Suleiman et al., 2006; Tharkar et al., 2010; Wang et al., 2009a, 2010),
with considerable proportions of the annual income being spent on diabetes care.
This relative cost burden was generally higher for people with relatively lower
household incomes (Khowaja et al., 2007; Ramachandran et al., 2007; Tharkar
et al., 2010). Health insurance coverage had some protective effects against OOP
expenditures, but mainly for those with higher incomes, while the poor often
lacked coverage (Khowaja et al., 2007; Ramachandran et al., 2007; Tharkar et
al., 2010). Nonetheless, once people were covered by health insurance their risk
of incurring catastrophic expenditures decreased significantly (Smith-Spangler
et al., 2012). An important cost factor that was predominantly investigated in
studies on LMICs were non-medical costs for transportation, informal healthcare
or food which were found to considerably add to the experienced diabetes cost
burden (Chatterjee et al., 2011; Esteghamati et al., 2009; Tharkar et al., 2010;
Wang et al., 2009a,b).
In terms of the costing methodology applied in COI studies, the number of
studies estimating the excess costs of diabetes increased since the Ettaro et al.
(2004) review. Those studies either used regression analysis or matching to adjust
for the differences between people with diabetes and those without, accounting
at least for age and gender, but often also for other socioeconomic, geographic
and demographic differences. Other widely used approaches to estimate direct
healthcare costs from the perspective of the healthcare system or private insurance
included the disease-attributable and—slightly less frequently—the attributable-
fraction approach. For cost assessment in LMICs, studies often either estimated
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total healthcare costs or carried out self-administered surveys. While Ettaro et al.
(2004) recommended the use of disease-attributable approaches to arrive at more
exact estimates of the costs of diabetes, the evidence found in this review indicates
that using an incremental cost approach via matching or regression analysis could
provide more accurate results, due to its ability to capture costs otherwise not
directly traceable to diabetes. Nonetheless, the use of the estimation technique
always hinges on the availability of appropriate data, with regression or matching
analyses requiring information on people without diabetes to be used as a control
group. Therefore, the estimation approach needs to be tailored to the available
data.
Compared with the evidence reviewed by Ettaro et al. (2004), the field has
generally advanced with respect to the analysis of costs in different ethnic and
age groups. Two studies investigated differences between racial groups in the
USA, showing that while ethnic minorities spend less on diabetes healthcare than
Whites, this difference seems to be mainly based on differences in access to care
between Whites and Blacks or Hispanics (Buescher et al., 2010; Lee et al., 2006).
In terms of age, studies found an increase in healthcare costs with age as well
as with, in some cases, the duration of diabetes. A recurring problem was that
many studies did not distinguish diabetes types, making it difficult to exactly
attribute the costs to the respective diabetes types.
To explore the reasons for the wide heterogeneity in direct cost estimates across
studies, we performed a regression analysis, which indicated that an important
determinant for the cost variation across countries could be the economic wealth
of the country (proxied by GDP per capita), similar to what was found in a review
of indirect costs of various chronic diseases (Zhao et al., 2013a), possibly due to
differences in the availability and affordability of diabetes care between HICs and
LMICs (Cameron et al., 2009; Cameron et al., 2011).
Further, studies on the USA seem to estimate consistently higher costs than
studies on other countries, even when accounting for differences in GDP per
capita. The higher direct costs of diabetes estimated for the USA are in line
with the generally higher healthcare expenditures in the USA compared with
countries with similar income levels, and could be the result of exceptionally high
service fees (Laugesen et al., 2011) and prices paid in the USA healthcare system
(Lorenzoni et al., 2014; Squires, 2012).
Because of the small sample size on which our analysis was based, these results
must be interpreted with caution, and other factors could still be important.
For instance, other evidence suggests that different costing approaches have a
considerable effect on diabetes cost estimates (Honeycutt et al., 2009; Tunceli
et al., 2010). Furthermore, the perspective taken, different data sources and
populations investigated and decisions on the cost components included are likely
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important in explaining within-country heterogeneity. In particular, the inclusion
of diabetes complications and decisions about which complication(s) to include,
as well as the extent to which costs for these diseases are attributable to diabetes,
can significantly affect the results. Not all studies in the review provide extensive
information about how they include complications and some do not include them
at all.
Finally, the quality of the data used could have affected the cost estimates.
Many studies in LMICs relied on self-reported data from small household sur-
veys, limiting their generalizability and leading their results to be prone to recall
bias. Further, these studies often identified people with diabetes via their use
of healthcare institutions, which excluded a potentially important section of the
population in LMICs unable to access formal care, possibly leading to an overes-
timation of the average diabetes-related costs.
Labour market studies
Turning to the effects of diabetes on the labour market, the existing studies
showed, almost consistently, with the exception of Canada (Latif, 2009) and one
study on the USA (Minor, 2013), that the employment probabilities of men were
affected more adversely by the disease than those of women. However, while most
studies have tried to tentatively explain these gender differences, the reasons
for this have not been investigated in depth. The studies also showed that,
when interpreting this research, it is important to consider whether a study has
tried to account for unobservable factors or reverse causality, as otherwise the
results might be misleading. Nonetheless, all studies using IV techniques used
similar instruments to achieve identification, providing scope for further research
using different identification strategies to explore how endogeneity might affect
the results. What has been apparent is the lack of research on labour market
outcomes of diabetes in LMICs, with only one study investigating the effect of
diabetes on labour income in China (Liu et al., 2014). This deficit might be due
to a limited availability of suitable data sources containing sufficient information
to allow for a similar investigation of the topic.
The potential for rich, good-quality data sources to aid the investigation of the
economic impact of diabetes can be illustrated by the several studies that used
data from the Lower Rio Grande Valley in Texas. These studies demonstrate
the evolution of methodology and data from the use of single equation regression
models (Bastida et al., 2002a) to the use of IV methods (Brown et al., 2005b)
and—finally—biometric data on blood glucose values (Brown et al., 2011). While
the first two methods allowed the investigation of the general effect of diabetes
on employment probabilities, the latter was able to assess the impact accord-
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ing to how diabetes was managed by the patient, as proxied by the measured
biomarkers. The study found that the main adverse effect was due to having
diabetes regardless of how it was managed and that improvements in manage-
ment only had minor positive effects. The authors concluded that investments in
the prevention of diabetes would likely be more effective than improved diabetes
management.
The latter study and the study by Liu et al. (2014) also show how biometric
data (e.g. blood glucose values) can be used to arrive at a deeper understanding
of the economic effects of diabetes. Biometric information makes it possible to
investigate the impact of diabetes according to the severity of the disease and
also allows for the consideration of previously undiagnosed people with diabetes,
increasing the policy relevance of the research.
Comparison of COI and labour market studies: common
themes and lessons learned
The results of both fields, COI and labour market studies, show a considerable
adverse impact of diabetes in terms of costs to society, health systems, individuals
and employers and in terms of a reduction in the productive workforce and pro-
ductivity in general. Both research strands particularly indicate that the adverse
effects of diabetes increase with diabetes duration as well as with the severity
of the disease, judged by the high complication costs estimated in COI studies
and the larger employment and income penalties for those with a longer disease
duration or higher blood glucose levels.
Nonetheless, several lessons can be learned for each field from advancements
in the other field. Future COI studies would, for instance, benefit from the more
frequent use of biomarker data. This would allow for a more precise analysis
of the costs of diabetes according to the severity of the disease and help inform
researchers and policy makers about the possible economic effects of achieving
certain treatment goals, e.g. a reduction in blood glucose values.
Also, and in contrast to the labour market outcomes literature, the endogeneity
problem has hitherto not been addressed in any form in studies estimating direct
healthcare or productivity costs, despite it being an equally important challenge
in this domain. A possible bias could arise if some people developed diabetes as a
result of an unobserved accident or illness, likely resulting in an overestimation of
the costs. Endogeneity could also be introduced if people with diabetes became
poorer as a result of the disease and consequently were not able to spend as much
on their treatment as they would like to, leading to an underestimation of the true
monetary cost of diabetes. Furthermore, an endogeneity bias would be introduced
if diabetes was correlated with poverty so that diabetes prevalence would be
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disproportionately high in subgroups with less resources and consequently less
access to care. This would lead to an underestimation of the healthcare costs
of diabetes. Endogeneity in COI studies has recently been addressed for the
estimation of healthcare costs of obesity, suggesting that direct costs would have
been underestimated, had the study not accounted for endogeneity (Cawley et
al., 2012). It appears that, on the basis of the studies identified in our review, a
similar—worthwhile—approach could and should be applied to the case of type
2 diabetes.
Yet the labour market studies also stand to gain from adopting certain ap-
proaches that are more common in COI studies. To date, only few labour market
studies have used the incidence approach found for COI studies to follow people
with diabetes over a certain time period from their diagnosis onwards, in order
to further explore how the effect of diabetes on employment and productivity
measures develops over time.
Some further recommendations may be derived for future COI and labour
market studies on diabetes:
1. For COI studies the estimation of incremental costs—wherever possible—
appears to be most suitable for diabetes, as it more accurately accounts for
costs of co-morbidities and for less obviously related disease costs (Honey-
cutt et al., 2009; Tunceli et al., 2010). More information that can guide
researchers in their choice of methods already exists and should be referred
to when performing a COI study (Akobundu et al., 2006).
2. If possible, the use of convenience samples of people with diabetes visiting
a healthcare institution should be avoided, particularly in LMICs, as it
excludes those not able to visit a clinic for treatment due to economic
reasons, leaving out a potentially important proportion of diabetes patients.
3. The interpretation of the COI results always hinges on the amount of infor-
mation provided about, among others, the aim of the study, the perspective
adopted and the cost components included as well as the used estimation
approach. A discussion of how these choices might affect the estimates
should also be part of every COI study. Researchers should therefore con-
sult available guidance from the literature that sets out what information
should ideally be included in a COI study (Larg et al., 2011) to increase
the transparency and usability of their research.
4. For labour market studies more evidence from LMICs is needed. There is
scope for exploring existing household datasets from LMICs that contain
information on diabetes (Seuring et al., 2014). In some cases, panel data
are (or may become) available, which would allow the investigation of the
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effects of diabetes over time as well as to improve the degree of causal
inference by controlling for unobserved heterogeneity.
5. As for labour market studies, other ways of achieving identification should
be explored to reduce the reliance on IV methods using the family history
of diabetes as the sole instrument. The increasing richness of information
provided in recent data sets could be used to this effect, also taking into
account other quasi-experimental econometric methods (Craig et al., 2012).
Limitations
A possible limitation of this review is the decision to refrain from excluding stud-
ies based on certain quality criteria, such as study design, costing methodology,
sample size or reporting standards. This might have resulted in the inclusion
of lower quality studies with less reliable estimates, compromising the compara-
bility across countries, particularly between LMICs and HICs, as study designs
differed considerably. On the other hand, our overarching objective was to ensure
a truly globally comprehensive overview of the literature on the economic impact
of diabetes, including evidence from LMICs, which, for reasons often beyond the
control of the researchers, may have been of limited quality and thus would have
been excluded, had we applied stringent quality benchmarks. Further, any at-
tempt to apply a quality threshold would have faced the challenge of dealing with
the absence of a formal checklist to follow in critically appraising the quality of
COI studies. Rather than interpreting it as a limitation, we see the identifica-
tion and synthesis of LMIC studies as a unique added value of this review, when
compared to the Ettaro et al. (2004) review.
Notably, we also abstained from any language restrictions, which would have
particularly excluded evidence from Spanish speaking and Eastern European
countries. Taken together, these factors have resulted in a large number of in-
cluded studies, allowing for an (albeit exploratory) statistical investigation of
the heterogeneity in diabetes cost estimates as a complement to the narrative
analysis. We therefore feel that the advantages of refraining from too stringent
inclusion criteria more than outweigh the possible negative consequences of in-
cluding potentially lower-quality studies.
Further, our search was limited to studies after the year 2000. While for COI
studies a previous review covered the literature until 2000, this is not the case
for the literature on labour market effects of diabetes and we therefore cannot
exclude the possibility of having missed some relevant (if old) studies. We have
checked the references of our included labour market studies for any relevant
studies published before 2001. We could find only one relevant study from 1998
investigating how employment chances and family income were affected by di-
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abetes in the USA, comparing samples from 1976, 1988 and 1992 and finding
significant adverse effects of diabetes on employment probabilities but not on
family income (Kahn, 1998). The effect for women decreased somewhat between
1976 and 1992, while the effect increased for men. The study did not account
for the possible endogeneity of diabetes nor selection bias when estimating the
effects on income.
Conclusion
This review has provided an updated and considerably expanded picture of the
literature on the global economic impact of type 2 diabetes. The results show
a considerable impact of diabetes in terms of costs to society, health systems,
individuals and employers and in terms of a reduction in the productive workforce
and productivity in general. Studies on the costs of diabetes now provide evidence
from HICs as well as LMICs, using a variety of study designs to estimate the costs
of diabetes. The evidence indicates a particularly strong and direct economic
impact of type 2 diabetes on people’s livelihoods in lower-income settings. Studies
on labour market outcomes so far have been confined, almost exclusively, to HICs,
leaving space for further studies in LMICs to provide additional evidence of the
effect of diabetes in these countries. An issue not yet covered in diabetes COI
studies—in striking contrast to labour market outcome studies—has been the
possible bias introduced by endogeneity, providing an opportunity for advancing
research in this area.
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3 The impact of diabetes on
employment in Mexico
Pre-amble
The systematic review in Chapter 2 identified a paucity of studies on the labour
market impact of diabetes in developing countries. Further, even studies on
high-income countries (HICs) did not provide much information regarding the
heterogeneity of effects across different socioeconomic subgroups. There was no
evidence on how diabetes may affect those in the formal compared to the informal
labour market or across the wealth distribution. Further, it was unclear what the
effects were for people unaware of their disease.
This study will use cross-sectional data from a large household survey in Mex-
ico, assessing the impact of diabetes on employment probabilities. An instru-
mental variable (IV) strategy inspired by preceding studies from HICs is used to
account for the potential endogeneity of diabetes due to unobserved heterogeneity.
Especially personal characteristics such as ambition and family background could
affect both the probability to develop diabetes, in particular type 2 diabetes, and
the probability of being employed. The aim is to investigate if diabetes has a
causal effect on employment probabilities and to provide evidence for the sub-
group of those in the informal labour market and the relatively poor, populations
of particular relevance in middle-income countries (MICs).
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Abstract
This study explores the impact of diabetes on employment in Mexico
using data from the Mexican Family Life Survey (MxFLS) (2005), tak-
ing into account the possible endogeneity of diabetes via an instrumental
variable estimation strategy. We find that diabetes significantly decreases
employment probabilities for men by about 10 percentage points (p<0.01)
and somewhat less so for women—4.5 percentage points (p<0.1)—without
any indication of diabetes being endogenous. Further analysis shows that
diabetes mainly affects the employment probabilities of men and women
above the age of 44 and also has stronger effects on the poor than on the
rich, particularly for men. We also find some indication for more adverse
effects of diabetes on those in the large informal labour market compared to
those in formal employment. Our results highlight—for the first time—the
detrimental employment impact of diabetes in a developing country.
Introduction
Diabetes, similar to other conditions that have been coined “diseases of aﬄuence”,
has traditionally been seen as mostly a problem of the developed, more aﬄuent
countries. Only in recent years the awareness has been growing of the sheer size
of the problem in health terms (Hu, 2011; Yach et al., 2006). Mexico is one
example of a middle-income country that has seen diabetes rates increase sharply
over the last years, from about 7.5% in 2000 (Barquera et al., 2013) to 12.6% in
2013 (International Diabetes Federation, 2014). The high prevalence of diabetes
in Mexico reflects an epidemiological transition from a disease pattern previously
characterized by high mortality and infectious diseases to low-mortality rates
and non-communicable diseases (NCDs) affecting predominantly adults (Stevens
et al., 2008). This transition has likely been reinforced by nutritional changes
away from a traditional diet towards an energy dense, but nutritionally poor
diet with an increasing amount of processed foods and sugars (Barquera et al.,
2008; Basu et al., 2013; Rivera et al., 2004), a reduction in physical activity, as
well as what appears to be a particular genetic predisposition of many Mexicans
to develop type 2 diabetes (Williams et al., 2013). While many of the high-
income countries may be in a position to cope resource-wise with the healthcare
consequences of diabetes, this will be less so the case for Mexico and other low-
and middle-income countries (LMICs). The most recent cost-of-illness estimates
put the costs of diabetes to the Mexican society at more than US$778 million
in 2010, with a large part of these costs being paid out-of-pocket (Arredondo
et al., 2011a). While the above includes some estimate of indirect costs, meant
to capture the cost burden attributable to foregone productivity resulting from
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diabetes, there exists no rigorous, econometric assessment of the effect of diabetes
on employment probabilities for Mexico, as the research has thus far focused on
high-income countries (Bastida et al., 2002a; Brown et al., 2005b; Latif, 2009;
Lin, 2011; Minor, 2011; Vijan et al., 2004; Zhang et al., 2009).
There are several reasons to expect a significant adverse effect of diabetes on
employment probabilities in Mexico and that this effect might be stronger than
in high-income countries. In Mexico type 2 diabetes is increasingly affecting
people in their productive age, raising the possibility that a larger share of people
with diabetes will have to cope with debilitating complications already relatively
early in life (Barquera et al., 2013; Villalpando et al., 2010). Further, only a
minority of Mexicans appears to successfully manage their diabetes condition,
with as much as 70% of the people with diabetes having poor control over their
disease (Villalpando et al., 2010). In addition, many Mexicans are working in
the large informal economy1, possibly limiting their access to quality healthcare
and hence to appropriate treatment options. All these factors are likely to both
increase the risk of developing debilitating diabetes complications as well as to
reduce productivity as a result. Against this background, the aim of this study is
to investigate how diabetes affects employment probabilities in a middle-income
country such as Mexico. To the best of our knowledge this is the first such
paper on Mexico and indeed on any LMIC. We also investigate if the impact
of diabetes on employment probabilities differs across age groups and—again for
the first time in this field—by wealth, as well as between those formally and
informally employed.
The majority of the more recent studies on the labour market impact of dia-
betes tried to account for the possible endogeneity of diabetes using family history
of diabetes as an instrument. Endogeneity might arise due to reverse causality:
employment status and its effect on a person’s lifestyle may also influence the
odds of developing diabetes. A job with long office working hours might push a
person’s diet or exercise pattern towards a more unhealthy and sedentary lifestyle
due to reduced leisure time, increasing the person’s risk for diabetes. In addition,
unobserved factors, such as personal traits, could simultaneously influence a per-
son’s employment as well as his or her diabetes status and introduce an omitted
variable bias. A less ambitious person could be less productive in a job, increasing
the risk of being laid off, and he or she could simultaneously have only modest,
if any, exercise goals or healthy eating habits, thereby increasing the chances of
developing diabetes.
Brown et al. (2005b) estimated the impact of the disease on employment in
1996–1997 in an older population of Mexican Americans in the USA close to the
1In 2005 around 58% of the working population in Mexico were employed in the informal
sector (Aguila et al., 2011).
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Mexican border, using an IV strategy. They found diabetes to be endogenous for
women but not for men. The results of the IV estimation suggested no significant
effect on women which, compared to the adverse effect found in the univariate
probit model, indicated an overestimation of the effect for women when endo-
geneity was not accounted for. For men, the univariate probit estimates showed
a significant adverse effect of about 7 percentage points. Latif (2009) estimated
the effect of the disease on employment probabilities in Canada in 1998. Con-
trary to Brown et al. (2005b), he found diabetes to be exogenous for females and
endogenous for males; taking this into account he obtained a significant negative
impact on the employment probabilities for women, but not for men. Because the
simple probit model showed a significant negative effect for males, Latif (2009)
concluded that not accounting for endogeneity resulted in an overestimation of
the effect on male employment probabilities. Minor (2011) investigated the effect
of diabetes on female employment, among other outcomes, in the USA in 2006.
This particular study differed from earlier work in that it not only analysed the
effects of diabetes in general, but also of type 1 and type 2 diabetes separately.
The study found diabetes to be endogenous and underestimated if exogeneity was
assumed. In the IV estimates, type 2 diabetes had a significant negative effect on
female employment probabilities. For Taiwan, Lin (2011) found diabetes to be
endogenous, with the IV results showing significant changes in the employment
effect of diabetes. The impact was found to be significantly negative for men in
the IV model indicating an underestimation in the standard probit model, where
the diabetes coefficient was also significant but much smaller in size. For women,
no significant effect was found in the IV estimation after the probit model had
indicated a significant and negative impact of diabetes.
Accordingly, at least in some cases, there seems to be the risk of biased es-
timates of the impact of diabetes on employment, when exogeneity is assumed,
with an a priori ambiguous bias. Hence, our decision in this study to also assess
if diabetes is endogenous and how precisely taking account of endogeneity might
affect the estimates. In order to account for this possible endogeneity we use
data from the second wave of the Mexican Family Life Survey (MxFLS) from
2005, which not only provides information on people’s diabetes status and so-
cioeconomic background, but also on parental diabetes, enabling us to construct
an instrumental variable similar to what has been used in the previous literature
on high-income countries.2 The data also allows the extension of the analysis to
test if the inclusion of information on parental education as an additional control
variable affects the IV parameter estimates.
2Studies that have used the family history of diabetes as an instrument for diabetes are Brown
et al. (2005b) for a Mexican-American community, Latif (2009) for Canada, Minor (2011)
for females in the USA and Lin (2011) for Taiwan.
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Methodology
Dataset and descriptive statistics
The dataset used for the empirical analysis is the Mexican Family Life Sur-
vey (MxFLS). It is a nationally representative household survey which was con-
ducted in 2002 and 2005. We use data from the second wave in 2005, which
includes almost 40,000 individuals. Interviews were conducted with all household
members aged 15+, and information on a wide range of social, demographic, eco-
nomic and health related topics was collected (Rubalcava et al., 2008). While
there are more recent datasets available on Mexico, none of these provide as ex-
tensive information on parental characteristics as does the MxFLS which includes
information on parental diabetes and education status, even if parents were not
alive any more or were living in a non-surveyed household at the time of the
survey. Diabetes is self-reported and 3.7% of males and 5.1% of females report
a diagnosis by a doctor.3 Unfortunately we cannot—with the data at hand—
distinguish between the different types of diabetes. It can be assumed, however,
that about 90% of the reported diagnoses are due to type 2 diabetes, which is by
far the most common type of diabetes (Sicree et al., 2011). The sub-sample used
for analysis is limited to the age group of 15 to 64 years, which represents the
majority of the working population. To allow for heterogeneity in the coefficients
across gender, the sample has been split to estimate the male and female groups
separately.
The descriptive statistics presented in Table 7 suggest that the groups of re-
spondents with and without diabetes differ significantly in various aspects. Both
males and females with diabetes have a lower employment rate than their counter-
parts. This would suggest that diabetes has a negative impact on the employment
probabilities of both males and females with diabetes. However, since the groups
with diabetes are also significantly older and differ in terms of education, this may
be a spurious relationship. As a result, only a multivariate analysis will provide
more reliable information on how diabetes truly affects employment probabilities.
3 This is well below the estimated prevalence rate for 2013 of almost 12%. This is likely due
to the fact that, according to the International Diabetes Federation (IDF), more than half
of the people with diabetes in Mexico are undiagnosed and consequently did not report it
(International Diabetes Federation, 2014). Further, the sample in the survey at hand is
restricted to people between the age of 15 to 64, which does not match exactly with the
population the IDF used for the diabetes prevalence estimates (20 – 79). Hence, our used
sample includes a greater share of young people with a very low diabetes prevalence and
excludes people above 64 years of age, which likely have a higher than average prevalence
rate. Taken together, this—as well as a further increase in prevalence since 2005—should
explain the difference between the diabetes prevalence in our sample and the one estimated
by the IDF.
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Table 7: Summary statistics for males and females with and without diabetes
Males Females
Mean with diabetes Mean without diabetes p (t-test) Mean with diabetes Mean without diabetes p (t-test)
Employed 0.714 0.804 0.000 0.229 0.313 0.000
Age 50.945 35.016 0.000 48.955 34.717 0.000
Age 15–24 0.008 0.294 0.000 0.036 0.282 0.000
Age 25–34 0.043 0.232 0.000 0.076 0.250 0.000
Age 35–44 0.161 0.196 0.162 0.180 0.221 0.042
Age 45–54 0.392 0.166 0.000 0.366 0.159 0.000
Age 55–64 0.396 0.111 0.000 0.342 0.089 0.000
Rural 0.337 0.399 0.047 0.391 0.399 0.723
Small city 0.082 0.126 0.038 0.144 0.123 0.204
City 0.145 0.102 0.028 0.103 0.098 0.737
Big city 0.435 0.372 0.042 0.362 0.379 0.475
Southsoutheast 0.208 0.203 0.864 0.184 0.206 0.270
Central 0.243 0.184 0.017 0.231 0.195 0.062
Westcentral 0.173 0.213 0.124 0.191 0.210 0.343
Northeastcentral 0.196 0.177 0.446 0.209 0.186 0.236
Northwestcentral 0.180 0.223 0.112 0.184 0.202 0.355
No education 0.090 0.062 0.070 0.151 0.081 0.000
Primary 0.518 0.352 0.000 0.607 0.368 0.000
Secondary 0.231 0.308 0.009 0.171 0.314 0.000
High school 0.059 0.158 0.000 0.043 0.138 0.000
College or university 0.102 0.120 0.379 0.029 0.098 0.000
Indigenous 0.137 0.121 0.448 0.133 0.118 0.341
Married 0.812 0.535 0.000 0.663 0.539 0.000
Children (under 15) 1.118 1.510 0.000 1.207 1.600 0.000
Wealth 0.179 −0.010 0.003 0.004 −0.003 0.885
Diabetes father 0.180 0.071 0.000 0.146 0.079 0.000
Diabetes mother 0.251 0.107 0.000 0.236 0.113 0.000
Education parents 0.596 0.697 0.001 0.528 0.699 0.000
Formal employment 0.286 0.306 0.508 0.083 0.140 0.001
Informal employment 0.529 0.560 0.342 0.191 0.220 0.155
N 255 6031 445 7798
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Econometric specification
We first estimate a probit model with the following specification
Employedi = β0 + β1Diabetesi + β2Xi + ui (1)
where diabetes is assumed to be exogenous. Employedi takes the value of 1
if person i is employed and 0 if unemployed. Employment status is defined as
having worked or carried out an activity that helped with the household expenses
for at least ten hours over the last week. This explicitly includes those employed
informally, for instance people working in a family business.
Diabetesi denotes the main independent variable of interest, taking the value
of 1 if individual i has reported a diagnosis of diabetes and 0 otherwise.
Xi contains various control variables. Because no information on job history is
available in the data to adequately account for work experience, we need to rely
on the combination of age and education to proxy for work experience (Aaronson,
2010). The effect of age is captured through dummy variables for age intervals.
Education is taken into account by dummy variables indicating if the highest level
of schooling attained was either primary school, secondary school, high school,
university or some other form of higher education with no education serving as
the reference category, to control for the impact of education on employment and
to account for the relationship between diabetes and education (Agardh et al.,
2011).
Since Mexico is a large and diverse country with regional socioeconomic differ-
ences we also include dummies for five different Mexican regions4. Apart from
the more obvious effects economic differences between regions can have on em-
ployment probabilities and diabetes through their impact on employment oppor-
tunities and lifestyles, the dummies should also account for less obvious effects
that macroeconomic problems, such as a high unemployment rate, could have on
employment probabilities and diabetes by affecting psychological well-being and
sleeping patterns (Antillón et al., 2014). Because differences in economic oppor-
tunities and lifestyles should also be expected between rural and urban areas,
three dummy variables are included to capture the effects these factors might
have on employment probabilities and diabetes, with living in a rural area being
the reference category5 (Villalpando et al., 2010). Further, to control for labour
4The region variables have been constructed after recommendations on the MxFLS-Homepage.
South-southeastern Mexico: Oaxaca, Veracruz, Yucatan; Central Mexico: Federal District
of Mexico, State of Mexico, Morelos, Puebla; Central northeast Mexico: Coahuila, Durango,
Nuevo Leon; Central western Mexico: Guanajuato, Jalisco, Michoacan; Northwest Mexico:
Baja California Sur, Sinaloa, Sonora.
5Rural: < 2,500 inhabitants; Small city: 2,500 to 15,000 inhabitants; City: 15,000 to 100,000
inhabitants; Big city: > 100,000 inhabitants.
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market discrimination and possible differences in genetic susceptibility to diabetes
of indigenous populations (Yu et al., 2007), a dummy for being a member of an
indigenous group is included. We also account for the marital status to control for
the impact of marriage on employment probabilities and lifestyle habits. Further
a variable capturing the number of children residing in the household below the
age of 15 is included, to control for their impact on employment probabilities and
for the effect of childbearing and related gestational diabetes on the probabilities
of women to develop type 2 diabetes (Bellamy et al., 2009).
To account for the effect that household wealth might have on diabetes and
employment probabilities, we use the well established method of principal com-
ponent analysis of multiple indicators of household assets and housing conditions
to create an indicator for household wealth (Filmer et al., 2001). Our composite
wealth index consists of owning a vehicle, owning a house or other real estate,
owning another house, owning a washing machine, dryer, stove, refrigerator or fur-
niture, owning any electric appliances, owning any domestic appliances, owning
a bicycle and owning farm animals. It further accounts for the physical condition
of the house, proxied by the floor material of the house, and the type of water
access.
The error term is denoted as ui. We do not control for the general health
status and other diabetes related chronic diseases as they are likely determined
by diabetes itself and, hence, could bias the estimates and compromise a causal
interpretation of the effect of diabetes on employment (Angrist et al., 2009).
As diabetes could be endogenous, the probit model might deliver biased esti-
mates. Therefore we employ an IV strategy, using a bivariate probit model to
estimate the following two equations simultaneously:
Diabetesi = δ0 + δ1Xi + δ2diabetesmotheri + δ3diabetesfatheri + ηi (2)
Employedi = β0 + β1Diabetesi + β2Xi + ui (3)
In equation. 2, Diabetesi is a dummy variable and is modelled as a function of
the same socioeconomic and demographic factors Xi as in equation 1 and of the
instrumental dummy variables diabetesmotheri and diabetesfatheri, indicating
if the father or the mother had been diagnosed with diabetes. The error term
is denoted as ηi. equation 3 is identical to the probit specification (equation 1)
and estimates the effect of diabetes on employment, now taking into account the
possible endogeneity of diabetes. Diabetes is exogenous if the error terms of both
equations are independent of each other (Cov(uiηi) = 0). Endogeneity is tested
using a likelihood ratio test based on the idea that if Cov(uiηi) = 0, the log-
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likelihood for the bivariate probit will be equal to the sum of the log-likelihoods
from the two univariate probit models (Knapp et al., 1998). If ui and ηi are
correlated, the estimation of equation 1 using a probit model will not provide
consistent estimates of the impact of diabetes on employment. In this case the
simultaneous estimation of both equations using the bivariate probit should be
preferred. For the estimation of the bivariate probit model it is assumed that ui
and ηi are distributed randomly and bivariate normal. To test the assumption of
normality, we use Murphey’s goodness-of-fit score test with the null-hypothesis
of bivariate normally distributed errors, as suggested by Chiburis et al. (2012).6
We choose the bivariate probit model over the linear IV model to account for
endogeneity, as there is evidence that it performs better if the sample is relatively
small (<5,000) and—more important in our case—when treatment probabilities
are low. In such cases the linear IV can produce uninformative estimates while the
bivariate probit model has been shown to provide much more reasonable results
(Chiburis et al., 2012). Because only 4% of males and 5.4% of females report a
diagnosis of diabetes, treatment probabilities are indeed low in the given case,
providing good justification for the use of the bivariate probit model.
In order to fulfil the conditions of a valid instrument, parental diabetes needs
to impact the diabetes risk of the offspring while at the same time being unre-
lated to the offspring’s employment chances. It has been shown that there is a
strong hereditary component of type 2 diabetes which predisposes the offspring
of people with diabetes to develop the condition as well (Herder et al., 2011; The
Interact Consortium, 2013). This is supported by the notion that genes seem to
play a crucial role, besides the recent epidemiological transition and the migra-
tion from rural to urban areas, in explaining Mexico’s high diabetes prevalence
according to a recent study by Williams et al. (2013). The authors identified a
specific gene particularly prevalent in Mexican and other Latin American popu-
lations with native American ancestry, which is associated with a 20% increase
in the risk of developing type 2 diabetes. Furthermore, research has shown that
parental lifestyle factors, socioeconomic background as well as parental body mass
index (BMI) can explain but a very small fraction of the increased risk of type
2 diabetes in the offspring, which is why we assume that the increased risk is
mainly due to genetic factors unrelated to lifestyle (Herder et al., 2011; The In-
teract Consortium, 2013). This is supported by Hemminki et al. (2010), who find
that adoptees whose biological parents had type 2 diabetes, had an increased
risk of developing type 2 diabetes even though they were living in a different
household, while if their adopted parents had the disease, they had no elevated
6Murphey’s score test “. . . embeds the bivariate normal distribution within a larger family of
distributions by adding more parameters to the model and checks whether the additional
parameters are all zeros using the score for the additional parameters at the bivariate probit
estimate.” (Chiburis et al., 2012, p. 19).
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risk.
Nonetheless, there might still be the chance that parental diabetes decreases
the offspring’s employment probabilities. The additional financial burden of di-
abetes or an early death due to diabetes could have prevented the parents from
investing in their children’s education the way they would have liked to or it
could have led to the child dropping out of school in order to support the family.
However, controlling for education should account for these effects if they exist.
Therefore parental diabetes should be a valid instrument which predicts diabetes
while not affecting employment probabilities through other unobserved pathways.
To further improve instrument validity we also account for the possibility that
parental education is simultaneously correlated with the parental diabetes status
as well as their children’s employment chances, by including a dummy variable
indicating if any of the parents had attained more than primary education.
A possible limitation of using parental diabetes as our instrument is that it
might directly affect the offspring’s employment decision through other pathways
than education. Conceivably, diabetes might deteriorate parental health in such
a way that the offspring has or had to give up its own employment in order to care
for its parents or is forced to take up work to financially provide for the parents.
With the data at hand we are unable to account for this, but if this effect exists
it should be picked up by the overidentification test.
We also estimate the linear IV model as it is consistent even under non-
normality (Angrist et al., 2009). The linear IV model takes the following form of
a first (equation 4) and a second stage (equation 5).
Diabetesi = pi0 + pi1Xi + pi2diabetesmotheri + pi3diabetesfatheri + ηi (4)
Employedi = β0 + β1Diabetesi + β2Xi + ui (5)
In the second stage, the potentially endogenous actual diabetes values are replaced
with the predicted values from the first stage. The covariates are the same as in
the bivariate probit case described in equation 2 and equation 3. In the linear
IV model the Hausman test is used to identify endogeneity. Validity of the
instruments is tested using first stage diagnostics of the linear IV model, as similar
tests are not available for the bivariate probit model. Average marginal effects
are presented for the probit and bivariate probit models.
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Results
This section presents the estimation results using 1) a probit model model that
assumes diabetes to be exogenous and 2) IV models with parental diabetes as an
instrument for diabetes, to determine if diabetes is endogenous or if instead the
results from the probit model can be used.
Probit results
Table 8 indicates that the effect of diabetes is negative for both sexes. For males,
it reduces the probability of being employed by 10 percentage points (p<0.01).
For females, the effect is also negative but smaller, and shows a reduction in
employment probabilities of about 4.5 percentage points (p<0.1).
The other covariates largely show the expected relationships. Employability
increases with age and is highest for the 35–44 years age group. Especially for
women, living in a more urban environment increases employment probabilities
compared to women living in rural areas. Also, women seem to benefit sub-
stantially from higher education in terms of employment probabilities. For men
the effects of education are also positive, though, not as marked as for women.
Perhaps surprisingly, being part of an indigenous population does not affect em-
ployment probabilities, neither for males or females.
The probit results suggest a significant negative effect of diabetes on the em-
ployment probabilities of males and likely also females in Mexico. In light of
the concern that diabetes could be endogenous the following section presents the
results of the IV estimations.
IV results
Using the bivariate probit model, the diabetes coefficient for males increases in
size and remains negative whereas for females it decreases but also remains neg-
ative. However, standard errors increase in both models and the results turn in-
significant, suggesting considerable loss of efficiency (see Table 9). The likelihood-
ratio test does not reject the null hypothesis of no correlation between the dis-
turbance terms of equation 2 and equation 3 for males and females, suggesting
exogeneity of diabetes. The test for normality of the error term does not reject
the null hypothesis of normality for the male and the female model, increasing our
confidence in the estimates. Nonetheless we also consider the results of the linear
IV model (see Table 10 displaying the main results and Table A5 in the appendix
presenting the complete first and second stage estimates): the test statistics indi-
cate sufficiently strong and valid instruments, as shown by the Kleibergen-Paap
Wald F statistic for weak instruments of 20.48 for men and 27.71 for women,
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Table 8: Impact of diabetes on employment probabilities (probit)
(1) (2)
Males Females
Age 25–34 0.124∗∗∗ (.011) 0.121∗∗∗ (.017)
Age 35–44 0.133∗∗∗ (.012) 0.232∗∗∗ (.018)
Age 45–54 0.085∗∗∗ (.014) 0.170∗∗∗ (.022)
Age 55–64 −.034 (.020) 0.039 (.026)
Small city −.013 (.017) 0.043∗∗ (.020)
City −.036∗ (.019) 0.042∗∗ (.021)
Big city 0.029∗∗ (.013) 0.101∗∗∗ (.014)
Central 0.027 (.015) −.032∗ (.018)
Westcentral 0.020 (.015) −.008 (.018)
Northeastcentral 0.003 (.016) −.053∗∗∗ (.017)
Northwestcentral −.037∗∗ (.016) −.100∗∗∗ (.016)
Primary 0.056∗∗∗ (.020) −.006 (.022)
Secondary 0.051∗∗ (.021) 0.058∗∗ (.025)
High school 0.040∗ (.023) 0.126∗∗∗ (.029)
College or university 0.047∗∗ (.023) 0.297∗∗∗ (.033)
Indigenous 0.005 (.016) −.005 (.020)
Married 0.092∗∗∗ (.012) −.231∗∗∗ (.012)
Children (under 15) 0.010∗∗ (.004) −.018∗∗∗ (.004)
Wealth 0.002 (.006) 0.037∗∗∗ (.007)
Education parents −.007 (.013) 0.000 (.013)
Diabetes −.100∗∗∗ (.029) −.045∗ (.023)
Log likelihood −2897.807 −4508.573
N 6286 8243
Notes Average marginal effects; robust standard errors in parentheses. ∗ p < 0.10, ∗∗
p < 0.05, ∗∗∗ p < 0.01.
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Table 9: Impact of diabetes on employment probabilities (bivariate probit)
(1) (2)
Males Females
Age 25–34 0.125∗∗∗ (.012) 0.109∗∗∗ (.015)
Age 35–44 0.134∗∗∗ (.012) 0.207∗∗∗ (.016)
Age 45–54 0.089∗∗∗ (.016) 0.149∗∗∗ (.021)
Age 55–64 −.025 (.025) 0.032 (.029)
Small city −.014 (.017) 0.039∗∗ (.018)
City −.035∗∗ (.018) 0.038∗∗ (.019)
Big city 0.030∗∗ (.013) 0.093∗∗∗ (.013)
Central 0.027 (.018) −.030∗ (.015)
Westcentral 0.019 (.018) −.007 (.016)
Northeastcentral 0.002 (.018) −.049∗∗∗ (.017)
Northwestcentral −.038∗∗ (.017) −.091∗∗∗ (.015)
Primary 0.057∗∗∗ (.020) −.006 (.021)
Secondary 0.052∗∗ (.023) 0.052∗∗ (.022)
High school 0.040 (.025) 0.113∗∗∗ (.027)
College or university 0.046∗ (.025) 0.273∗∗∗ (.032)
Indigenous 0.006 (.017) −.005 (.016)
Married 0.093∗∗∗ (.012) −.215∗∗∗ (.011)
Children (under 15) 0.010∗∗ (.004) −.016∗∗∗ (.004)
Wealth 0.002 (.006) 0.033∗∗∗ (.007)
Parental education −.006 (.013) 0.000 (.012)
Diabetes −.185 (.143) −.021 (.108)
Instruments
Diabetes father 0.048∗∗∗ (.011) 0.041∗∗∗ (.010)
Diabetes mother 0.037∗∗∗ (.008) 0.054∗∗∗ (.008)
Log likelihood −3737.766 −5939.588
Score goodness-of-fit
(H0=normality of errors) 12.32 8.85
p value 0.196 0.451
Endogeneity
(H0: Diabetes exogenous) 0.443 0.039
p value 0.506 0.844
N 6286 8243
Notes Average marginal effects; robust standard errors in parentheses. The presented coefficients
and standard errors for the instruments result from the estimation of the model specified in equation
2, indicating the effect of parental diabetes on a person’s diabetes risk. ∗ p < 0.10, ∗∗ p < 0.05,
∗∗∗ p < 0.01.
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Table 10: Impact of diabetes on employment probabilities (linear IV)
Males Females
Diabetes 0.098 0.239
(.215) (.214)
R2 0.067 0.120
F stat (H0: weak instruments) 20.483 27.706
Sargan test (H0: valid instruments) 0.862 0.295
p value 0.353 0.587
Endogeneity (H0: Diabetes exogenous) 0.864 1.796
p value 0.353 0.180
N 6286 8243
Notes Robust standard errors in parentheses. Instruments: diabetes of
mother, diabetes of father. Other control variables: age, region, urban,
education, indigenous, marital status, children, wealth, parental education.
Critical values for weak identification test F statistic: 10% maximal IV size
19.93, 15% maximal IV size 11.59, 20% maximal IV size 8.75, 25% maximal
IV size 7.25. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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being above the critical value of 19.93 for 10% IV size and well above the rule of
thumb of 10 for weak identification not to be considered a problem (Baum et al.,
2007; Staiger et al., 1997). The Sargan test does not reject the null hypothesis
of instruments uncorrelated with the error term and instruments correctly ex-
cluded from the estimated equation. The coefficients of the linear IV model
are very different from the bivariate probit model, turning positive for males and
females, but also very imprecise as indicated by the large standard errors. As
mentioned before, Chiburis et al. (2012) show that the estimates of the linear IV
model are likely to be imprecise when low treatment probabilities exist and can
differ substantially from the bivariate probit model, which seems to be the case
here.7 Since the linear IV models fail to reject exogeneity of diabetes as well,
we are confident that the standard probit model provides unbiased and efficient
estimates of the effect of diabetes on employment chances in Mexico and should
therefore be used for inference.
The next section investigates the effects of diabetes for two different age groups,
15–44 and 45–64, to explore whether, and if so, how the effect of diabetes on
employment probabilities differs between older and younger people. There might
be reason to believe that diabetes has a more adverse effect in older age groups,
when those suffering from diabetes are likely to have accumulated more years
lived with diabetes, and hence are more likely to develop complications.
Differences by age groups
When divided into an older and younger age group using the cut-off point of 45
years, the negative effect of diabetes is mainly found in the older age group, for
males and females alike (see Table 11), where 12.5% report having diabetes, com-
pared to only 1.7% in the younger age group. The probability of being employed
is reduced by 11 percentage points for men between 45 and 64 years at the 1%
significance level, while there is no significant effect on younger men. For women,
the employment probability is reduced by about 6 percentage points, with the ef-
fect being significant at the 5% level. Similar to men, there is no effect of diabetes
on younger women. To investigate in more detail for which age group the effect
is strongest, we run separate regressions for both age groups above 44 years. The
results (Table A6 in the appendix) show that for men the strongest effect ap-
pears in the oldest age group (i.e. 55–64 years), where employment probabilities
are reduced by almost 13 percentage points. For females, a significant effect is
7It could also be the case that the difference in estimates is due to the fact that while the
bivariate probit model estimates the average treatment effect of the variable of interest for
the whole sample, the linear IV model estimates the local average treatment effect, which
estimates the effect of diabetes on employment only for those that have diabetes and whose
parents have or have had diabetes as well. Therefore, the estimates of both models can be
different (Angrist et al., 2009; Chiburis et al., 2012).
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Table 11: Impact of diabetes on employment probabilities by age group (probit)
15-44 45-64
(1) (2) (3) (4)
Males Females Males Females
Diabetes −.009 −.004 −.110∗∗∗ −.057∗∗
(.062) (.042) (.034) (.025)
Log likelihood −1987.285 −3354.003 −925.409 −1167.491
N 4415 5997 1871 2246
Notes Average marginal effects; robust standard errors in parentheses. For the younger age
group, the model contains the age categories 25–34 and 35–44 with 15–24 as the reference
category. For the older age group, the model contains the age category 55–64 with 45–54 as
the reference category. Other control variables: region, urban, education, indigenous, marital
status, children, wealth, parental education. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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found solely for those between 45 and 54 years, where employment probabilities
are reduced by 7.6 percentage points. Hence, there appear to be relevant differ-
ences between males and females in the age at which the biggest adverse effect of
diabetes on employment probabilities occurs.
The use of IV methods in the age stratified samples is compromised due to
a reduction in instrument power, sample size and particularly treatment proba-
bilities. Especially for the younger age group, where treatment probabilities are
close to zero, a meaningful interpretation of the IV results is difficult. Further,
because no endogeneity was found in the pooled samples for males and females,
we would not expect endogeneity of diabetes in the age stratified samples. We
nonetheless test for the possibility of diabetes being endogenous using the bi-
variate probit model and an approach suggested by Lewbel (2012), to improve
instrument strength (see Table A7 and Table A8 in the appendix).
Differences by wealth
To explore the heterogeneity of the effect of diabetes on employment across dif-
ferent levels of wealth, we divide the sample into two wealth groups at the 50th
percentile of our constructed wealth index.
We run separate regressions for both groups stratified by gender, finding the
strongest negative effect for less wealthy males, where employment probabilities
are reduced by 15 percentage points, and a smaller and less significant effect for
less wealthy females (see Table 12). Whereas the coefficients for wealthier males
and females have a negative sign, they are not significant at the 10% significance
level. This indicates that mainly the less wealthy experience an adverse effect from
diabetes. To further explore this, we stratified the sample into wealth quartiles
(see Table A9 in the appendix), finding that significant adverse effects for males
appear in the first and second wealth quartile, where employment probabilities
are reduced by about 14 percentage points. For females a highly significant and
strong effect is only found in the poorest quartile, where employment chances are
reduced by 10 percentage points. Together these results indicate that the impact
of diabetes on employment probabilities varies with wealth, with men and women
being more affected when being in the lower wealth quartiles.
To consider the possible endogeneity of diabetes in the upper and lower wealth
half, we again present the results of the IV models. The stratification into wealth
groups significantly reduces instrument power as well as sample size. For none of
the wealth groups the bivariate probit model indicates endogeneity (see Table A10
in the appendix). This does not change even when using the Lewbel approach
to increase instrument strength and we therefore rely on the probit results for
inference.
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Table 12: Impact of diabetes on employment probabilities by wealth group (pro-
bit)
Poor Rich
(1) (2) (3) (4)
Males Females Males Females
Diabetes −.150∗∗∗ −.047∗ −.060 −.038
(.047) (.027) (.038) (.035)
Log likelihood −1459.235 −2040.517 −1408.746 −2421.910
N 3140 4091 3106 4117
Notes Average marginal effects; robust standard errors in parentheses. Other control variables:
region, urban, education, indigenous, marital status, children, wealth, parental education. ∗
p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Differences by employment type
To investigate the effect of diabetes on the employment probabilities in the formal
and informal labour market, respectively, we estimate separate models with being
employed in the formal and informal sector as the respective dependent variables.
We define formal employment on the basis of having a written labour contract.
Informal employment is defined as working without a written contract, being
self-employed or working in semi-subsistence agriculture.
For this investigation we use two restricted samples: for the estimation of the
effect of diabetes on informal employment we exclude those currently in formal
employment and for the effect of diabetes on formal employment we exclude those
in informal employment from our sample. We further assume that those who have
worked previously and are currently unemployed are looking for employment in
the same sector, i.e. if they were previously employed in the informal (formal)
labour market they are again looking for an informal (formal) employment. We
therefore exclude those previously working in the informal (formal) labour market
from our estimation of the effect of diabetes on employment in the formal (in-
formal) labour market. The respective sample thus only contains those currently
working in the informal (formal) labour market, those previously employed in the
informal (formal) labour market and those that have never worked before. Using
this assumption allows the use of a normal probit model and the investigation of
a possible endogeneity bias using IV techniques.
Admittedly, the assumption that the currently unemployed look for work in the
same labour market they had previously worked in is quite strong and is likely
not true for everybody. We therefore additionally estimate a multinomial logit
model which is most useful if the decision to work is not binary but there are
more than two choices, such as the choice of being either unemployed, employed
in the informal or employed in the formal labour market (Wooldridge, 2002).
Being unemployed is used as the reference category.
All estimated models (see Table 13 and Table A12 in the appendix), regard-
less of the estimation approach, indicate that diabetes significantly reduces the
chances of being in informal employment, while it has no effect on formal em-
ployment.8 This applies to both males and females. This indicates that people
with diabetes are less likely to be working in the informal labour market relative
to being unemployed, while there is no difference for those working in the formal
labour market. We further find no indication of endogeneity (see Tables A13 and
8Please note, however, that the coefficients of the multinomial logit and the probit model
cannot be directly compared as they are based on different assumptions. The former takes
into account that a person can choose from more than two employment outcomes (i.e. being
unemployed, being formally employed or being informally employed), while the latter only
allows for a binary outcome without considering any other options (e.g. being unemployed
or informally employed without considering the possibility of formal employment).
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Table 13: Impact of diabetes on employment probabilities by employment status
(probit)
Males Females
(1) (2) (3) (4)
Informal Formal Informal Formal
Diabetes −.063∗∗ −.041 −.051∗∗ 0.019
(.031) (.043) (.022) (.022)
Log likelihood −1780.023 −1021.771 −3818.588 −1859.048
N 4604 2204 6983 5652
Notes Average marginal effects; robust standard errors in parentheses. Other control variables:
region, urban, education, indigenous, marital status, children, wealth, parental education. ∗
p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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A14 in the Appendix). Overall, there seem to be strong differences in terms of the
impact of diabetes on people in formal and informal employment, with diabetes
having a stronger negative effect for those without a written contract.
Conclusion
The contribution of this paper has been to analyse—for the first time for a
LMIC—the impact of diabetes on employment in Mexico, taking into account
the potential endogeneity in the relationship between diabetes and employment
probabilities. The presented results add to the growing literature on the adverse
economic effects of diabetes. They indicate that having diabetes substantially
reduces the chances to work for men and likely also for women. Hence, diabetes
may contribute to a reduction in the pool of the productive workforce available
to the Mexican economy.
We have also shown that diabetes reduces employment probabilities particu-
larly in older people, likely because in this age group people are more common
to already have developed diabetes-related complications which reduce their pro-
ductivity and eventually force them into unemployment. Further, particularly
for men the effects of diabetes on employment chances seem to be particularly
strong when they belong to the poorer half of the population. While there might
be some self-selection into the poorer group by those who lost their job due to
diabetes and as a result descended into the lower wealth group, this finding is
indicative of potentially substantial adverse equity impacts. This is also in line
with our finding that diabetes reduces employment probabilities particularly for
the informally employed, whereas those in formal employment seem to be less
affected. Nonetheless, in order to establish causality more research in this area
will be needed.
While in parts of the earlier literature diabetes was found to be exogenous only
for either males or females (Brown et al., 2005b; Latif, 2009), our study found
diabetes to be exogenous using the samples stratified into males and females,
allowing the use of the more efficient probit model to arrive at a consistent esti-
mate of the effect of diabetes on employment probabilities. Further, we found no
endogeneity of diabetes for the sample comprised of the age group above the age
of 44, for the samples stratified into an upper and lower wealth half and for the
samples stratified by employment type. For the younger age group, the bivariate
probit model only indicated exogeneity of diabetes for males, while for females
diabetes was shown to be endogenous and having a significant positive effect of
diabetes on employment. This result is rather counter-intuitive because there is
no obvious reason why diabetes should increase employment probabilities. Be-
cause all samples stratified into age, wealth and employment groups suffered from
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reduced instrument strength which could cause biased IV estimates, we used a
method proposed by Lewbel (2012) to create additional instruments and increase
instrument power. Using this method we no longer found a significant positive
effect of diabetes on female employment probabilities in the younger age group
and could not reject the assumption of exogeneity of diabetes in this sample.
Also, for all other wealth, age and employment samples, the Lewbel IV method
did not reject the assumption of exogeneity. We are therefore confident that we
can rely on the probit estimates for inference.
Why was diabetes found to be exogenous in the Mexican case? We can only
speculate on the potential reasons. Diabetes being exogenous seems to indicate
that a person’s employment status might not have such a strong effect on his or
her diabetes risk through the potential pathways such as lifestyle changes. Rather,
the rapid epidemiological transition experienced in Mexico over the last decades
(Barquera et al., 2006; Barquera et al., 2008; Rivera et al., 2002) together with
the heightened genetic susceptibility of Mexicans to diabetes (Williams et al.,
2013), seem to have increased the risk of developing diabetes in both employed
and unemployed Mexicans.
Taking our results for the older age group and comparing them to those of
Brown et al. (2005b) for the USA, whose sample of Mexican Americans 45 years
and older might be the best suited for a meaningful comparison, our findings
indicate a stronger negative impact of diabetes on males and particularly females
residing in Mexico.9 This finding lends some support to our hypothesis that the
adverse impact of diabetes on employment could be larger in LMICs than in
high-income countries. Comparing the study to Lin (2011) for Taiwan, who also
used a sample of people between 45 and 64 years of age, our results are similar
in that a larger absolute effect is found for males than for females. However,
when compared to other studies in more developed countries, with more advanced
health systems and very different populations, such as Latif (2009) for Canada
and Minor (2011) for women in the US, our results differ in that they do find
effects for men and potentially also women.
While the results for women in the main analysis do not reach the levels of
statistical significance that those for men do, the negative impact on women is
supported by the subgroup analysis. When we take into account the lower overall
female employment rates (31%) compared to men (80%), the absolute reduction in
employment probabilities in women translates into an even larger relative decrease
of over 16% for women compared to 12.5% for men. This suggests that diabetes
has a considerable impact on employment probabilities of both men and women.
9This is based on comparing our estimates to the appropriate models in Brown et al. (2005b)
based on their test for endogeneity, which indicates the use of the bivariate probit results
for women and the probit results for men.
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A limitation of this study is the use of cross-sectional data, which does not allow
for the use of fixed effects and hence for the control of unobserved time-invariant
heterogeneity. Data spanning a longer time period would be required to be able to
observe changes in the diabetes and employment status which would allow the use
of fixed effects. A further limitation is the somewhat old data from 2005, which
precedes the main implementation period of the public health insurance scheme
called Seguro Popular. This should be taken into account when interpreting our
results as the effects might be different today, where most Mexicans have access
to some sort of health insurance (Knaul et al., 2012). The presented results
rather show the effects of diabetes on employment probabilities in 2005 in an
environment were insufficient healthcare coverage was common for parts of the
Mexican population. We nonetheless deliberately chose this particular dataset
as it provided us with a sensible instrument in parental diabetes as well as an
array of other socioeconomic information which—as far as we have been able to
ascertain—is not provided by any other dataset in LMICs. Finally, due to data
limitations, we were not able to investigate the relationship between diabetes
duration and employment probabilities and how long it takes for an employment
penalty to develop. Recent research by Minor (2013) on the US has shown that
the effect of diabetes on employment probabilities changes with the duration of
diabetes and is biggest in the first five years after diagnosis for males, whereas
for females effects appear only about 11–15 years after diagnosis.
Looking ahead, it would evidently be worthwhile to investigate the effects of
diabetes on employment in Mexico using more recent data. In light of the recently
completed implementation of Seguro Popular—which increased its coverage from
about 10 million people in 2005 to over 50 million in 2012 and now provides
almost all previously uninsured Mexicans with access to healthcare (Knaul et al.,
2012)—the results of this paper might be used as a baseline to judge the success
of Seguro Popular in reducing the adverse effects of diabetes on employment.
In conclusion, this paper shows that diabetes represents a large burden for
people in Mexico and likely in other LMICs, not only due to the associated
disease and medical cost burden but also because of its effect on employment
probabilities. This is particularly a problem for the poor who are more adversely
affected by diabetes than the more aﬄuent. To alleviate some of the negative
effects of diabetes, Seguro Popular may provide an opportunity to further improve
the prevention and treatment of diabetes for the poor, especially if the health
system adapts to the challenges presented by chronic diseases (Samb et al., 2010).
Evidence of possible cost-effective interventions for secondary prevention in the
context of Seguro Popular already exists (Salomon et al., 2012). There remains,
however, an evidence gap on cost-effective strategies for the primary prevention
of diabetes.
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4 The impact of diabetes on labour
market outcomes in Mexico: a
panel data and biomarker analysis
Pre-amble
This study builds on the results of the preceding chapter. Instead of using an
instrumental variable (IV) approach to address the issue of endogeneity, it takes
advantage of the recently released third wave of the Mexican Family Life Survey
(MxFLS) to allow the construction of a longitudinal data set containing three
waves. This enables the use of panel data methods to arrive at a potentially
causal interpretation of the estimates, without having to rely on an IV approach.
Further, the study provides additional evidence for the effect of self-reported
diabetes on wages and working hours in a developing country. Finally, it addresses
another area identified by the systematic review in Chapter 2. Using biomarker
data it investigates in how diabetes effects the labour market outcomes of the
large undiagnosed population, also providing information about whether findings
based on self-reported diabetes can be used to infer on the entire population
with diabetes. This should help to better interpret estimates using self-reported
diabetes as provided in Chapter 3.
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Abstract
There is limited evidence on the labour market impact of diabetes, and
existing evidence tends to be weakly identified. Making use of Mexican
panel data to estimate individual fixed effects models, we find evidence
for adverse effects of self-reported diabetes on employment probabilities,
but not on wages or hours worked. Complementary biomarker informa-
tion for a cross-section indicates that a large population with diabetes is
unaware of the disease. The results indicate that the adverse effects found
for self-reported diabetes do not extend to those unaware of their diabetes.
Further analysis suggests that this difference stems from worse general
health among the self-reports rather than more severe diabetes.
Introduction
Diabetes, and particularly its most common variant, type 2 diabetes, has in-
creased worldwide and is expected to continue to rise over the next decades (NCD
Risk Factor Collaboration, 2016). It has become a problem for middle-income
countries (MICs) and high-income countries (HICs) alike, with over two-thirds
of people with diabetes living in the developing world (International Diabetes
Federation, 2014). Mexicans and Mexican-Americans appear to be particularly
affected by diabetes, also in comparison to other Latino populations living in the
USA (Schneiderman et al., 2014). In Mexico itself, diabetes prevalence has been
estimated to have grown from 6.7% in 1994 to 14.4% in 2006, including both
diagnosed and undiagnosed cases (Barquera et al., 2013), and is expected to in-
crease further over the next decades (Meza et al., 2015). Already now, diabetes
is the number one cause of death in Mexico (Barquera et al., 2013).
The observed trend has been attributed to a deterioration in diet and a reduc-
tion in physical activity (Barquera et al., 2008; Basu et al., 2013), while genetic
predisposition among Mexicans with pre-Hispanic ancestry may also have played
a role (Williams et al., 2013). Recent evidence indicates that the onset of di-
abetes has been occurring at an ever earlier age in Mexico (Villalpando et al.,
2010). With treatment as ineffective as it currently is—only a minority achieves
adequate blood glucose control (Barquera et al., 2013)—the earlier onset will
increase the likelihood of complications during the productive lifespan.
Diabetes is a term used to describe various conditions characterized by high
blood glucose values, with the predominant disease being type 2 diabetes account-
ing for about 90% of all diabetes cases (Sicree et al., 2011). The elevated blood
glucose levels, that are a result of the body’s inability to use insulin properly
to maintain blood glucose at normal levels, can entail a range of adverse health
effects for the individual concerned. However, via effective self-management of
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the disease much if not all of the complications can be avoided (Gregg et al.,
2012; Lim et al., 2011). In the absence of effective self-management—or in the
case of inadequate treatment—diabetes has been documented to lead to condi-
tions such as heart disease and stroke, blindness, kidney problems, and nerve
problems which together with impaired wound healing can lead to the loss of
limbs (Reynoso-Noverón et al., 2011). These conditions can be seriously debili-
tating and may therefore reduce an individual’s economic activity, including its
productivity and labour market participation.
The effect of diabetes on labour market outcomes has been studied predomi-
nantly in HICs—with the exception of a study on Mexico (Seuring et al., 2015b)
and one on China (Liu et al., 2014) each. In the HIC studies diabetes has been
found to be associated with reductions in employment probabilities as well as
wages and labour supply (Brown et al., 2005b, 2011; Brown, 2014; Latif, 2009;
Minor, 2011, 2013; Minor et al., 2016; Seuring et al., 2015a).
While these studies have provided useful evidence on the potential labour mar-
ket effects of diabetes, many of the complexities of the relationship have not been
comprehensively addressed in any given study. First of all, unobserved hetero-
geneity presents a challenge to estimate the relationship between diabetes and
labour market outcomes. Especially time-invariant unobserved individual char-
acteristics, e.g. health endowments—often related to health during uteru, infant
and child years, and to low household income or adverse health shocks during
these early years—as well as risk preferences, have been shown to adversely affect
health in general and the propensity to develop type 2 diabetes more specifically
(Ewijk, 2011; Li et al., 2010; Sotomayor, 2013). These and other unobserved
personal characteristics (e.g. ability) may also affect employment probabilities,
wages or working hours directly through their effects on contemporaneous pro-
ductivity (Currie et al., 2013) and indirectly by limiting educational attainment
and human capital accumulation (Ayyagari et al., 2011). Further, only focusing
on the overall effect of a self-reported diabetes diagnosis does not reveal when
potential labour market penalties appear, given the dynamic aspect of diabetes
and the potential differences in its effects over time. Additionally, apart from its
health impact, diabetes might also affect labour market outcomes through other
channels. For instance, people aware of their condition may be less inclined to
continue working if this interferes with their disease management, or could be suf-
fering from psychological consequences (depression, anxiety) of becoming aware
of the disease; they may also use the diagnosis as a justification for decreasing
their labour supply, leading to a potential justification bias in the estimated effect
of diabetes (Kapteyn et al., 2009). Importantly, for these reasons the labour mar-
ket effects may also be distinct for people with self-reported versus those unaware
of their condition, potentially leading to biased estimates if the analysis is solely
96
based on self-reports.
The objective of this study is to provide new evidence on the impact of dia-
betes on labour market outcomes, while improving upon previous work by paying
close attention to the above challenges. We use three waves of panel data from
Mexico covering the period 2002–2012, provided by the Mexican Family Life Sur-
vey (MxFLS). The MxFLS is particularly useful for the analysis of diabetes as it
allows us to account for the above complexities in a more refined way than has
been the case so far. Using individual level fixed effects (FE) analysis for the
first time in this literature, we take account of time-invariant heterogeneity when
assessing the impact of self-reported diabetes and self-reported diabetes duration
on labour market outcomes.1 Further, we add to the current literature in explor-
ing the role of undiagnosed diabetes, using novel and rich biomarker data—an
issue of considerable importance in light of the large prevalence of undiagnosed
diabetes (see Beagley et al. (2014)) that remained unaccounted for in most ear-
lier studies which typically relied on self-reported information. Doing so sheds
light on the issue of measurement error and the potentially differential effects of
self-reported and undiagnosed diabetes.
Our results using self-reported diabetes suggest an economically important de-
crease in the employment probability of people aware of their disease. Wages
and working hours, however, do not appear to be negatively associated with self-
reported diabetes. We further find that employment probabilities are reduced
with each additional year since diagnosis, with some evidence for an even larger
effect per year after the initial 10 years.
The biomarker analysis indicates that self-reported diabetes entails a significant
employment penalty, while biometrically measured diabetes does not. Overall,
undiagnosed diabetes does not appear to affect any of the labour market outcomes
examined here, suggesting that adverse effects mainly occur to those self-reporting
a diagnosis. We argue that, nonetheless, the effects found for self-reported dia-
betes in this study are largely unbiased as long as inference is not extended to
the unobserved undiagnosed population, and are economically important in light
of the sheer size of the diagnosed population in Mexico.
Diabetes and labour market outcomes—existing
evidence
Several studies have investigated the effects of diabetes on labour market out-
comes.
For the USA, Brown et al. (2005b) estimate the impact on employment in 1996–
1We are not aware of any other evidence on the effect on wages and working hours in a MIC.
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1997 in an elderly population of Mexican Americans living close to the Mexican
border, using a bivariate probit model. The study finds diabetes to be endoge-
nous for women but not for men. For the latter, the estimates show a significant
adverse effect of 7 percentage points. For women, the negative effect becomes in-
significant when using IV estimation. In another study, again for a cross-sectional
sample of Mexican-Americans, Brown et al. (2011) look at how diabetes manage-
ment, inferred from measured glycated hemoglobin (HbA1c) levels, is associated
with employment probabilities and wages. The authors detect a linear negative
association between HbA1c levels and both employment probabilities and wages
for men.
Two further studies also examine the impact of diabetes on employment and
productivity for the USA: Minor (2011) focuses on the effect of diabetes on female
employment, earnings, working hours and lost work days in 2006, finding diabetes
to be endogenous and its effect underestimated if exogeneity is assumed. In the
IV estimates, diabetes has a significant negative effect on female employment as
well as annual earnings but not on working hours. In a later study, Minor (2013)
investigates the relationship of diabetes duration and labour market outcomes
using a cross-sectional analysis, providing evidence of a non-linear relationship,
with employment probabilities declining shortly after diagnosis for men and after
about 10 years for women; wages are not affected by duration. Finally, a recent
study by Minor et al. (2016) investigates the association of self-reported diabetes
and undiagnosed diabetes with employment probabilities and working hours in
an adult USA population, using cross-sectional data. This study indicates a
reduction in the coefficient size of diabetes if undiagnosed diabetes cases are in-
cluded in the diabetes indicator instead of only self-reported diabetes. Further,
they find that there is no association of undiagnosed diabetes with employment
probabilities itself. However, the results of the study, particularly those for undi-
agnosed diabetes, are based on a very small number of cases, warranting further
investigation.
For Canada, Latif (2009) estimate the effect of the disease on employment
probabilities using an IV strategy similar to Brown et al. (2005b). His results
suggest diabetes to be exogenous for females, and both endogenous and overes-
timated for males in the univariate model, with the estimates of the bivariate
model indicating a significant negative impact on the employment probabilities
for women, but not for men. For Australia, Zhang et al. (2009) analyse the effects
of diabetes on labour force participation using a multivariate endogenous probit
model. Their results demonstrate reduced labour market participation for males
and females as a result of diabetes, with the effects appearing overstated if the
endogeneity of diabetes is unaccounted for.
To the best of our knowledge only two studies exist for non-HICs. Liu et al.
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(2014) investigate the effect of a diabetes diagnosis on labour income in China,
exploiting a natural experiment to identify causality, finding a significant reduc-
tion in income for those with a recent diagnosis. An earlier study for Mexico
explored the effect of self-reported diabetes on the probability of employment
using only cross-sectional data from the 2005 wave of the MxFLS, and found a
significant (p<0.01) reduction in employment probabilities for males by about
10 percentage points and for females by about 4.5 percentage points (p<0.1),
using parental diabetes as an IV (Seuring et al., 2015b). The scarcity of evidence
for low- and middle-income countries (LMICs) is also documented in a recent
systematic review of the economic cost of diabetes (Seuring et al., 2015a).
Overall, the majority of existing studies, including those on high income coun-
tries, tend to suffer from at least four key limitations:
1. They rely exclusively on cross-sectional data, limiting the possibilities to
account for unobserved individual characteristics.
2. The use of the family history of diabetes, which has been the sole instrumen-
tal variable employed so far, relies on the genetic and heritable component
of type 2 diabetes that could theoretically provide valid identification of
the true effect of diabetes. However, it remains unclear whether the vari-
able fully satisfies the exclusion restriction, as it may also proxy for other
genetically transferred traits, including unobserved abilities that impact
labour market outcomes directly. This traditional identification strategy
also abstracts from intrahousehold or intergenerational labour supply ef-
fects (Seuring et al., 2015b).2
3. The use of self-reported diabetes can introduce non-classical measurement
error due to systematic misreporting which has been shown to cause esti-
mates of economic impacts to be potentially biased and overstated (Cawley
et al., 2015; O’Neill et al., 2013; Perks, 2015).
4. A final potential limitation lies in the selection into diagnosis as a result
of disease severity: those who are more severely ill are more likely to have
visited a medical doctor and be diagnosed.
To overcome some of these limitations, this paper applies an individual level
FE panel estimation strategy and makes use of biomarker data. We also estimate
models for different types of employment, i.e. non-agricultural wage employment,
agricultural employment and self-employment, as ill health may have distinct
effects across these activities.
2It is conceivable that diabetes might deteriorate parental health in such a way that the
offspring either has to give up their employment to provide care, or has to increase labour
supply to compensate for lost income.
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Data
We use the Mexican Family Life Survey (MxFLS), a nationally representative,
longitudinal household survey, which has three waves conducted in 2002, 2005–
2006 and 2009–2012. All household members aged 15 and above were interviewed,
covering information on a wide range of social, demographic, economic and health
characteristics of the individuals and their families (Rubalcava et al., 2013). Apart
from self-reported diabetes information that is available in all rounds, we also
use information on the self-reported year of diagnosis as well as biomarker data
including HbA1c levels for a subsample of respondents. Our main analysis uses all
three waves, taking advantage of the large amount of observations and the panel
structure of the data. Our variable of interest is self-reported diabetes, which is
based on the survey question: “Have you ever been diagnosed with diabetes?”.
Because we found some inconsistencies in the self-report of a diabetes diagnosis
over time in a small subset of observations, we investigate and try to increase the
consistency of the self-reported diabetes variable, using disease information from
earlier and ensuing waves to infer on the current, missing or inconsistent, dia-
betes status (see page 269 in the Appendix for further details on our correction
procedures). A further, and no less important, source of measurement error is
the omission of those with undiagnosed diabetes. In order to investigate how this
may affect estimates of the labour market impact of diabetes we use informa-
tion from a subsample of the 2009-2012 wave, containing over 6000 respondents
(everybody aged 45+ and a random subsample of those aged 15–44 (Crimmins
et al., 2015)) that have biometrically measured blood glucose values, allowing for
the identification of those with undiagnosed diabetes. Throughout our analysis
the samples we use are restricted to the working age population (15–64). To pre-
vent pregnant women from biasing our results due to the increased diabetes risk
during pregnancy and its effects on female employment status, we have dropped
all observations of women reporting to be pregnant at the time of the survey
(N=764). We further exclude everybody currently in school.
The detailed information in the MxFLS allows us to consider the following out-
come variables of interest: employment3, hourly wage and weekly working hours4.
3Employment status is defined as having worked or carried out an activity that helped with
the household expenses the last week and working for at least four hours per week. This ex-
plicitly includes those employed informally, for instance people working in a family business
or as peasants on their own land. The number of working hours needed to be considered as
working is lower than in Chapter 3. We took this decision because we wanted to assess the
impact of diabetes on driving people out of work completely. Any effect on working hours
should be captured in the respective working hours models. We also tested if changing the
definition of being employed to having worked at least ten hours per week as in Chapter 3.
This only led to marginal changes in the coefficients and standard errors, not affecting the
interpretation of the results.
4Hourly wage was calculated by adding up the reported monthly income from the first and
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For the pooled data of all three waves (Table 14), diabetes was self-reported by 5%
of men and 6% of women, respectively. This is consistent with other prevalence
estimates of self-reported diabetes for this time period in Mexico.5 About half of
the respondents in the sample live in rural areas. Looking at our outcome vari-
ables, 86% of men report some form of employment compared to 37% of women.
Interestingly, men do not report considerably higher hourly wages than women
but work more hours per week. Also, men are working more often in agricultural
jobs while women are more likely to be self-employed or in non-agricultural wage
employment. Women also have lower educational attainment on average.
Turning to the biomarker subsample of the third wave (2009–2012), respondents
are somewhat older on average than in the pooled sample, as it includes everybody
above the age of 44 but only a random subsample of those aged 44 or below
(Crimmins et al., 2015). Also, self-reported diabetes is higher than in the pooled
sample6. Regarding the other control and outcome variables, the sample is fairly
similar to the pooled sample. Remarkably, a relatively large share of people
have an HbA1c indicative of diabetes, defined by the World Health Organization
(WHO) as levels above or equal 6.5% (World Health Organization, 2011)7: 18%
of males and females are unaware of their diabetes. This suggests that relying
on self-reported diabetes as a measure for diabetes in Mexico might considerably
understate the true extent of diabetes, potentially leading to biased estimates of
its economic impact.
second job (if any) and dividing it by the average number of weeks per month. This gave
us the average earnings per week which were then divided by the weekly working hours to
arrive at an hourly wage estimate. Labour income was either reported as the total amount
for the whole month or more detailed, containing information on the monthly wage, income
from piecework, tips, extra hours, meals, housing, transport, medical benefits and other
earnings. Over 80% of respondents reported the total amount instead of a detailed amount.
Respondents were also asked for their annual income and we used that information to arrive
at an hourly wage if information for monthly labour income was missing. Those working
self-employed or as a peasant on own land were also asked to provide their monthly and/or
annual monetary income. We exclusively used information on monetary income provided in
the survey, and consequently do not account for the value of agricultural produce used for the
own consumption or the value generated by working in a family business without receiving
any monetary remuneration. Finally, we adjusted the calculated wage for inflation from the
year of the interview up to 2013 and took the log of those values. Due to a considerable
number of missing or zero income reports the sample used for the wage estimation is smaller
than the sample for working hours. Working hours were calculated summing up the self-
reported working hours of the first and—if applicable—the second job. Working hours were
calculated for every type of work, irrespectively of receiving a monetary remuneration or
not.
5Barquera et al. (2013) show that the prevalence of diagnosed diabetes in Mexico was 7.5%
in 2006, only somewhat above our results, which may be the result of the slightly different
age groups considered.
6As well as in the full sample of wave 3.
7In one of the first analyses of these new biomarker data, Frankenberg et al. (2015) show that
the rates of elevated HbA1c levels in Mexico are very high when compared to HbA1c data
from similar surveys in the USA and China.
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Table 14: Descriptive statistics for panel and biomarker sample.
Panel Biomarker
Males Females Males Females
Dependent variables
Employed 0.86 0.37 0.86 0.34
(0.34) (0.48) (0.35) (0.47)
Hourly wage (Mexican Peso) 42.47 40.49 36.30 35.23
(485.87) (142.08) (53.69) (43.63)
Weekly working hours 46.82 38.99 46.00 38.15
(16.79) (18.90) (16.89) (19.65)
Agricultural worker 0.22 0.04 0.25 0.03
(0.41) (0.20) (0.43) (0.18)
Self-employed 0.19 0.28 0.21 0.32
(0.39) (0.45) (0.41) (0.47)
Non-agricultural worker
or employee 0.59 0.68 0.53 0.64
(0.49) (0.47) (0.50) (0.48)
Diabetes variables
Self-reported diabetes 0.05 0.06 0.09 0.12
(0.22) (0.24) (0.29) (0.32)
Diabetes duration if self-
reported diabetes (years) 7.49 7.83 7.48 7.99
(6.01) (7.83) (6.07) (7.03)
Glycated hemoglobin (HbA1c) 6.46 6.58
(1.89) (2.02)
HbA1c ≥ 6.5% 0.26 0.28
(0.44) (0.45)
Undiagnosed diabetes 0.18 0.18
(0.39) (0.39)
Education and demographic variables
Age 36.03 36.29 42.78 42.79
(13.62) (13.17) (14.28) (13.94)
Rural village of < 2,500 0.44 0.43 0.50 0.46
(0.50) (0.50) (0.50) (0.50)
Married 0.54 0.54 0.60 0.56
(0.50) (0.50) (0.49) (0.50)
Number of children (age < 6)
in household 1.48 1.57 1.18 1.22
(1.45) (1.47) (1.29) (1.32)
Indigenous group 0.19 0.19 0.19 0.18
(0.39) (0.39) (0.39) (0.39)
Secondary 0.30 0.30 0.26 0.26
(0.46) (0.46) (0.44) (0.44)
High school 0.16 0.13 0.14 0.12
(0.36) (0.34) (0.34) (0.33)
Higher education 0.11 0.09 0.12 0.09
(0.32) (0.29) (0.32) (0.28)
Observations 21388 27341 2785 3623
Notes Mean values, standard deviations in parenthesis. Results for the other variables, i.e. the Mexican states,
log hourly wage and wealth, are omitted to save space.
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Estimation strategy
Strauss et al. (1998) provide a useful framework to think about the relationship
between health and labour market outcomes:
L = L(H, pc, w(H;S,A,B, I, α, ew), S, A,B, V, ξ) (6)
where L is labour supply or labour market participation, pc is a vector of prices
for consumer goods, w is the real wage, H is an array of measured health status,
S is education, A is a vector of demographic characteristics, B is the family
background of the individual, I captures the local community infrastructure, α
is an array of unobservables (e.g. ability), ew represents the measurement error,
V is non-labour income and ξ is the taste parameter.
The equation showcases the joint effect of health on both wages and labour
supply or labour market participation. Health affects labour supply and par-
ticipation directly by impacting the ability to work and indirectly by changing
wages.
There are several ways diabetes may affect H. First of all, diabetes can de-
teriorate health if it remains untreated, with the adverse effects becoming more
severe over time. Second, a diagnosis of diabetes and ensuing treatment may
lead to better health compared to the undiagnosed state. However, compared to
healthy people even those receiving treatment for their diabetes may still have
worse health outcomes. Third, there is also evidence that the diagnosis itself may
affect one’s own health perception and could lead to worse self-perceived health
(Thoolen et al., 2006). We therefore expect diabetes to adversely affect health
and consequently labour market outcomes.
When estimating equation 6 empirically with observational data, unobserved
heterogeneity may bias the results. As mentioned in the introduction of this
chapter, unobserved factors captured in α such as early childhood investments,
innate ability and risk preference could affect wages as well as the probability
to develop diabetes. Further, changes in wages or employment status may also
affect the probability to develop diabetes by affecting dietary and physical ac-
tivity patterns. Finally, measurement error ew may be an important issue due
to the large undiagnosed population with diabetes, particularly if being diag-
nosed is related to employment or wages via better access to healthcare through
employment benefits and higher income.
The following section describes our estimation strategy for the different parts
of the data.
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Panel data on self-reported diabetes
We investigate the relationship between self-reported diabetes and three labour
market outcomes: employment, wages and weekly working hours, respectively, us-
ing a FE model. While using individual level FE does not allow to fully identify
a causal relationship, this strategy does improve on the degree of causal infer-
ence, compared to a simple cross-sectional analysis.8 In particular it does allow
controlling for unobserved personal characteristics that could bias the estimates,
without the drawbacks of an at least debatable IV strategy that has been widely
applied in this literature. We have also estimated random effects models but do
not present them here as the Hausman test suggested the use of the FE model
throughout.9
We estimate the following model:
Yit = β0 + β1Diabetesit + β2Xit + ci + γt + uit. (7)
where Yit is a binary variable taking a value of 1 if respondent i reports being
in employment at time t and 0 otherwise, Diabetesit is a binary variable taking
a value of 1 at time t if the respondent reports having ever received a diagnosis
of diabetes10, Xit is a vector of control variables, ci represents an individual fixed
effect, γt represents year dummies, and uit is the error term.
For the relationship of self-reported diabetes with wages and working hours our
empirical models are estimated conditional on having positive wages and being
employed, respectively. In these models Yit represents the log hourly wage of
respondent i at time t or the weekly working hours over the last year.
The control variables in both FE specifications include dummy variables to cap-
ture the effects of the living environment, of living in a small, medium or large
city with rural as the reference category, and state dummies. We also include
a marital status dummy and the number of children residing in the household
below the age of 6 to control for the impact of marriage and children on labour
market outcomes and the effect of childbearing and related gestational diabetes
on the probability of developing type 2 diabetes (Bellamy et al., 2009). To ac-
count for the effect of changes in household wealth on diabetes and employment
probabilities, we use standard principal component analysis of multiple indicators
of household assets and housing conditions to create an indicator for household
8Other forms of unobserved heterogeneity could also affect our estimates—for instance time-
variant unobserved heterogeneity or omitted variables simultaneously driving labour market
outcomes and health.
9See the respective table for the results of the cluster robust Hausman test
10We are not able to distinguish between type 1 diabetes and type 2 diabetes using this data.
Other studies that tried to assess the effect of type 1 diabetes on labour market outcomes
have found no association (Minor, 2011; Minor et al., 2016). Including type 1 diabetes
therefore likely attenuates any adverse relationship we may find.
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wealth11 (Filmer et al., 2001). Finally, a quadratic age term and calendar year
dummies are included to capture the non-linear effect of age and any trends over
time, respectively.
Before moving on, it bears emphasizing that despite our efforts to reduce any
bias in our estimates, the estimated coefficients do not reflect true causal effects
since time-variant unobserved heterogeneity may still bias the estimates. With
respect to employment status, one potential issue would be that job loss affects
lifestyle choices that increase the probability to develop diabetes, which could
then in turn negatively affect labour market outcomes. So far, the evidence of
the health effects of job loss does not indicate important effects of job loss on the
probability to develop diabetes (Bergemann et al., 2011; Schaller et al., 2015), but
this has so far only been researched in a high-income country context. Another
example relates to stress at work, which has been linked to the development of
type 2 diabetes (Eriksson et al., 2013; Heraclides et al., 2012). However, while
stress levels may change over time, a person’s coping mechanisms to deal with
stress are likely time-invariant (Schneiderman et al., 2005). While we cannot ex-
clude the role of these time variant unobserved factors, it seems that the role of
time-invariant variables, e.g. genetic predisposition and relatively stable person-
ality traits, is predominant. The applied FE approach should then limit the bias
resulting from these time-invariant confounding factors.
Self-reported diabetes duration
To explore the role of the duration of diabetes for labour market outcomes, we
estimate the following model using a self-reported measure of the years since
diagnosis:
Yit = β0 + β1Dyearsit + β2Xit + ci + uit, (8)
where β1Dyearsit is a continuous variable indicating years since first diabetes
diagnosis.
In an effort to capture possible non-linearities in the relationship of interest we
then use a spline function that allows for the effect of an additional year with
diabetes to vary over time.
Yit = δ0 + g(Dyearsit) + δ2Xit + ci + uit. (9)
with g(Dyearsit) =
∑N
n=1 δn · max{Dyearsit − ηn−1}Iin and Iin = 1[ηn−1 ≤
11Our composite wealth index consists of owning a vehicle, a second house, a washing machine,
dryer, stove, refrigerator or furniture, any electric appliances, any domestic appliances, a
bicycle or farm animals. It further accounts for the physical condition of the house, proxied
by the floor material of the house, and the type of water access.
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Dyearsit < ηn], with ηn being the place of the n-th node for n = 1, 2, . . . , N . We
choose three nodes that—based on visual inspection (see Figures 5, 6 and 7 on
pages 111, 112 and 113, respectively)—best captured any possible non-linearity in
the relationship between diabetes duration and labour market outcomes. These
are located at 4, 11 and 20 years after diagnosis. The first four years should
capture any immediate effects of the diagnosis, the years five to eleven should
capture any effects of adaptation to the disease. After 11 years it is conceivable
that many of the debilitating complications of diabetes would appear that could
deteriorate health and lead to adverse effects on labour market outcomes. The
coefficient δn captures the effect of diabetes for the n-th interval. The effects are
linear if δ1 = δ2 =, . . . ,= δn.
Because the year of diagnosis was only reported in the third wave, duration
of diabetes (or time since diagnosis) for the earlier waves was only calculated for
those that had also been interviewed in the third wave, reducing the comparability
of the results to those using the binary diabetes indicator.12
One caveat of using FE is that, when year dummies are included, any vari-
able that varies by one unit in each time period is not separately identified
(Wooldridge, 2012). Because this is also the case for diabetes duration, in equa-
tion (8) and equation (9) identification of this variable relies on the presence
of people without diabetes in the sample, for which diabetes duration does not
increase at the same rate as time.13 As a robustness check, we also estimate
two models that only use between-individuals variation, i.e. a linear probability
model (LPM) that uses only data from the third wave, the only wave where year
of diagnosis was originally reported, and a pooled LPM that used data from all
three waves.14
Cross-section: biomarker and self-reported data
Self-reported diabetes only captures part of the population with diabetes as many
individuals remain undiagnosed; it may also contain cases of people who misreport
having diabetes. Estimations based on self-reports may therefore suffer from
selection bias in at least three ways:
1. Systematic overreporting of diabetes: people without diabetes may re-
port a diabetes diagnosis, unintentionally—for instance due to a misdi-
agnosis, either from a health professional or because of self-diagnosis, or
12To obtain the time passed since diagnosis, the year of diagnosis was subtracted from the year
of the interview.
13Consequently, those that reported a diagnosis in the year of the interview were counted
as ’one year since diagnosis’. From this follows that if the respondent reported to having
been diagnosed in the year before the interview he or she was counted as ’two years since
diagnosis’ and so on.
14Models also excluding the calendar year dummies provide similar results.
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intentionally—for instance with a view to justifying some other adverse
event or status in their life (e.g. being unemployed).
2. Systematic underreporting of diabetes: people with diabetes may also un-
derreport because they are concerned about negative stigma associated with
the condition. Furthermore, diabetes often remains undiagnosed leaving
people unaware of their condition.
3. Diagnosis is more likely for those who are more likely to have visited a doc-
tor, for instance because they are more affected by the condition, wealthier,
or hypochondriac.15
Overreporting may attenuate the effect of diabetes if those falsely reporting a
diabetes diagnosis are in fact in good health; it may also lead to an overestimation
of the impact if some of those misreports reflect other factors that negatively affect
labour market outcomes (e.g. other illnesses or general ill health), or if they are
used to justify other adverse events that may negatively affect labour market
outcomes. Similarly, underreporting may lead to an overestimation if those with
undiagnosed diabetes are generally healthier, hence more likely to have positive
labour market outcomes than those with self-reported diabetes. However, if the
undiagnosed and the diagnosed groups are similar in terms of health, then this
would lead to an underestimation of the effect of diabetes.
The health information received at a diabetes diagnosis may also have an effect
in itself. It may for instance affect an individual’s psychology which in turn
may influence economic behaviour. Two studies found a diabetes diagnosis and
subsequent treatment to increase the odds of psychological problems, including
depression and anxiety (Paddison et al., 2011; Thoolen et al., 2006), while similar
results have not been found for people with undiagnosed diabetes (Nouwen et al.,
2011). Looking at behavioural change, health information has been shown to
affect behaviour after the diagnosis of not only diabetes (Slade, 2012) but also
of other chronic diseases (see Baird et al. (2014), Gong (2015), Thornton (2008),
and Zhao et al. (2013b)). However, little is known about the effects of health
information on labour market outcomes. For diabetes, only Liu et al. (2014)
investigate the effect of receiving a diabetes diagnosis on labour income in Chinese
employees. This study finds a reduction in labour income which was attributed
to the psychological effects of the diagnosis.16
15More formally, assume that the true model of the effect of diabetes on labour market outcomes
is y = X∗β+. Because we do not observe the true values of X∗ we have to use self-reported
measures that contain errors: X = X∗ + u. Since u may be correlated with  - in contrast
to classic measurement error which is randomly distributed, we cannot sign the bias of β.
16In a very different context Dillon et al. (2014), using a randomized intervention, find that the
news stemming from a diagnosis of malaria affect productivity and income, but not labour
supply among sugar cane cutters in Nigeria.
107
The use of biomarker data allows to explore the relationship of measured dia-
betes with labour market outcomes which can then be compared to the estimated
effect of self-reported diabetes. The biomarker data also enable us to look at dia-
betes severity, as measured by HbA1c values. Since these data are only available
for a subsample of one wave—the most recent one—our analysis here is limited to
cross-sectional data no longer directly comparable to the panel-based results in
this paper. Nonetheless, the data allow for a first exploration of the relationships
of measured diabetes and disease severity with labour market outcomes.
Our analysis of the biomarker sample consists of three steps. We first estimate
equation 10 to assess the association of self-reported diabetes with labour mar-
ket outcomes as before, but this time for the biomarker sample only, using the
following specification:
Yi = β0 + β1Dsri + β2Xi + ci + ui. (10)
We then estimate the relations between diabetes, as defined by our biomarker,
and labour market outcomes, via the following equation:
Yi = β0 + β1Dbioi + β2Xi + ci + ui. (11)
Here Dbioi is equal to 1 if HbA1c ≥ 6.5%.
To find the effect of undiagnosed diabetes, we include both variables at the
same time and estimate:
Yi = β0 + β1Dsri + β2Dbioi + β3Xi + vi + ui. (12)
For the biomarker analysis we rely on within-community variation vi for iden-
tification in order to account for unobserved community characteristics, such as
the access to healthcare and the quality of healthcare in the community, poverty
and unemployment levels in the community, or the amount of public green space
and recreational possibilities available. These factors potentially affect both the
propensity to develop diabetes and to receive a diagnosis; they may also be related
to labour market outcomes.17
17We did not account for fixed household characteristics as the average number of observa-
tions per household was close to one, i.e. for most households only one member provided
biomarker information in our subsample, significantly limiting the variation within house-
holds that would be needed for identification.
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Results
Incidence of self-reported diabetes
Table 15 presents the estimation results of the FE model using equation 7. They
indicate significant and substantial reductions in the probability of employment
for men and women with self-reported diabetes. The coefficients are similar for
both sexes, showing a reduction in employment probabilities of over 5 percent-
age points. In relative terms—taking into account the lower employment rates
for women compared to men—these absolute reductions translate into relative
reductions in employment probabilities of 14% for women and of 6% for men,
suggesting a stronger impact of diabetes on women than men.
The results in Columns 3–6 show no significant relationship between self-
reported diabetes and wages or working hours. One may expect this relation-
ship to differ by the type of work, as those with diabetes working in an agricul-
tural job that requires strenuous physical efforts may see their productivity more
adversely affected than those engaged in more sedentary work. We therefore
estimate a model including interaction terms between self-reported diabetes and
agricultural employment and between self-reported diabetes and self-employment,
respectively, using non-agricultural wage employment as the comparison group,
and restricting our sample to those employed only.
The results in Table 16 show that while male agricultural workers have lower
wages in general, the relationship with diabetes does not depend on the type of
work, as none of the interaction terms show up as significant. In the working
hours regression, one interaction term is significant, suggesting that those with
self-reported diabetes working in agriculture supply 5 hours less relative to non-
agricultural workers and employees. However, because we have more than two
work types we cannot draw conclusions solely on the basis of the t-statistic. We
therefore perform a Wald test for the overall significance of the interaction term
which does not reject the null of no interaction effects (p = .15), indicating that
the effect of diabetes on working hours does not vary significantly by type of
work.
In summary, we find no evidence for an association between self-reported di-
abetes and wages or working hours. This lack of effects may be explained by
selection: potentially, only those with ’mild’ or asymptomatic diabetes are still in
the same job continuing to earn similar wages. Only once complications become
increasingly severe would they switch activity (or drop out of the labour mar-
ket), without going through a notable phase of reduced productivity and labour
supply.
To explore whether diabetes affects the selection into certain types of work we
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estimate FE models of the probability of being in non-agricultural wage employ-
ment, agricultural employment or self-employment, using three dummy variables
indicating the respective type of work as the left hand side variables. The re-
sults in Table 17 indicate a negative association with self-employment, though
the estimates are quite imprecise. For women, those who self-report diabetes are
less likely to work in agriculture and potentially self-employment. This may sug-
gest that having diabetes drives people out of self-employment and agricultural
jobs, for instance because these jobs are physically more demanding and possibly
also because they provide less protection in terms of insurance and employment
duration.1819
18We also estimated a pooled multinomial logit model augmented with the within-between
approach (Bell et al., 2015), based on the work of Mundlak (1978), which allows interpreting
the coefficients of all time-varying variables as within-effects by including individual means
of all time-varying covariates. Several other studies in economics have used this approach
recently, e.g. Boll et al. (2016), Geishecker et al. (2011), and Wunder et al. (2014). The
results indicate a very similar pattern both in size and significance.
19Using the same methods, we also investigated the impact of diabetes on changes in the type
of work for those already employed, finding no evidence that diabetes leads to changes in
the type of work.
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Table 15: Self-reported diabetes and labour market outcomes.
Employment Log hourly wages Weekly working hours
(1) (2) (3) (4) (5) (6)
Males Females Males Females Males Females
Self-reported diabetes −.054∗∗ −.059∗∗ 0.054 0.081 −.524 −1.955
(.025) (.024) (.067) (.158) (1.499) (2.517)
Hausman test 255.260 388.822 1084.317 91.096 967.007 106.455
p-value 0.000 0.000 0.000 0.000 0.000 0.000
N 21388 27341 13828 7068 17616 9112
Notes Individual level fixed effects. Robust standard errors in parentheses. Reference category: dependent non-
agricultural worker or employee. Other control variables: state dummies, urbanization dummies, education dummies,
married dummy, number of children < 6, wealth, health insurance status, age squared and calender year dummies. ∗
p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table 16: Effect of self-reported diabetes on wages and working hours, by type of
work.
Log hourly wage Weekly working hours
(1) (2) (3) (4)
Males Females Males Females
Agricultural worker −.078∗ −.280 −3.577∗∗∗ −4.473∗
(.044) (.186) (.800) (2.702)
Self-employed 0.028 −.144∗ −1.452∗∗ −4.713∗∗∗
(.043) (.087) (.704) (1.388)
Self-reported diabetes 0.105 0.064 0.617 −.524
(.076) (.169) (1.606) (2.252)
Self-reported diabetes x
agricultural worker −.242 −.409 −5.495∗ −3.535
(.188) (.373) (2.833) (22.300)
Self-reported diabetes x
self-employed −.105 0.125 0.306 −4.149
(.192) (.326) (2.503) (4.739)
Hausman test 280.491 912.537 4086.461 995.171
p-value 0.000 0.000 0.000 0.000
N 13828 7068 17616 9112
Notes Individual level fixed effects. Robust standard errors in parentheses. Reference category:
non-agricultural worker or employee. Other control variables: state dummies, urbanization dum-
mies, education dummies, married dummy, number of children < 6, wealth, health insurance status,
age squared and calender year dummies. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table 17: Relationship between self-reported diabetes and selection into types of work.
Males Females
(1) (2) (3) (4) (5) (6)
Non-agric. Agric. Self-employed Non-agric. Agric. Self-employed
Self-reported diabetes −.006 −.008 −.043 −.001 −.022∗∗ −.029
(.029) (.022) (.026) (.018) (.009) (.018)
Hausman test 2196.390 2005.383 1249.080 1126.933 86.400
p-value 0.000 0.000 0.000 0.000 0.000
N 20719 20719 20719 26577 26577 26577
Notes Individual level fixed effects. Robust standard errors in parentheses. Other control variables: state dummies, urbanization
dummies, education dummies, married dummy, number of children < 6, wealth, health insurance status, age squared and calender
year dummies. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Duration of self-reported diabetes
Because diabetes is a chronic and generally life-long disease, we investigate how
soon after the first diagnosis diabetes may affect labour market outcomes. Given
that complications of diabetes develop over time, the effect may increase linearly
as the years go by. Non-linear relationships are also plausible: health problems
that have led to the diagnosis as well as psychological effects after the diagnosis
may affect labour market outcomes immediately after having been diagnosed
with diabetes. Similarly, management of the disease may be successful only after
some initial period. It is also possible that after some time complications start
to appear, again reducing health and leading to reductions in labour supply and
productivity.
To obtain an initial idea of the relationship between our outcome variables
and diabetes duration we use a non-parametric kernel-weighted local polynomial
regression. As Figure 5 shows, the relationship between diabetes duration and
the probability of employment for men shows a more or less steady decline that
becomes more pronounced as time progresses. For women, a first drop-off occurs
right after diagnosis; thereafter no consistent pattern is observed.20 A similar
analysis for wages shows somewhat more erratic relationships, although there
seems to be a long term negative trend for women but not for men (see Figure
6). Similar trends are observed for working hours (see Figure 7).
Tables 18 and 19 present the results of the linear and non-linear duration
models (for which we created the following splines to capture the immediate,
intermediate and long-term relationships: 0–4, 5–11, 12–19 and 20+), starting
with the results of the cross-sectional LPM, followed by the pooled LPM and
then the FE model as specified in equation (8) and equation (9).
For male employment probabilities (Table 18) the results indicate a yearly re-
duction throughout all models, with the biggest effects being suggested by the
FE model. For women, the coefficient shows a reduction of up to almost 1 per-
centage point per year in the FE model, though statistical significance is lower
than in the ordinary least squares (OLS) models. Focusing on the FE results, the
coefficients in the spline models provide some evidence for an immediate effect
of diabetes, which then levels off for some time after which it becomes stronger
again. Nonetheless, for males and particularly females, the coefficients are quite
imprecisely measured.
Turning to wages (Table 19), the FE model indicates a reduction in female
wages of about 7% per year with diabetes. For men we find no consistent effect.
The results of the non-linear specification indicate that there may be a reduction
20Since long run estimations suffer from large standard errors—as the sample size is strongly
reduced—this limits its interpretation and we therefore truncate the graphs at a disease
duration of 24 years.
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in wages 5–11 years after the initial diagnosis for both men and women. We also
find associations for women with more than 20 years of diabetes, but these esti-
mates may be spurious due to the considerably reduced number of observations
in this group.21 Interestingly, the reductions in wages found in the non-linear
specification appear exactly at the time where employment probabilities are less
affected. This could suggest that at this point reductions in productivity affect
wages but are not so severe that they would cause job loss. There appears to be
no consistent relationship between working hours and time since being diagnosed
with diabetes.
Overall, these results suggest a fairly constant decrease in the probability of
employment for both men and women and in earnings for women, which contrasts
with estimates for the USA (Minor, 2013), where no such linear relationship
is observed. Minor (2013) finds a reduction in employment probabilities of 82
percentage points for females after 11 to 15 years and a reduction of 60 percentage
points for males after 2-5 years, indicating very large employment penalties, in
particular in comparison to our results for Mexico. However, our non-linear
results are not directly comparable to these estimates as Minor used pooled cross-
sectional data, constructed dummy variables instead of splines and used different
duration groups.22
21There are only 9 and 3 observations for male and female wages with more than 20 years since
diagnosis in wave 3, respectively, and 17 and 7 in the pooled sample, respectively. For male
and female working hours there are 12 and 7 observations with more than 20 years since
diagnosis in wave 3, respectively, and 20 and 12 for the pooled sample, respectively.
22We estimated a comparable model to that of Minor (2013) using dummy variables and find a
significant reduction in employment probabilities throughout, regardless of whether we use
our duration groups to construct the dummies or the duration groups used by Minor (2013).
For men, we find a significant reduction of about 6 to 12 percentage points, depending on
the specification used, in the first 2 and 4 years after diagnosis, respectively. In the following
years the effect size tends to increase somewhat. For women, we find less evidence for an
immediate effect of diagnosis, but effects do emerge after about 2 years of living with the
disease and also increase somewhat over time.
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Figure 5: Kernel-weighted local polynomial regression of employment status on
diabetes duration.
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Figure 6: Kernel-weighted local polynomial regression of log hourly wages on di-
abetes duration.
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Figure 7: Kernel-weighted local polynomial regression of working hours on dia-
betes duration.
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Cross-sectional biomarker analysis
In this section we gain additional insights from using the biomarker data collected
in the third wave of the MxFLS. These data enable us to identify respondents with
HbA1c levels equal to or above the internationally recognized diabetes threshold
of 6.5%. This will allow the investigation of the direction of bias introduced when
relying on self-reported diabetes only and when it is not possible to identify those
unaware as well.
We first present a cross tabulation of self-reported diabetes and the results of
the biomarker analysis (Table 20). The table shows that 27% of the sample have
HbA1c levels indicative of diabetes and 81% of those self-reporting a diabetes di-
agnosis also have HbA1c levels equal to or above the diabetes threshold. Overall,
of the people with diabetes according to the biomarker analysis, 32% self-report
a diagnosis, while 68% do not.
To further investigate the relationship of self-reported and biomarker tested
diabetes, we estimate the models presented in equations 10, 11 and 12. The
results in columns 1 and 2 of Table 21 show that the earlier longitudinal results
using self-reported diabetes are robust for the biomarker sample. The coefficients
in column 3 and 4 indicate that the associations with employment probabilities
are much weaker when using diabetes defined by the biomarker instead of self-
reported diabetes.23 In columns 5 and 6, obtained from estimating equation 12,
the coefficient for the biomarker diabetes population Dbioi now reflects the effect
of undiagnosed diabetes, as the regression includes a control for self-reported
diabetes, revealing that undiagnosed diabetes is not associated with any of the
labour market outcomes.
23We also created a dummy variable that additionally to measured diabetes accounted for those
with a self-reported diabetes diagnosis but biomarker levels below the diabetes threshold.
This allowed us to investigate the effect for the entire population with diabetes. The coef-
ficients and their statistical significance are only marginally different to those presented in
columns 3 and 4 of Table 21, which is why we do not present them here.
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Table 18: Relationship between self-reported years since diagnosis and employ-
ment probabilities using continuous duration and duration splines.
Males Females
(1) (2) (3) (4) (5) (6)
OLS OLS FE OLS OLS FE
(Wave 3) (Pooled) (Wave 3) (Pooled)
Panel A: linear
Diabetes duration −.008∗∗∗ −.007∗∗∗ −.017∗∗∗ −.005∗∗∗ −.004∗∗∗ −.009∗
(.002) (.002) (.006) (.002) (.001) (.005)
Hausman test 153.024 200.073
p-value 0.000 0.000
Panel B: splines
Diabetes duration
0–4 −.007 −.007 −.026∗ −.010 −.015∗∗ −.017
(.007) (.006) (.014) (.007) (.006) (.016)
5–11 0.000 −.003 −.003 −.004 0.004 −.003
(.009) (.006) (.009) (.008) (.006) (.008)
12–20 −.030∗∗ −.017∗ −.029∗ 0.005 −.004 −.014
(.012) (.010) (.016) (.008) (.006) (.011)
> 20 0.011 0.007 −.046∗ −.010∗ −.003 −.015
(.016) (.014) (.028) (.006) (.003) (.018)
Hausman test 161.953 198.692
p-value 0.000 0.000
N 8217 16292 16292 10467 22407 22407
Notes The table presents the results of three estimation methods. Panel A presents the results of the linear specifications. Panel
B presents the results of the non-linear specifications. Robust standard errors in parentheses. Other control variables: state
dummies, urbanization dummies, education dummies, married dummy, number children < 6, wealth, age squared and calendar
year dummies. The OLS and pooled OLS models additionally control for age. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table 19: Relationship between self-reported years since diagnosis and log hourly
wage / weekly working hours using continuous duration and duration
splines.
Males Females
(1) (2) (3) (4) (5) (6)
OLS OLS FE OLS OLS FE
(wave 3) (pooled) (wave 3) (pooled)
Log hourly wages
Panel A: linear
Diabetes duration 0.001 0.010∗∗ −.019 −.014∗ −.009 −.073∗∗
(.006) (.005) (.018) (.008) (.008) (.029)
Hausman test 838.213 93.232
p-value 0.000 0.000
Panel B: splines
Diabetes duration
0–4 0.034∗ 0.046∗∗∗ 0.033 0.027 0.030 0.015
(.017) (.016) (.055) (.031) (.026) (.138)
5–11 −.041∗ −.037∗∗ −.055∗ −.039 −.034 −.101∗
(.021) (.018) (.033) (.030) (.024) (.056)
12–20 0.015 0.044 0.062 −.032 −.071∗ −.051
(.033) (.029) (.056) (.042) (.039) (.047)
> 20 0.053 0.014 −.111 −.007 0.041∗∗∗ −.204∗∗∗
(.054) (.040) (.104) (.028) (.015) (.053)
Hausman test 1037.290 96.266
p-value 0.000 0.000
N 5509 10767 10767 2874 5741 5741
Weekly working hours
Panel A: linear
Diabetes duration 0.069 0.048 0.181 −.020 −.124 0.208
(.124) (.102) (.330) (.187) (.127) (.652)
Hausman test 704.904 107.709
p-value 0.000 0.000
Panel B: splines
Diabetes duration
0–4 −.033 −.233 0.709 0.739 0.470 2.014
(.421) (.325) (.938) (.645) (.586) (2.947)
5–11 0.269 0.338 −.218 −.410 −.479 −.508
(.539) (.399) (.568) (.728) (.553) (1.020)
12–20 0.209 0.137 0.698 −.164 −.051 −.402
(.730) (.538) (.945) (.995) (.700) (1.207)
> 20 −1.300 −.768 0.039 −.499 −.418 8.117∗∗∗
(.944) (.930) (2.184) (.930) (.305) (1.612)
Hausman test 724.225 112.627
p-value 0.000 0.000
N 6807 13581 13581 3591 7383 7383
Notes The table presents the results of three estimation methods for the two dependent variables: log hourly wages
and weekly working hours. Panel A presents the results of the linear specifications. Panel B presents the results of the
non-linear specifications. Robust standard errors in parentheses. Other control variables: state dummies, urbanization
dummies, education dummies, married dummy, number children < 6, wealth, age squared, calendar year dummies, type of
work (agricultural and self employed with dependent non-agricultural wage employment as the base) and health insurance
status. The OLS and pooled OLS models additionally control for age. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table 20: Number of observations with diabetes (HbA1c ≥ 6.5%) and self-
reported diabetes.
HbA1c < 6.5% HbA1c ≥ 6.5% Total
No self-reported diabetes 4544 1181 5725
79% 21% 100%
97% 68% 89%
Self-reported diabetes 129 554 683
19% 81% 100%
3% 32% 11%
Total 4673 1735 6408
73% 27% 100%
100% 100% 100%
Notes The first row of each category presents absolute values, the second row presents row
percentages and the third row present column percentages.
122
As discussed earlier, differences in effects between self-reported diabetes and
those undiagnosed are likely to stem from selection into the diagnosed popula-
tion, for instance those in worse health, with higher HbA1c levels or a longer
disease duration are more likely to go to the doctor and be diagnosed as well
as to lose their job because of their diabetes. To further explore this, we first
estimate models additionally controlling for self-reported health status, to cap-
ture differences in subjective individual health. Secondly, we estimate models
accounting for measured HbA1c levels, to investigate in how far current diabetes
severity affects our labour market outcomes. If current severity would be related
to labour market outcomes and explain the difference between self-reported and
undiagnosed diabetes, one would expect an adverse association with increasing
HbA1c levels, for both self-reporting and undiagnosed. To investigate this, we
construct three dummy variables using HbA1c groups above the diabetes thresh-
old (i.e. 6.5–7.9, 8–11.9 and 12–14), each for those with self-reported diabetes
and for those unaware of their diabetes (Table 22, Panel B).
When additionally controlling for subjective health status, we find that for
men and women the difference between self-reported diabetes and undiagnosed
diabetes is reduced due to a smaller coefficient for self-reported diabetes (Table 22,
Panel A). Especially for women, the point estimates for self-reported diabetes and
undiagnosed diabetes are now virtually the same size, suggesting that differences
could be due to the differences in self-reported health. For men, factors not
captured by self-reported health may still play a role.24
Turning to Panel B, we do not find a consistent relationship of increasing HbA1c
levels with employment chances, especially for those self-reporting, suggesting
that current disease severity may not explain the different employment effects of
diabetes for the aware and unaware.
To the best of our knowledge only one study has previously used biomarkers to
analyse the relationship with labour market outcomes in a comparable population.
Brown et al. (2011) use data for a Mexican American population in a broadly
comparable way to this paper, though stopping short of investigating the labour
market impact of undiagnosed diabetes. In concordance with our results, this
study also finds that once diabetes is diagnosed, current management plays a
minor role in determining labour market outcomes. This is not surprising given
that HbA1c levels only provide a picture of blood glucose levels over the last
three months. They therefore may not be representative of blood glucose levels
in the years before and after the diabetes diagnosis which ultimately determine
how soon complications appear and how severe they will be.
24Additionally accounting for measures of overweight and obesity, self-reported hypertension,
heart disease and depression does not further affect the interpretation of the diabetes coef-
ficient.
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Table 21: Biomarker results
Self-reported diabetes HbA1c ≥ 6.5 HbA1c ≥ 6.5 and self-reported d.
(1) (2) (3) (4) (5) (6)
Males Females Males Females Males Females
Dependent variable: Employment
Self-reported diabetes −.051∗∗ −.044∗ −.053∗∗ −.032
(.026) (.023) (.026) (.026)
HbA1c ≥ 6.5 −.012 −.031∗ 0.003 −.022
(.016) (.018) (.017) (.019)
N 2785 3623 2785 3623 2785 3623
Dependent variable: Log hourly wages
Self-reported diabetes −.010 −.040 −.006 −.010
(.065) (.113) (.078) (.119)
HbA1c ≥ 6.5 −.007 −.057 −.006 −.055
(.044) (.070) (.049) (.075)
N 1803 884 1803 884 1803 884
Dependent variable: Weekly working hours
Self-reported diabetes −.293 −.751 −.286 −1.566
(1.305) (2.178) (1.419) (2.351)
HbA1c ≥ 6.5 −.088 1.153 −.012 1.525
(.844) (1.462) (.925) (1.565)
N 2302 1144 2302 1144 2302 1144
Notes Community level fixed effects. Robust standard errors in parentheses. Other control variables: age, age squared, state
dummies, urbanization dummies, education dummies, married dummy, number children < 6 and wealth. Calender year dummies
are included as data collection for the third wave was stretched out over several years. The wage and working hour models
additionally control for type of work (agricultural and self employed with non-agricultural wage employment as the base) and
for health insurance status. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table 22: Self-reported diabetes, biomarkers, diabetes severity and self-reported
health and their association with labour market outcomes
Employment Log hourly wages Weekly working hours
(1) (2) (3) (4) (5) (6)
Males Females Males Females Males Females
Panel A (self-reported health)
Self-reported diabetes −.036 −.023 0.002 0.060 0.123 −2.191
(.026) (.027) (.079) (.121) (1.433) (2.386)
HbA1c ≥ 6.5% 0.003 −.023 −.004 −.051 −.066 1.829
(.017) (.019) (.049) (.075) (.926) (1.569)
Self-reported health status
good 0.023 0.057∗ 0.061 −.115 −1.131 3.521
(.025) (.034) (.074) (.124) (1.376) (2.499)
fair −.007 0.006 0.025 −.157 −1.606 4.646∗
(.026) (.034) (.076) (.128) (1.424) (2.607)
bad −.127∗∗∗ −.024 −.016 −.371∗ −6.190∗∗ 6.918∗
(.043) (.046) (.135) (.189) (2.521) (3.858)
very bad −.165 0.117 −.331 0.316 −1.869 −17.400∗
(.110) (.116) (.300) (.439) (6.433) (9.005)
N 2785 3621 1803 883 2302 1143
Panel B (HbA1c levels)
Self-reported diabetes
6.5− 7.9 −.126∗∗ −.040 −.228∗ 0.041 1.218 −9.170∗
(.059) (.051) (.127) (.269) (2.921) (4.864)
8− 11.9 −.052 −.051 0.026 0.225 −1.332 −1.086
(.051) (.042) (.107) (.206) (2.298) (4.395)
12+ 0.011 0.021 −.106 −.427 1.979 −2.518
(.062) (.069) (.156) (.279) (3.692) (5.335)
Undiagnosed diabetes
6.5− 7.9 0.005 −.002 0.015 −.040 1.003 3.616
(.022) (.025) (.058) (.099) (1.178) (2.323)
8− 11.9 0.006 −.027 0.014 −.204 −1.004 −.077
(.035) (.031) (.078) (.129) (1.485) (2.614)
12+ 0.015 −.055 −.019 0.169 −1.581 1.753
(.040) (.046) (.087) (.181) (2.099) (3.978)
N 2785 3623 1803 884 2302 1144
Notes Community level fixed effects. Robust standard errors in parentheses. Other control variables: age, age squared,
state dummies, urbanization dummies, education dummies, married dummy, number children < 6 and wealth. Calender
year dummies are included as data collection for the third wave was stretched out over several years. The wage and
working hour models additionally control for type of work (agricultural and self employed with non-agricultural wage
employment as the base) and for health insurance status. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Minor et al. (2016) finds for a general USA population, similar to us, that
people with undiagnosed diabetes likely, if at all, experience smaller employment
penalties than people self-reporting the disease. He finds, however, much bigger
effects than we do when estimating the impact of biometrically measured diabetes
instead of distinguishing between the self-reporting and those unaware. This may
be explained by the fact that in that study the undiagnosed population made up
a much smaller share of the overall population with diabetes compared to our
study, so that self-reported diabetes was still the predominant factor driving the
result.
Conclusion
Diabetes has become one of the most common chronic diseases in middle- and
high-income countries, with the potential to severely impact the health and eco-
nomic well-being of those directly (and possibly indirectly) affected. Yet there
remains only limited ’hard’ evidence on the economic consequences, especially for
these countries. Moreover, what evidence does exist at best partially tackles the
econometric challenges involved.
This paper improves on existing work by addressing several methodological
challenges that arise due to the nature of the disease and types of data available,
using rich longitudinal panel data from Mexico, a MIC for which the biomarker
data used in this paper indicates that diabetes, including undiagnosed diabetes,
has reached alarming levels.
Apart from providing unique evidence for a developing country, the paper
makes methodological contributions for the estimation of labour market effects of
diabetes. By estimating individual fixed effects the analysis provides an improved
accounting for the endogeneity of self-reported diabetes, as this allows cancelling
out the potential role of unobserved individual traits that may affect both labour
market outcomes and the propensity to self-report (or suffer from) diabetes. Us-
ing further information on the year of diagnosis enables us to investigate the
potential heterogeneity in the effect of self-reported diabetes on labour market
outcomes over time. Finally, taking advantage of biomarker data to identify the
entire population with diabetes, i.e. including those with undiagnosed diabetes,
allows for an assessment of the potential bias in estimates relying on self-reported
diabetes (which is still the most frequent measure in the previous literature).
The first part of our results confirms a considerable gap in employment prob-
abilities for both men and women reporting a diabetes diagnosis, compared to
those that do not report the condition. We also find some evidence that diabetes
is more likely to reduce the probability of employment in the agricultural and
self-employment sector, characterized predominantly by informal arrangements,
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compared to the rest of the workforce. Those who remain employed do not suf-
fer any wage or labour supply effects, possibly because they are still relatively
healthy or are able to resort to a type of work that does not entail their diabetes
status limiting their work-related performance. More research will be needed to
confirm and further investigate this finding as well as its interpretation.
Regarding the heterogeneity in the effects of diabetes over time, our results in-
dicate an adverse impact of self-reported diabetes on employment chances, with
the impact growing in magnitude especially after the first 10 years post-diagnosis.
This is plausible in that as time lived with diabetes evolves, complications asso-
ciated with diabetes tend to become more frequent and more severe (Adler et
al., 2003). Looking at wages as our labour market outcome, we uncover some ad-
verse effects for females, indicating a sizeable reduction with time since diagnosis.
These findings may bode ill for countries where diabetes has started appearing
at an increasingly younger age, causing people to live with the disease for larger
parts of their productive lifespan, possibly exacerbating the economic effects of
reduced employment due to diabetes (Hu, 2011; Villalpando et al., 2010).
The second part of our results indicates that only relying on self-reported di-
abetes can lead to an overestimation of the relationship between diabetes and
labour market outcomes. We find that a negative relationship only exists for
those with self-reported, but not for those with undiagnosed diabetes. This per-
haps surprising, notable difference, is at least mediated by the subjective health
status being worse for those self-reporting compared to the undiagnosed. Current
disease severity, as proxied by HbA1c levels, does not appear to play an important
role in this context.
Our findings bear several implications. First, when interpreting labour market
impact estimates relying on self-reported diabetes, one cannot assume that the
results extend to those with undiagnosed diabetes. However, the strategy of sim-
ply merging those self-reporting and those undiagnosed in one diabetes category
may not be ideal either, as doing so will fail to account for the heterogeneity
between the groups in the amount of health information they possess, the time
they have already been exposed to elevated blood glucose levels and consequently
their subjective as well as true health status, leading to a potentially important
loss of information. If, by contrast, both groups are separately accounted for
in the model, thereby acknowledging their inherent differences, this allows us to
gain information about the distribution of the economic burden across the two
groups.
In the case of Mexico, given that more than 7% of the Mexican population
have been diagnosed with diabetes, the identified reduction in employment prob-
abilities for those with self-reported diabetes still amounts to a significant overall
economic burden being associated with (diagnosed) diabetes.
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Our results add further weight to the case for reducing the incidence and pro-
gression of diabetes. On top of the well-documented health benefits, it appears
there are considerable potential gains to be had in terms of increasing the pro-
ductive lifespan of people. This is of particular importance in LMICs, where
parental health shocks, related job loss and increasing health expenditures can
have repercussions across the entire household. Other family members, including
children, may be forced to increase their labour supply and to reduce non-health
expenditures in order to prevent deterioration of the household’s economic situ-
ation. This can lead to forgone investments into child education, showcasing the
potential for adverse long-term effects of health shocks due to diabetes (Bratti
et al., 2014). Moreover, the large proportion of undiagnosed people indicates that
diagnosis—at least in Mexico—happens too late or not at all, thereby significantly
reducing the possibility to prevent complications via appropriate treatment and
self-management, which has repercussions by increasing the risk of severe compli-
cations appearing early. Hence, much of the health and economic burden may be
prevented by earlier diagnosis and, given the generally limited success in achiev-
ing good control in Mexico, better treatment of those already diagnosed with
diabetes. Ultimately, of course, there will be a need to invest in the prevention of
diabetes cases in the first place. Taxation of sugar sweetened beverages may be
one promising way forward (Colchero et al., 2016), though the long-term effects
in terms of diabetes prevention remain to be demonstrated.
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5 The relationship between
diabetes, employment status and
behavioural risk factors: An
application of marginal structural
models and fixed effects to
Chinese panel data
Pre-amble
Chapters 3 and 4 provided evidence of the adverse impact of self-reported dia-
betes on employment probabilities in Mexico. However, if this is also the case
in other middle-income countries (MICs) is unclear. Chapter 5 adds to this us-
ing panel data covering a period of rapid economic transition in China, again
estimating the relationship of diabetes and employment status. Moreover, it pro-
vides information about the ability of people with diabetes achieving changes in
behavioural risk factors important for the prevention of diabetes complications,
as studies have shown that smoking cessation and weight loss after a diagnosis
can have beneficial effects on blood glucose control and the risk of complications.
Importantly, it not only addresses time-invariant unobserved heterogeneity by
using individual level fixed effects as in the previous chapter, but also accounts
for the potential effects of time-variant confounding by using marginal structural
models.
This method is widely applied in epidemiology and able to account for con-
founding over time, where prior outcomes can affect the current treatment, for
example the previous employment status affects the current diabetes status. This
potential source of bias has been assumed to not exist in previous studies, but
could potentially have biased the estimate of the effect of diabetes on labour mar-
ket outcomes. This chapter thereby makes several contributions compared to the
previous chapters: It provides information about the robustness of the identified
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relationship of diabetes with employment status by using an alternative estima-
tion strategy in a different setting, thereby also taking into account the potential
effect of behavioural risk factors, and it gives first evidence in how far people
with diabetes in China are able to change their behavioural risk factors after a
diabetes diagnosis.
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Abstract
A diabetes diagnosis entails important consequences for its recipients.
Diagnosed patients obtain health information but also face the challenge
of having to manage the condition via lifestyle adjustments, with potential
consequences for—among other things—their economic activity. We inves-
tigate the causal effect of a diabetes diagnosis on employment status and
behavioural risk-factors, two potentially intertwined factors, using longi-
tudinal data from the China Health and Nutrition Survey (CHNS) that
cover the years 1997 to 2011. Two complementary statistical techniques—
marginal structural models and fixed effects panel estimation—are used
for the statistical analysis, and generate very similar results despite their
different underlying assumptions. Both strategies find distinct patterns for
males and females. They suggest a decrease in female employment proba-
bilities after a diagnosis (over 11 percentage points) and further show that
women are mostly unable to positively change their behavioural risk fac-
tors by loosing weight and reducing energy intake. Men, however, do not
see their employment probabilities affected by diabetes and also respond
to a diagnosis by losing weight and reducing energy intake as well as their
intake of alcohol in ways that are sustained over time. These results sug-
gest important inequities in the impact of diabetes between sexes in China
and point to the potential of reducing behavioural risk factors for women
to narrow these inequities.
Introduction
The effect of diabetes on employment status has received relatively little attention
in middle-income countries (MICs), including China. The scarce existing evidence
indicates that diabetes can affect labour market outcomes in high-income coun-
tries (HICs), but also in MICs (Seuring et al., 2016). This is of growing relevance
especially with diabetes appearing increasingly earlier in a person’s productive
lifespan, likely due to increasing obesity at earlier ages. Importantly, once diag-
nosed, the onset of diabetes and diabetes complications, strongly depends on the
patient’s behaviour. Behavioural risk factors, like alcohol consumption, smoking,
caloric consumption and weight gain, are all related to the onset of diabetes as
well as ensuing diabetes complications. Research shows, for instance, that be-
haviour changes after a diabetes diagnosis can have positive health effects and
reduce the risk of subsequent cardiovascular events (Long et al., 2014) and may
help in effectively managing blood glucose levels and achieving further treatment
goals (Zhou et al., 2016). Consequently, if these risk factors can be reduced it
may be possible to prevent some of the health and economic burden of diabetes.
Thus, it seems that a diabetes diagnosis may present an important opportunity
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to reduce risk factors for diabetes complications (De Fine Olivarius et al., 2015)
and hence also reduce the economic burden of diabetes to the individual. This
raises the question how a diabetes diagnosis affects both labour market outcomes
and health behaviour over time.
However, one of the challenges of determining a causal relationship between
diabetes, employment status and changes in behavioural risk factors is their po-
tential bidirectional interrelatedness. For example, employment status might be
affecting weight status by reducing the time spend on physical activity due to re-
ductions in available leisure time, or it may promote risk factors such as smoking
behaviour or energy intake that can both affect the probability of developing di-
abetes as well as diabetes related complications, for instance by increasing stress
levels. In an effort to investigate the dynamic impact of unemployment on health
behaviours, Colman et al. (2014) found heterogeneous effects of unemployment
which led to slight weight gain, a decrease in smoking and decreases in fast-food
consumption. Macroeconomic evidence also indicates that job loss can lead to
changes in health, especially in mental health (Charles et al., 2008), which may
have further downstream effects on health behaviours.
Research on the impact of diabetes on labour market outcomes has so far ig-
nored the potentially simultaneous relationship of diabetes with employment and
behavioural diabetes risk factors. Using regression techniques, such as ordinary
least squares (OLS) or fixed effects (FE), it was assumed that the investigated
independent variables are unaffected by prior values of the dependent variable.
However, if prior changes in employment status are causally related to a diabetes
diagnosis or affect the risk factors for diabetes complications, not accounting for
this can lead to biased estimates.1 Similarly, studies investigating the impact of
a diabetes diagnosis on behavioural risk factors while not taking into account the
effect of employment status on both diabetes and these risk factors, may pro-
duce biased estimates. Moreover, apart from time-varying confounding due to
observed covariates, unobserved variables present a further challenge. In partic-
ular, time-invariant confounders—such as poor early life conditions or personal
traits—may simultaneously increase the probabilities to develop diabetes, to be
unemployed and to engage in unhealthy behaviour.
The goal of this study is therefore to assess the impact of a diabetes diagnosis
on both employment probabilities and behavioural risk factors while account-
ing for the potentially intertwined relationships between diabetes, employment
1One solution is to include lagged values of the dependent variable on the right hand side, but
this raises challenges of its own, including difficulty of interpretation, but also potentially
biased estimates. The lagged dependent variable will be correlated with the time-invariant
part of the error-term, violating the assumption of exogeneity of the right-hand side vari-
ables. Further, if the other covariates are correlated with the lagged-dependent variable,
they will also be biased (Anderson et al., 1982; Nickell, 1981).
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and health behaviours. This is done via the use of marginal structural mod-
els (MSMs), an estimation strategy that is increasingly common in epidemiology
and is able to account for time-dependent confounding across time (Robins et al.,
2000) when estimating the impact of a treatment, here a diabetes diagnosis, on
the outcome of interest. This is, by our knowledge, the first time this estimation
strategy is used to estimate the impact of diabetes on an individual’s employment
status or behavioural risk factors. We complement this strategy and test the ro-
bustness of the MSM estimates to the potential violation of one of its crucial
assumptions, namely that there are no unmeasured confounding factors. To do
this, we compare the MSM estimates with FE models which, although unable
to account for the potentially bidirectional relationship, account for unobserved
time-invariant confounding factors in addition to confounding due to observed
variables. Very different results to the MSM would suggest a violation of the as-
sumption of no unobserved confounding. To further investigate and understand
the role of confounding factors, we also estimate random effects (RE) models and
compare the results. We thereby further extend the evidence base for the impact
of diabetes on labour market outcomes in MICs, where currently empirical infor-
mation is only available for Mexico (Seuring et al., 2016). At the same time, the
study provides, as far as we are aware, the first longitudinal evidence for the effect
of a diabetes diagnosis on behavioural risk factors in any low- and middle-income
country (LMIC).
More information about the effects of a diabetes diagnosis may be particu-
larly important for LMICs such as China, where diabetes prevalence has surged
from 1% in the early 1980s to about 10% in recent years (Hu, 2011; NCD Risk
Factor Collaboration, 2016). Confronting this diabetes epidemic puts a strain
on healthcare systems (Seuring et al., 2015a), increasing the need to find highly
cost-effective prevention and treatment options applicable in MICs (Silink et al.,
2010). However, to do this it is important to assess how successful people with
diabetes currently are in preventing adverse economic effects and reducing their
risk factors for diabetes complications.
The literature trying to identify a causal relationship between diabetes and
employment has relied on instrumental variable (IV) strategies (Brown et al.,
2005b; Latif, 2009; Seuring et al., 2015b) and individual FE models (Seuring
et al., 2016). However, while an IV approach could potentially account for all
forms of confounding, the validity of the instruments used is at least questionable
(see discussion in Chapter 4). The FE model, as discussed above, also relies on
important assumptions that may be violated. Turning to the relationship between
a diabetes diagnosis and behavioural risk factors, only one study has intended
to causally relate a recent diabetes diagnosis with changes in health behaviours,
finding positive behaviour changes shortly after diagnosis in a USA population.
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The effects were mostly short lived and tended to dissipate over time, particularly
considering weight loss (Slade, 2012). To isolate the causal effect, Slade (2012)
created an ’at risk’ control group without diabetes that was intended to be similar
to the treatment group with diabetes, apart from not having received a diagnosis.
He used information on diabetes biomarkers to estimate the propensity score of
those without a diabetes diagnosis to be above a specific at risk threshold, so
that everybody above a certain propensity score was used to form the control
group. He then estimated dynamic population average models, including the
lagged dependent variable on the right hand side, as well as FE models to identify
a causal relationship. While this approach likely improves the control group by
increasing its similarity in the diabetes risk profile to the diagnosed population,
the use of a lagged dependent variable may have biased the estimates due to
unobserved time-invariant variables being correlated with the lagged dependent
variable, violating the exogeneity assumption and potentially introducing bias in
the other covariates. This is also true for the FE model (Anderson et al., 1982;
Nickell, 1981). Further, the study did not account for employment status as one
of the control variables.
A different identification approach was used by Zhao et al. (2013b) when inves-
tigating the effects of a hypertension diagnosis on nutritional outcomes in China.
They used a regression-discontinuity design and biomarker information on blood
pressure. A crucial assumption in that study was that people above the hyper-
tension threshold were indeed informed about their hypertension while those just
below the threshold were not. These two groups were then compared to isolate
the particular effect of the additional health information on food consumption
in the following wave. The results indicated that a diagnosis leads to reductions
in fat consumption, but no other nutritional outcomes, and only for those eco-
nomically better off. Several caveats exist for this study and the used approach.
According to Zhao et al. (2013b), it was not always clear to what extent par-
ticipants were informed about their hypertension status and whether they had
received just the actual blood pressure measurement information, leaving the in-
terpretation to the participants, or whether they were made explicitly aware of
their hypertension (or also pre-hypertension) status. Further, the results may
have limited generalisability, since the measured treatment effect may have been
a very local one, depending on the representativeness of the population distribu-
tion below and above the threshold of the overall population above the threshold.
In the case of significant differences between the populations, the results would
only be applicable to the population around the hypertension threshold. Finally,
the study only provides information for a relatively short period until the first
wave after diagnosis, unable to capture any changes further away from the point
of diagnosis.
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Accordingly, there is a need to provide new evidence on the effects of a diabetes
diagnosis on employment status as well as behavioural risk behaviours that could
affect the development of diabetes complications, using longitudinal data and
alternative estimation strategies. Thereby this study adds in several ways to the
existing literature. First, it shows the impact of a diabetes diagnosis on labour
market outcomes in China, not only over the short term, but for a period covering
the entire decade of the 2000s, allowing for a more long term investigation of
the effects. This both confirms and extends earlier evidence for other settings
and using different methods. Second, it provides information on the effect of a
diabetes diagnosis on health behaviours. Third, by considering the effects over
time on both employment and health behaviour, the results shed light on potential
pathways through which the impact on employment may work. Fourth, the study
provides a methodological innovation by using both MSM and FE estimation
methods, offering insights not only on the robustness of the MSM results, but
also on the validity of some of its assumptions.
Methods
Study sample
The China Health and Nutrition Survey (CHNS) is an international collaborative
project, led by the Carolina Population Center at the University of North Carolina
at Chapel Hill, investigating nutrition and health behaviours in nine provinces
of China (Zhang et al., 2014). We use data from 1997 onwards, which was the
first time survey participants provided diabetes information. In total we use six
waves (1997, 2000, 2004, 2006, 2009 and 2011) obtained from the longitudinal
dataset released in 2015. The data provide extensive information on nutrition
and health, and also include anthropometric measures of weight and height that
reduce potential measurement issues plaguing self-reported data. The dataset fur-
ther provides socioeconomic information, most importantly for this study about
employment. The sample is limited to the adult population aged 18–64. The
sample is not nationally representative and as such does not provide sampling
weights (Popkin et al., 2010).
Overall, 84% to 90% of the survey participants were followed up in the con-
secutive wave, with attrition being highest after 2006. Attrition in the CHNS
due to mortality was around 1% (Popkin et al., 2010). Other reasons mentioned
by Popkin et al. (2010) are loss in follow up due to migration, natural disasters
and redevelopment of housing in the urban centres leading to relocations. We
investigated whether any of our variables of interest were significantly related to
attrition at any wave. Lower calorie consumption and being unemployed were
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associated with attrition. Further, attrition was strongly related to urbanization,
a higher level of education, being of younger age and having lower family income,
suggesting that mostly participants of younger age, more urbanized but from less
well-off households tended to leave the survey. Having diabetes was not related
to attrition. Attrition rates between the waves are shown in Table A16 in the
appendix.
Assessment of diabetes
We used self-reported information on a diabetes diagnosis to construct our dia-
betes indicator. We only relied on incident cases of self-reported diabetes, exclud-
ing individuals with self-reported diabetes at baseline. Given the chronic nature
of diabetes, we assumed that after the initial diagnosis diabetes persists for the
rest of one’s life. This is a reasonable assumption given the medical evidence
(Steven et al., 2016).2 To construct a measure of diabetes duration for incident
cases we used self-reported information on the year of diagnosis. If we found that
the year of diagnosis was reported to be before the last wave without a reported
diagnosis or if the year of diagnosis was not reported, we used the midpoint be-
tween the last wave without diagnosis and the first wave with a diagnosis as the
year of diagnosis.3
Assessment of outcomes
The economic outcome of interest is employment status, and is measured through
self-reported response stating whether the respondent is currently working. Re-
spondents who reported not to be working because they were students are ex-
cluded, while those who are not working for any other reason, such as doing
housework, being disabled or being retired, are included.
The behavioural risk factor outcomes we estimate are current smoking status,
if alcohol was consumed equal to or more than three times per week4, body mass
index (BMI), waist circumference in centimetres and daily calorie consumption.
Smoking status and alcohol consumption are self-reported, while BMI and waist
circumference are based on anthropometric measurements, minimizing potential
reporting errors and indirectly indicating dietary and activity behaviour. Waist
circumference is reported in centimetres. Finally, daily calorie consumption is
2Recently, a study showed successful remission of at least 6 months in some patients after
the initiation of a very low-calorie diet (Steven et al., 2016). However, while this shows
that type 2 diabetes may be reversible, this cannot be expected for patients diagnosed and
currently treated in any healthcare system.
3The number of observations replaced at each wave was: 21 (2000), 44 (2004), 51 (2006), 78
(2009), 59 (2011). Overall it affected 43% of the self-reports of the year of diagnosis.
4We also estimated models investigating alcohol cessation instead of alcohol reduction, sug-
gesting very similar effects.
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a constructed variable, available in the CHNS, based on the average daily con-
sumption of carbohydrates, protein and fat of every individual in the survey,
measured on three consecutive days. As robustness tests, we also considered bi-
nary overweight and obesity indicators instead of the continuous BMI and waist
circumference variables. We applied thresholds suggested by the China Obesity
Task Force of a BMI ≥ 24 to define overweight and a BMI ≥ 28 to define obesity
(China Obesity Task Force, 2004). Since there is considerable discussion about
the correct thresholds to use for Asian populations to define overweight and obe-
sity (He et al., 2015; World Health Organization, 2004; Zeng et al., 2014), we do
not include these results in our main analysis but report them in the appendix
(page 285).
Statistical analysis
Our analysis focuses on two statistical approaches to account for potential con-
founding and selection bias: marginal structural models (MSMs) and fixed ef-
fects (FE). Additionally, also RE models are estimated.
Marginal structural models
MSMs apply inverse probability of treatment weights (IPTW) to adjust for con-
founding and selection bias as a result of time-varying confounders being affected
by prior exposure to the treatment (Robins et al., 2000). Under the assumptions
of the MSM (Robins et al., 2000)—the reported treatment is the treatment that
has actually been received (consistency), there are no unmeasured confounders
(exchangeability) and every person in the sample has a non-zero chance of receiv-
ing the treatment (positivity) (see the Discussion section for a discussion of the
validity of these assumptions in our case)—the causal direct acyclic graph (DAG)
shown in Figure 8 displays the association between confounders and outcomes and
a diabetes diagnosis.
In our context it seems possible that, for example, BMI could affect the prob-
ability of being diagnosed with diabetes which then itself may affect subsequent
BMI levels, confounding the relationship between a diabetes diagnosis and BMI
due to non-random selection. Similarly, employment history and current employ-
ment could affect the probability of a diabetes diagnosis through their impact on
lifestyle and hence diabetes risk factors. For example, an increase in disposable
income or a reduction in leisure time as a result of a new job and the subsequent
effect on risk behaviours, such as weight gain or higher alcohol consumption,
could confound the relationship between a diabetes diagnosis and employment
status. MSM accounts for this by calculating inverse probability weights based
on the potential risk of a person being diagnosed at each point in time, estimated
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by logistic regression.
For the estimation of MSMs, first unstabilized IPTW for being diagnosed with
diabetes are calculated for each individual at each wave. The IPTW are pro-
portional to the inverse of the probability of a person having her own observed
exposure through that wave and allow the creation of a pseudo population that is
exchangeable with the study population within the levels of confounders (Cole et
al., 2008). The unstabilized IPTW are using time-variant confounders measured
at baseline, time-variant confounders lagged by one period, and time-invariant
confounders as right-hand side variables to predict the cumulative probability of
developing diabetes at each wave. We use lagged time-variant confounders to
make sure that the predictors of diabetes were determined previous to the mani-
festation of diabetes. Otherwise, because the diagnosis happened at an unknown
point of time between two waves, the key assumption that the time-variant vari-
ables used to predict the probability of a diabetes diagnosis are determined before
the diabetes diagnosis may have been violated.
The unstabilized IPTW are calculated using the following predictors: age and
age squared to account for changes in risk with increasing age; an index of ur-
banization pre-constructed within the CHNS data, ranging from 1 to 120 as the
level of urbanization increases (Zhang et al., 2014), to account for the impact of
urbanization on diabetes risk (Attard et al., 2012); binary variables for secondary
and university education, being married, having any medical insurance, being of
Han ethnicity, living in a rural area, the different Chinese regions and the re-
spective survey waves; inflation adjusted per-capita household income to adjust
for any effects of household wealth on diabetes; and employment status, alcohol
consumption, smoking status, BMI, waist circumference and average daily calorie
consumption. To create IPTW that account for each individual’s entire reported
history of diabetes risk factors, cumulative probabilities of diabetes are calculated
by multiplying the predicted probabilities in the current and all previous waves,
for each wave after the baseline wave.5
Because unstabilized IPTW can be highly variable and therefore less precise,
it is recommended to stabilize the weights, especially when the predicted prob-
abilities of exposure are close to zero (Cole et al., 2008). To calculate stabilized
IPTW, an additional set of IPTW are created by predicting the diagnosis of di-
abetes using only baseline values of time-variant and time-invariant confounders
as right-hand side variables. Similar to the calculation of unstabilized IPTW,
cumulative probabilities are calculated by multiplying the predicted probabilities
in the current and all previous waves, for each wave after the baseline wave. To
calculate stabilized IPTW the just created weights are divided by the unstabilized
5To calculate the inverse probability weights we followed the Stata code provided by Fewell
et al. (2004).
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Figure 8: Direct acyclic graph for the marginal structural model
Notes MSMs assume the absence of unobserved time-invariant and unobserved time-variant
confounders but allow the past treatments to affect the current outcomes (arrows going from
Diabetes to time-variant covariates in the same wave) and the past outcomes to affect the
current treatment (arrows going from time-variant covariates to Diabetes). Lagged time-variant
covariates, baseline and time-invariant covariates predict current diabetes status.
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IPTW. The resulting stabilized IPTW now only reflect the confounding due to
the time-varying covariates, which cannot be appropriately adjusted for by stan-
dard regression models (Cole et al., 2008). Because our analysis is stratified by
males and females, we create separate weights for each gender.
The MSMs for any of the outcome variables are then estimated adjusting for
any baseline and time-invariant confounders used in the calculation of the IPTW,
except for the respective outcome of interest, and weighted by the stabilized IPTW
to adjust for time-variant confounding. OLS regression models are used for con-
tinuous outcomes (BMI, waist circumference and calorie consumption) and a
logistic model for the binary outcomes (employment status, smoking status and
alcohol consumption). For the logistic model we calculate average marginal effects
for greater comparability with the results of the FE models. Robust standard er-
rors to account for intra-class correlation of repeated outcome measurements in
individuals are used throughout. In our primary analysis, we present the results
of the MSM with untruncated stabilized weights, as these provide theoretically
unbiased estimates, albeit they may be less efficient than truncated weights if the
IPTW have a wide range considerably diverting from 1 (Cole et al., 2008). Given
that our IPTW do not include very extreme values and have a mean weight of
1 (see Table A18), using untruncated weights likely leads to very little loss in
efficiency in our case, supporting the decision to use untruncated weights in our
primary analysis.
Fixed effects
While the MSM can account for pre-treatment selection on observable and time-
variant confounders, it assumes that there are no unobserved time-invariant con-
founders such as family background, cognitive abilities, and other personal char-
acteristics. This is a strong assumption that might be violated in practice. The
individual level FE model can help remedy this problem as it is able to account
for both observed time-variant and invariant variables as well as time-invariant
unobserved variables as shown in the DAG in Figure 9. It does so by demean-
ing all covariates at each time point with the overall individual mean across all
observed time points. It then uses solely the within-person variation for identifi-
cation, thereby accounting for any time-invariant observed or unobserved as well
as observed time-variant effects.
This comes at a price: due to the demeaning, time-invariant variables, such
as Han ethnicity, are dropped from the model and their association with the
outcomes cannot be estimated. Further, because the FE model is not able to
account for any effects of a diabetes diagnosis on other time-variant confounders,
only a more limited set of confounders can be included compared to the MSM.
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Otherwise the estimates of the effect of a diabetes diagnosis would likely be
biased due to the inclusion of ’bad controls’. Bad controls are control variables
that have been affected by the treatment itself—such as BMI or smoking status
after a diabetes diagnosis—and therefore likely capture part of the causal effect of
diabetes on the outcome of interest, biasing the diabetes coefficient (Angrist et al.,
2009). Also age is dropped from our FE estimations because in FE models two or
more variables that change at the same rate between waves cannot be separately
identified. In our case this applies for age and time-dummies, as both variables
increase by one unit each additional year (Wooldridge, 2012). Consequently, for
the estimation of the effect of time since diagnosis, we have to rely on the presence
of people without diabetes in the sample, for which diabetes duration does not
increase at the same rate as time. Our FE specifications thus only include controls
for age squared, the level of urbanization, education, being married, having any
medical insurance, living in a rural area, region and time dummies as well as per
capita household income. FE models also make another assumption, which has
received much less attention, namely that there is no dynamic causal relationship
between treatment and outcomes, i.e. that past treatments have no direct effect
on current outcomes, and that past outcomes have no direct effect on current
treatment. If this assumption is violated, then results based on FE are biased
(Imai et al., 2016). Accordingly, the choice between the use of a FE model or a
MSM depends on the trade-off between unobserved time-invariant confounding
and dynamic causal relationships between diabetes and our outcome variables.6
Random effects
Random effects assume, similar to the MSM, no unmeasured confounding and,
similar to the FE model, no dynamic relationship between diabetes and our out-
comes. Under these assumptions the RE model is efficient and consistent, making
it the preferable estimator if its assumptions are not violated. It is also preferable
over the pooled OLS estimator, as the RE estimator takes into account the serial
correlation of the errors across time (Wooldridge, 2012).
To discriminate between the RE and FE estimator, a robust Hausman test is
carried out using the user written Stata command xtoverid. A rejection of the
null hypothesis suggests that the underlying RE assumptions are false and the
FE model should be used instead (Wooldridge, 2012).7
6Because it is not possible to retrieve average marginal effects from a logistic FE model,
we prefer to use a linear FE model instead. It generally produces very similar estimates
compared to non-linear models (Angrist et al., 2009).
7We use the original non-imputed data to carry out the Hausman test.
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Figure 9: Direct acyclic graph for the fixed effects model
Notes FE models account for time-invariant unobserved confounding (light grey circle), but
still assume the absence of unobserved time-variant confounding. They further do not allow for
past outcomes to affect the current treatment, i.e. diabetes status.
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Multiple imputation
To avoid excluding participants with missing data on one or more variables, we
used chained multiple imputation to impute the missing values in Stata 13 us-
ing the user written ICE command (Royston et al., 2009). For most of the
included variables, less than 10 percent of the observations were missing. Only
the anthropometric measures of BMI and waist circumference had both about
thirteen percent missing data which had to be imputed (see Table A17 in the
appendix for detailed information on the number of missing observations). In
total—before imputation—close to 20 percent of all cases were incomplete, i.e.
had at least one variable that had missing data. Thirty imputed data sets were
imputed, and the regression results obtained from each set were combined so as
to ensure correct standard errors. In each imputed data set the imputed values
of each missing variable varies randomly, centred on the value predicted for that
record, so as to avoid spurious correlation between the variable and its predictors.
When analysing multiply imputed data, increased precision is obtained by using
more imputed data sets. Thirty imputed data sets is well above the commonly
suggested rule of thumb that the number of imputations should be similar to the
percentage of incomplete cases in the data (see for example Bodner (2008) and
White et al. (2011) for practical suggestions regarding the optimal number of
imputations). Imputation models included all variables used in the MSMs. We
imputed missing data in the same wave for which some data were recorded; we
did not impute completely missing waves. Further, we assumed that once a dia-
betes diagnosis was reported, the individual had diabetes in every ensuing wave,
even when the observation was missing. If diabetes was never reported in any
wave, we assumed that the individual never had diabetes. We then only imputed
missing values for those observations that had a non-missing diabetes status. For
the calculation of the marginal effects in the MSM logit models, Rubin’s rules
were applied using the user written Stata command mimrgns (Klein, 2014).
Numbers of observations
Because we used lagged independent variables to construct the stabilized weights
for the MSMs, the number of observations used in the MSMs is lower than those
used in the FE and RE models, where we do not use lagged variables. The
summary statistics shown in Table 23 are based on the observations used in the
FE models. The number of observations is stated below each table.
Sensitivity analyses
We conduct three additional sensitivity analyses in order to test the robustness of
our results. First, we truncate weights at the 1st and 99th percentile to investigate
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the sensitivity of the MSMs to the most extreme weights. While untruncated
weights provide unbiased estimates under the assumptions of the MSM, they
may not be the most efficient and tend to have larger standard errors (Cole et al.,
2008). Second, we estimate the FE and MSMs using the original non-imputed
data to ascertain the extent to which multiple imputation affected the results.
Third, we report in the appendix the estimates of models using overweight and
obesity instead of BMI and waist circumference as the outcomes of interest, to
investigate the effect of a diabetes diagnosis on changes in the probabilities to be
overweight or obese.
Results
From the descriptive statistics (Table 23), we can observe that people with dia-
betes in any wave are less likely to be employed. Looking at health behaviours,
the prevalence of smoking and drinking is lower for men with diabetes; they
also consume fewer calories compared to men without diabetes. Note that it is
mainly men who smoke and report alcohol consumption while very few women
do so. Further, the diabetes group has both higher BMI and waist circumference
levels. They are also older, live in more urbanized areas, are more likely to have
insurance and men are somewhat better educated while women are less educated
compared to their counterparts without diabetes. Both men and women with
diabetes report an average time since diagnosis of around 4.5 years. Looking at
per capita household income, men and women with diabetes come from house-
hold with higher income levels than those without a diabetes diagnosis. Further,
it appears that in China it is less educated women that report a diagnosis, while
men with diabetes are better educated compared to those without diabetes.
Predicting the denominator for the stabilized weights (Table 24) we find that
for men a higher baseline BMI increases the risk of a diabetes diagnosis. Further,
increases in age, waist circumference as well as urbanization levels are associated
with higher chances for men to be diagnosed with diabetes throughout the survey.
Interestingly, becoming employed decreases the chances of being diagnosed with
diabetes slightly, justifying the use of the MSM in our employment models as
well. Because these are not causal estimates, it may be that it is more likely for
men with a lower risk of diabetes to select into employment.
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Table 23: Sample means for males and females, by diabetes status
Males Females
No diabetes Diabetes p-value (t-test) No diabetes Diabetes p-value (t-test)
Employed 82% 68% <0.001 67% 29% <0.001
Smokes 58% 47% <0.001 3% 4% 0.409
Any alcohol consumption 63% 53% <0.001 9% 4% <0.001
Daily Kcal eaten (3-day average) 2422 2166 <0.001 2068 1931 0.001
BMI 22.99 24.90 <0.001 23.10 25.80 <0.001
Waist circ. (cm) 82.02 88.81 <0.001 78.80 87.55 <0.001
Age 42.27 52.76 <0.001 43.24 55.32 <0.001
Han ethnicity 87% 89% 0.292 87% 93% 0.002
Rural area 69% 52% <0.001 68% 51% <0.001
Married 83% 93% <0.001 88% 87% 0.392
Secondary education 65% 68% 0.439 50% 43% 0.007
University education 5% 11% <0.001 4% 1% 0.017
Any health insurance 51% 82% <0.001 50% 71% <0.001
Urbanization Index 60.87 74.48 <0.001 61.77 68.68 <0.001
Per capita household income (Yuan (2011)) 8617 16328 <0.001 8581 11101 <0.001
Years since diabetes diagnosis − 4.5 − − 4.65 −
Observations 23159 284 23369 333
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Higher household income levels are not predictive of a diagnosis for men or
women, despite what the descriptive statistics indicated. For women, higher age
and waist circumference at baseline, increases in BMI as well as living in a non-
rural environment predict a diabetes diagnosis.
The results of our regression analysis are presented in Table 25. Both the
MSMs and FE models indicate that women with a diabetes diagnosis have lower
probabilities of being employed than their counterparts without diabetes, with a
reduction of 11.7 percentage points in the MSM and 11.2 percentage points in the
FE model. This translates into a relative reduction in employment probabilities
between 16–17%. For men no such effect is observed.
A more ambiguous picture is painted for the effect of a diabetes diagnosis on
behavioural risk factor outcomes. According to the MSM, for males a diabetes
diagnosis leads to smoking cessation, reductions in alcohol consumption as well
as BMI, waist circumference and calorie consumption. Results for women look
different. While the point estimates indicate a reduction in all outcomes, these
tend to be smaller than those for men and only exhibit strong statistical sig-
nificance for smoking cessation and alcohol consumptions, factors where women
already have a very low prevalence. Compared to the MSM, the FE model finds
similar effects for men, apart from a less important effect on smoking cessation.
For women, however, it finds much larger, and statistically significant, reductions
in BMI and waist circumference compared to the MSM.
The results of the RE models show an even stronger effect of diabetes on female
employment probabilities and smaller reductions in male and female BMI and
waist circumference, even suggesting a positive association between a diabetes
diagnosis and female waist circumference. For the other outcomes, results are
very similar to those from the MSMs and FE models. Nonetheless, the Hausman
test still rejects the use of the RE model throughout (see Table A24).
Exploring the effect of a diabetes diagnosis over time, we first estimate a spec-
ification using time since diagnosis as a continuous variable. The results of the
MSMs (Table 26) indicate a steady reduction of female employment probabilities
of close to two percentage points per year and of male alcohol consumption, BMI,
waist circumference and calorie consumption. The FE model again supports the
finding of the MSM, showing very similar, though somewhat larger effects in
terms of size and statistical significance. The evidence for changes in risk factors
for females is less consistent across models and outcomes, with the MSM sug-
gesting almost no effects while the FE model indicates a reduction in BMI. The
effect sizes for changes in health behaviours in women are consistently lower than
those found for men.
The RE models again find larger effects on female employment probabilities
and a smaller impact of a diabetes diagnosis on reductions in BMI and waist
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Table 24: Time variant and invariant predictors of a diabetes diagnosis (denomi-
nator of stabilized weights): logistic regression models
Males Females
(1) (2) (3) (4)
β SE β SE
Age (bl) −.000 0.001 0.004∗∗ 0.002
Age squared (bl) 0.000 0.000 −.000∗∗ 0.000
BMI (bl) 0.001∗∗∗ 0.000 0.001 0.000
Waist circumference (cm) (bl) 0.000 0.000 0.000∗ 0.000
3-Day Ave: Energy (kcal) (bl) −.000 0.000 0.000 0.000
Smoking (bl) 0.001 0.002 0.003 0.006
Alcohol consumption (bl) 0.003∗ 0.002 0.000 0.005
Urbanization index (bl) −.000 0.000 −.000 0.000
Secondary educ. (bl) −.001 0.003 0.003 0.003
University educ. (bl) −.000 0.006 − −
Married (bl) −.002 0.004 −.000 0.004
Any medical insurance (bl) 0.002 0.002 −.000 0.002
Employed (bl) 0.002 0.003 0.001 0.002
Han ethnicity 0.001 0.003 −.002 0.003
Rural −.001 0.002 −.005∗∗∗ 0.002
Per capita household income (2011 Yuan) (bl) −.000 0.000 −.000 0.000
Survey year
2004 0.002 0.002 −.001 0.002
2006 0.003 0.002 −.003 0.003
2009 0.009∗∗∗ 0.003 −.001 0.004
2011 0.001 0.003 0.001 0.004
Age 0.003∗∗ 0.001 −.002 0.002
Age squared −.000∗∗ 0.001 0.000 0.000
BMI −.001 0.000 0.001∗∗ 0.000
Waist circumference (cm) 0.000 0.000 −.000 0.000
3-Day Ave: Energy (kcal) −.000 0.000 −.000 0.000
Smoking −.003 0.002 0.000 0.006
Alcohol consumption −.004∗∗ 0.002 −.003 0.006
Urbanization index 0.000 0.000 0.000 0.000
Secondary education 0.001 0.003 0.000 0.003
University education 0.001 0.006 − −
Married −.000 0.004 −.003 0.004
Any medical insurance 0.001 0.002 −.001 0.002
Employed −.004∗∗ 0.002 −.003 0.002
Per capita household income (2011 Yuan) (2011 Yuan) 0.000 0.000 −.000 0.000
Notes Average marginal effects based on logistic regression. Results for province dummies omitted to preserve space.
University education was dropped in the female sample as having university education perfectly predicted diabetes status.
N=16047 (male sample), N=16658 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table 25: Analysis of the effect of a diabetes diagnosis on employment status and
behavioural outcomes using MSM, FE and RE
(1) (2) (3) (4) (5) (6)
Employment Smoking Alcohol BMI Waist (cm) Calories (kcal)
Marginal structural model
Male sample
Diabetes −.009 −.070∗∗ −.094∗∗∗ −.735∗∗∗ −1.887∗∗∗ −135.061∗∗
(.026) (.032) (.036) (.180) (.574) (58.593)
Female sample
Diabetes −.117∗∗∗ −.015∗ −.029∗∗ −.388 −.335 −45.630
(.029) (.008) (.012) (.240) (.631) (33.530)
Fixed effects
Male sample
Diabetes 0.022 −.023 −.104∗∗∗ −.715∗∗∗ −2.217∗∗∗ −168.297∗∗∗
(.030) (.032) (.036) (.183) (.610) (62.115)
Female sample
Diabetes −.112∗∗∗ −.027∗∗ −.012 −.644∗∗ −1.251∗∗ −61.175
(.035) (.013) (.010) (.263) (.616) (47.420)
Random effects
Male sample
Diabetes −.022 −.064∗∗ −.104∗∗∗ −.379∗∗ −.756 −172.467∗∗∗
(.028) (.029) (.029) (.177) (.542) (48.768)
Female sample
Diabetes −.152∗∗∗ −.021∗∗ −.019∗∗∗ −.263 0.459 −39.267
(.027) (.011) (.006) (.247) (.570) (34.256)
Notes The coefficients of the MSM for outcomes 1–3 represent average marginal effects based on logistic regression models. All
other coefficients are from linear regression models. Robust standard errors in parentheses. Other control variables for FE/RE:
Age squared, region, urban, education, Han ethnicity, marital status, urbanization index, time dummies, health insurance status,
household expenditures. RE additionally controls for age. MSM controls for baseline values of the same variables as the
FE/RE models additionally to baseline values of age, alcohol consumption, smoking status, BMI, waist circumference and
calorie consumption. Fixed/random effects: N=23443 (male sample), N=23702 (female sample); MSM: N=16047 (male sample),
N=16658 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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circumference for both sexes.
In a second step we estimate a specification using year dummies to capture
the potential non-linearity in the relationship between time since diagnosis and
our outcomes. The results for the different estimation methods are visualized in
Figures 10 and 11 and presented in Tables A19, A20 and A21 in the appendix
for the MSM, FE and RE model, respectively. The MSM and FE model indicate
a statistically significant reduction in female employment probabilities in the
first eight years after diagnosis, with the exception of the fifth and sixth year,
where the effects are not statistically significant. Further, male BMI and waist
circumference are also reduced significantly in most years, especially using the FE
model which finds significant effects in the first six years after diagnosis and then
in years nine to twelve. The MSM still indicates reductions but these tend to be
of lower statical significance. Calorie consumption is not found to be reduced in
a consistent and statistically significant manner, either in the MSM or the FE
model. Behavioural risk factors for women are again not found to be reduced
consistently, apart from BMI where some trend towards a reduction over time is
visible. Interestingly, female employment already decreases rapidly in the first to
second year after diagnosis and it does not appear that females are able to increase
their employment probabilities later on. Unfortunately, it was not possible to
estimate the effects on female smoking status and alcohol consumption due to
the low prevalence of these risk factors in females and the lower sample size in
the MSM. Using the FE model, all point estimates indicate similar effects. The
RE model again suggests larger effects on female employment and lower effects
on BMI and waist circumference than both other estimation methods.
The sensitivity analyses using truncated weights shows very similar effects to
those using the untruncated weights (Tables A22 and A23 in the appendix),
suggesting no important bias and supporting the decision to use untruncated
weights. The results using non-imputed data are broadly similar (Tables A24,
A25, A26, A27 and A28 in the appendix), in particular for the FE model, and
also indicate a reduction in female employment probabilities and male alcohol
consumption, BMI and waist circumference. The coefficients of the MSM still
point into the same direction as those using the imputed data, but the estimated
effects are smaller in size and confidence intervals are relatively large. The RE
model still shows a stronger effect on female employment probabilities and smaller
reductions in especially the weight measures BMI and waist circumference. Using
overweight and obesity instead of BMI and waist circumference as indicators for
weight changes, we do not find as consistent reductions in weight status for men
as we did using the continuous estimates (Tables A29 and A30 and Figure A1
in the appendix). Nonetheless, the point estimates still show a reduction in
obesity, in particular over time and for men, supporting the reductions found
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Table 26: Analysis of the effect of each year since diabetes diagnosis on employ-
ment status and behavioural outcomes using MSM, FE and RE
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Marginal structural model
Male sample
Time since diagnosis −.003 −.010∗ −.014∗∗ −.127∗∗∗ −.340∗∗∗ −21.770∗∗
(.004) (.005) (.007) (.031) (.099) (9.842)
Female sample
Time since diagnosis −.017∗∗∗ −.002 −.004 −.066∗ −.072 −8.735
(.005) (.001) (.003) (.040) (.109) (5.589)
Fixed effects
Male sample
Time since diagnosis −.001 −.003 −.017∗∗ −.150∗∗∗ −.520∗∗∗ −22.286∗∗
(.007) (.006) (.007) (.037) (.121) (11.083)
Female sample
Time since diagnosis −.019∗∗∗ −.003 −.000 −.102∗∗∗ −.215∗ −6.747
(.007) (.002) (.001) (.039) (.117) (7.028)
Random effects
Male sample
Diabetes −.006 −.009∗ −.015∗∗∗ −.099∗∗∗ −.269∗∗∗ −24.703∗∗∗
(.006) (.006) (.005) (.035) (.096) (8.655)
Female sample
Diabetes −.023∗∗∗ −.002 −.002∗∗ −.056 0.013 −6.444
(.006) (.002) (.001) (.039) (.114) (5.670)
Notes The coefficients of the MSM for outcomes 1–3 represent average marginal effects based on logistic regression models. All
other coefficients are from linear regression models. Other control variables for FE/RE: Age squared, region, urban, education,
Han ethnicity, marital status, urbanization index, time dummies, health insurance status, household expenditures. RE additionally
controls for age. MSM controls for baseline values of the same variables as the FE/RE models additionally to baseline values of
age, alcohol consumption, smoking status, BMI, waist circumference and calorie consumption. FE/RE: N=23443 (male sample),
N=23702 (female sample); MSM: N=16047 (male sample), N=16658 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
150
using continuous measurements.8
8The coefficients for overweight are difficult to interpret as it is unclear if the negative coeffi-
cient is caused by people transferring into obesity or into normal weight.
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Figure 10: The effect of time since diabetes diagnosis on employment, smoking and alcohol consumption (duration groups)
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Figure 11: The effect of time since diabetes diagnosis on BMI, waist circumference and calorie consumption (duration groups)
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Discussion
The evidence for the impact of a diabetes diagnosis on employment probabilities
and behavioural risk factors remains scarce, in particular in MICs, where diabetes
has become a major contributor to the burden of disease. We added to this
evidence by exploring these relationships using longitudinal data from China,
also improving upon previously used methodologies by taking into account the
potential relationship over time between diabetes and these outcomes.
Our results suggest that receiving a diabetes diagnosis in China leads to a strong
and lasting reduction in female, but not male, employment probabilities. We
also found reductions in male BMI and waist circumference, alcohol and calorie
consumption and potentially smoking to be associated with a diabetes diagnosis.
We did not, however, find similar changes in behavioural risk factors for women.
Accordingly, it appears that women in China have to endure stronger adverse
labour market effects of diabetes and at the same time are less successful then men
at making risk behaviour changes to reduce their risk of diabetes complications.
The MSMs and FE models indicated very similar results suggesting that they
are robust and that time-invariant confounding factors may play a limited role
over and above baseline and time varying confounding factors. The MSM re-
sults suggest that in particular BMI and waist circumference levels as well as
employment status can cause selection into a diabetes diagnosis and are then
later themselves affected by the diagnosis, justifying the use of a MSM. The
RE models further indicate that insufficiently accounting for confounding can—
at least in this setting—lead to an overestimation of the impact of diabetes on
employment status and an underestimation of the effects of a diagnosis on weight
measures (BMI and waist circumference). However, confounding may only be
of limited relevance for alcohol consumption, where the RE models showed very
similar results.
Limitations
The study has several limitations. While we used two estimation methods to
reduce the influence of observed and unobserved confounding, respectively, none
of the models is able to account for both forms of confounding. Therefore a
causal interpretation is only possible under restrictive assumptions, namely no
unobserved time-variant confounding for the FE model and positivity, exchange-
ability and consistency for the MSM. The assumption of positivity is likely to
hold, given that every person should have at least a small chance of receiving a
diabetes diagnosis. This is also supported by the relatively small range of stabi-
lized weights and absence of zero-weights. The assumption of exchangeability or
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no unmeasured confounding could potentially be violated if not all time-invariant
and time-variant confounders were accounted for, but this cannot be known for
certain from existing data. We tested for part of this assumption by estimat-
ing a FE model and, given that the results remained very similar, this suggests
that unobserved time-invariant confounding may be of limited relevance in this
case, even though this remains speculative as the Hausman test indicated some
time-invariant confounding. Consistency would have been violated if a diabetes
diagnosis had been reported but the person had actually not been diagnosed with
diabetes. This was likely only violated in very rare cases of misreporting, given
that specificity of diabetes self-report is very high in China (Yuan et al., 2015).
Because we were interested in the effect of a diabetes diagnosis, unobserved dia-
betes did not violate the consistency assumption.
A limitation of the FE model is the possibility of time-variant confounding
due to prior outcomes (for example employment status) affecting the current
treatment (a diabetes diagnosis). We found some evidence that prior outcomes
could affect selection into a diabetes diagnosis, potentially introducing bias in our
FE estimates. Given that the FE estimates were close to those of the MSMs, it
could be that this bias may not have been very strong. Overall, it remains difficult
to pin down the potential source of a potential bias as, for example in the female
employment models, both the MSM and the FE results are very similar while the
RE results indicate a somewhat bigger adverse effect. We have some evidence for
both models that their underlying assumptions may not hold, with the Hausman
test suggesting time-invariant confounding and the results of Table 24 indicating
some time-variant confounding due to prior outcomes.
Finally, a limitation is that in this study we only observe the combined effect
of all that entails a diabetes diagnosis. However, a diabetes diagnosis can entail
a variety of ’treatments’ that are difficult to disentangle and may each have a
distinct effect on the explored outcomes.
Potential mechanisms
The effects of diabetes on employment and behaviour could work through sev-
eral mechanisms. Firstly, the provision of information at diagnosis may causes
increases in stress and anxiety, but could also reduce anxiety by providing an ex-
planation for the experienced symptoms (Peel et al., 2004), with both potentially
affecting productivity. Secondly, a diagnosis is also the starting point for medical
treatment, which could help to alleviate symptoms and to lose weight, but also
poses new challenges, in particular if treatment entails the exogenous provision of
insulin or adherence to strict meal plans, likely adding to the burden of diabetes
in daily life (Pibernik-Okanović et al., 1996; Vijan et al., 2005). Thirdly, ad-
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herence to medical treatment may be heterogeneous across people with diabetes,
with non-adherence likely leading to a further worsening of risk factors for com-
plications, while good adherence may prevent or delay debilitating complications
(Asche et al., 2011). Fourthly, a diagnosis may also cause lifestyle changes such
as increasing exercise levels, eating healthier and reducing smoking or alcohol
consumption, all potentially affecting the risk of developing further complica-
tions and of changes in productivity. In the current study, it is not possible to
ascertain the role of each of these factors in affecting employment probabilities
and behavioural risk factors. Only for the reductions in smoking and alcohol con-
sumption, it seems reasonable to attribute them to diagnosis induced awareness
of the need to reduce these risk factors, as other pathways appear less likely to
be relevant.
The found adverse effect of diabetes on employment is in line with other studies
on the labour market impact of diabetes that have found diabetes to reduce
employment probabilities for women (Harris, 2009; Latif, 2009; Minor, 2011;
Seuring et al., 2016)—often more than for men. Most comparable to our results
are likely the results from Mexico in Chapter 4, which were also based on FE
estimations and data for a similar time period (Seuring et al., 2016). The study
found significant reductions for both males and females of about 5 percentage
points. Taking into account the lower overall employment rate of Mexican women
compared to men, this translated into a 16% reduction in female employment
probabilities, a figure comparable to the effect on Chinese women. However, in
Mexico also men experienced adverse effects, unlike to what we found for China.
The effects on behavioural risk factors can be compared to the study by Slade
(2012). Slade finds reductions in alcohol consumption and smoking, though it
appears that these reductions were not maintained over a longer time period. Un-
fortunately, Slade only provided information for the entire sample and the male
sample, so that we cannot compare them directly with our results for women.
In terms of the effect on weight, again both studies cannot be directly compared
because Slade investigated the effect of a diagnosis on being overweight or obese,
while we used continuous weight measures in our primary analysis due to the
discussed difficulties of defining cut-off values for Asian populations. Slade found
an initial reduction in weight status, but also that people with diabetes tended
to become more likely to be overweight or obese after some time. Our results
using overweight and obesity could tentatively be interpreted to indicate a more
constant reduction in obesity over time, suggesting that reductions in weight in
Chinese men may be longer lived than in the USA. Importantly—and in concor-
dance with our findings—he found that simple covariate adjustment led to biased
estimates of the impact on weight status, finding a positive relationship. This
underlines the importance of accounting for potential sources of confounding.
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The permanent reduction in male BMI and waist circumference we have found
has also been observed in a cohort of Danish patients (De Fine Olivarius et
al., 2015), where weight increased in the years preceding diagnosis, while after
diagnosis weight decreased. The exact reasons for this decrease were unknown.
De Fine Olivarius et al. (2015) attributed them to motivation changes as a result
of the diagnosis, concluding that the time around the diagnosis may represent
a window of opportunity to obtain long lasting weight change. Nonetheless,
reductions in weight may also be the result of treatment initiation with metformin
or other diabetes drugs that have been shown to lead to weight reductions (Yang
et al., 2014). Importantly, in the present study the reduction in male BMI levels
and waist circumference were accompanied by reduced energy intake, suggesting
that the changes in weight were at least partly the result of lower energy intake.
Further, given that in China diabetes incidence has been especially attributed
to a high accumulation of visceral fat and central obesity (Ma et al., 2014),
the reductions in waist circumference may have had a particular positive effect
on diabetes control and the prevention of comorbidities. Together, the lower
levels of energy intake and waist circumference after the diagnosis allow for the
interpretation that the reductions in BMI were due to fat loss and not lower lean
body mass (Klein et al., 2007).
For women, however, we did not find similar strong evidence for reductions
in BMI, waist circumference or energy intake. The relatively smaller effects for
women could indicate a lower ability to change behaviours supportive of weight
loss. This appears to be supported by the smaller reductions in energy intake.
This could have—at least partly—contributed to a higher risk for diabetes com-
plications further down the line, also adversely affecting employment probabil-
ities. Apart from this, other explanations for the lower weight loss and larger
employment penalty for women compared to men include their lower educational
attainment, which has been indicated as a factor in preventing better glucose
control (Luo et al., 2015) and may also affect the ability to successfully change
behaviours. Lower income levels for females compared to men may also have neg-
atively affected the ability to receive adequate treatment following a diagnosis,
limiting their ability to change health behaviours (Luo et al., 2015), increasing
the risk of complications. We found that women with diabetes lived in house-
holds with lower income levels compared to men with diabetes, however, these
income levels were still higher then for those without diabetes. Nonetheless, it
may still be the case that women were less likely to access care due these differ-
ences in income. Moreover, there are likely biological factors that lead to worse
health outcomes for women compared to men. There is some evidence that, due
to different ways of fat storage between men and women, men tend to cross the
diabetes threshold at an earlier point in time and at a comparatively healthier
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metabolic state then women (Peters et al., 2015, 2014a,b). Women are more
likely to have spend more time in a pre-diabetes state (Bertram et al., 2010)
and to cross the threshold only once their metabolic health has significantly de-
teriorated, leading to a greater risk of cardiovascular disease and stroke (Peters
et al., 2015). Supporting this, a study for China found a greater prevalence of
diabetes comorbidities in Chinese women compared to men (Liu et al., 2010). In
this light it may not be surprising that we find more conclusive evidence of wors-
ening employment probabilities for women. If women are less likely to receive
proper treatment and to change their health behaviours and at the same time
have a greater risk for complications than men, the long term effects of diabetes
on their health are likely more severe than for men and consequently affect their
employment status to a greater extent.
Taken together, the results suggest a lower risk of unemployment for men with
diabetes potentially due to their greater ability to reduce behavioural risk factors,
while the effect of diabetes on employment for women is substantial potentially
because no such changes in behaviour take place. Further analysis is needed to
test this formally and is beyond the scope of this paper.
Conclusion
Our results indicate worse outcomes for women then men after a diabetes diagno-
sis, with women experiencing a reduction in employment probabilities accompa-
nied by and potentially partly due to an inability to reduce important risk factors
for diabetes complications. For males, the opposite pattern is found as they do
not experience adverse employment effects and are able to achieve reductions in
the investigated risk factors. These findings are robust to the application of two
distinct, but complementary econometric techniques. Overall, given the large
prevalence of undiagnosed diabetes, our results indicate that an early diagnosis
may be a good way to foster early behaviour change that could lead to more
positive health and economic outcomes for people with diabetes over time. It
appears, however, that greater emphasis needs to be put on reducing the burden
of diabetes for women to reduce the observed inequities in the impact of diabetes.
Future research should try to unravel the mechanisms behind these differential
outcomes for men and women, investigating more formally whether differences in
behavioural risk factors could be a potential explanation.
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6 Discussion and conclusions
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Chapter overview
Diabetes has reached epidemic proportions in middle-income countries (MICs)
and is a major contributing factor to poor health and early mortality, as also
discussed in Chapter 1. The economic impact of diabetes on individuals and
healthcare systems has, however, received limited attention. In particular, we
have a limited understanding of the effect of diabetes on individual labour mar-
ket outcomes. Moreover, little is known about how people with diabetes currently
achieve positive change in behaviour risk factors to prevent the disabling com-
plications of diabetes, and whether this plays a role in the effect if the disease
on labour market outcomes. The main goal of this thesis has been to assess the
economic burden of diabetes in MICs, focusing on two predominant and large
countries with an increasing diabetes disease burden. This should help to better
understand the importance of primary and secondary prevention of diabetes and
to identify those populations most susceptible to the adverse economic effects of
diabetes.
Four separate studies were conducted that intended to answer the research
questions posed in Chapter 1. This concluding chapter has four parts. Firstly, it
summarises the principal findings. Secondly, it contextualises the findings within
the wider literature and provides implications for policies. Thirdly it reflects on
the methods. Finally, there are suggestions for future research and concluding
comments.
Summary of principal findings
Chapter 2 set out to provide an overview of and critically assess existing studies
on the economic costs of type 2 diabetes globally. This not only included cost-
of-illness (COI) studies but also studies on labour market outcomes. Systematic
review methods were used and the evidence was synthesized narratively. 86 COI
studies and 23 labour market studies were identified. Of those, 24 came from
low- and middle-income countries (LMICs), with 23 being COI studies.
For COI studies, the review found a large range of estimated costs, with the
largest per-capita costs being observed in the USA while costs were generally
lower in LMICs. However, in LMICs treatment costs were paid almost entirely
out-of-pocket by the poor due to a lack of health insurance coverage, consuming
considerable parts of their annual income. The review also found considerable
differences in the used methodologies and in the study quality. This made it
difficult to directly compare the results across studies. While in many high-income
country (HIC) studies an incremental costing approach was used and data sources
were representative for a distinct population, studies in developing countries often
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had to rely on non-representative, relatively small convenience samples, often
lacking a control group. Many studies also lacked explicit mentioning of the
study perspective or of the costing components that were included.
For labour market impact studies, most found adverse effects of self-reported
diabetes on employment probabilities, wages or working days. Studies were con-
centrated on a few HICs, in particular the USA. More recent studies took into
account potential biases due to the endogeneity of diabetes, mainly using an
instrumental variable (IV) strategy with the family history of diabetes as an in-
strument. However, the direction of bias was ambiguous across different studies
and countries.
The review also identified methodological and thematic areas that previous re-
search had only covered sparingly. No COI study took into account the possibility
of biased estimates as a result of the endogeneity of diabetes. Consequently, there
is a lack of evidence in the literature about the potential bias in the cost esti-
mates of diabetes COI studies. Further, few studies used an incidence approach
to investigate lifetime costs of people with diabetes, which could provide better
information about the dynamics of cost increases post diabetes diagnosis.
Despite these identified limitations of the COI literature, the review provided
a picture of the healthcare costs of diabetes in almost every continent. This was
not the case for labour market studies, where almost no evidence was found for
LMICs. There is reason to expect the labour market impact of diabetes to be very
different in LMICs compared to HICs, given the LMICs’ less advanced healthcare
systems, later diagnosis but—in some populations—earlier onset of diabetes and
greater susceptibility to develop it, the larger informal labour market and overall
different labour market structure in LMICs. Also, in terms of methodology,
studies had not taken advantage of panel data techniques to get closer to a causal
interpretation of their estimates. Especially studies on the effect on employment
probabilities had instead relied on the same—at least debatable—identification
strategy using IVs. Therefore, a study using a different identification strategy
was warranted.
Importantly, no study investigating the impact of undiagnosed diabetes on
labour market outcomes was identified by the review. Hence, an important part
of the population with diabetes had been mostly neglected. This left open the
question in how far results for self-reported diabetes were applicable to the part
of the population that was unaware of its diabetes status.
Based on the findings of the review, the three research studies that followed
addressed parts of the identified gaps, in particular focusing on labour market
outcomes.
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Chapter 3 provided the first evidence for the impact of diabetes on employ-
ment probabilities in a developing country, where diabetes had become a public
health concern. Because little was known about the equity impacts of diabetes,
a further goal was to investigate the heterogeneity of effects across formal and
informal employment and for the ’rich’ and ’poor’. Due to the unavailability of an
alternative identification strategy, the study applied the already established IV
approach using parental diabetes as the instrument. Using further background
information on parental education, it improved upon earlier studies by control-
ling for a potential confounding pathway that could have invalidated the specific
instrument. It further used two methods to implement the IV approach. The
main analysis was based on a bivariate probit model that had been shown to be
better suited for our specific data, in comparison to a standard linear IV model.
We nonetheless also provided the results of the latter approach. Both models
found no indication of diabetes being exogenous in this context so that a simple
univariate probit model was used for inference. The results showed an adverse
effect of diabetes on employment probabilities in Mexico of about 10 percent-
age points for men and 5 percentage points for women. The subgroup analysis
suggested that the adverse employment effects impacted mainly those above age
44, while younger people seemed less affected. Also, being poorer increased the
exposure to negative employment effects of diabetes. The same was the case for
those in the informal compared to those in the formal labour market. Across all
models, the point estimates were bigger for males than for females.
Chapter 4 went on to address several questions identified in Chapter 2 that had
not been investigated in the first Mexico study. Further, the robustness of the
findings of Chapter 3 had to be tested using more extensive and recent data and
a different identification strategy. Chapter 4 thereby took advantage of a recent
extension to the data used in Chapter 3. The data now spanned three waves and
eight years, which allowed for the use of a longitudinal individual fixed effects (FE)
model to estimate the relationship of self-reported diabetes with employment.
Additionally, the investigated labour market outcomes were extended to wages
and working hours. Also, it was now possible to investigate the relationship of
diabetes duration with labour market outcomes, in order to better understand
the timing of any diabetes impact on labour market outcomes. Importantly, the
additional wave also provided information on diabetes biomarkers to separately
explore the effects of diabetes for the entire population with diabetes as well as
those unaware of diabetes.
The analysis carried out in Chapter 4 confirmed the adverse relationship of
self-reported diabetes with employment, finding a 5 percentage point reduction
for males and females alike. Given the relatively low female employment rate, this
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translated into a 14% relative decrease in employment probabilities for women
compared to 6% for men. Compared to the cross-sectional results of Chapter 3,
the estimated effects of the FE model are about half the size for men, but are
similar and of stronger statistical significance for women. This is likely due to
the additional data used in Chapter 4, but could also partly be the result of the
different estimation technique. For wages and working hours no adverse effects
of self-reported diabetes were found.
Further analysis showed that the most adverse effects were concentrated among
self-employed and independent agricultural workers, potentially due to lower job
security and access to healthcare in these often informal jobs. Further, Chapter 4
revealed that the adverse effect of diabetes on employment appeared shortly after
diagnosis, then levelled off for some time until it appeared again. This pattern
was observed for both males and females, albeit only statistically significant for
the former. Interestingly, it was found that when the employment effects levelled
off, wages started to fall, again for both genders. This suggested that during this
period diabetes, plausibly through reductions in productivity, mainly reduced
wages, without affecting job loss.
Finally, the results of the biomarker analysis presented in Chapter 4 showed
that relying on self-reported diabetes information can lead to measurement bias
in the coefficient of diabetes. Using the biomarker data to identify people with
diabetes, smaller effects especially on employment probabilities were found com-
pared to self-reported diabetes, caused by the non-existent associations between
undiagnosed diabetes and employment probabilities. It was further found that
part of the difference in effects between self-reported and undiagnosed diabetes
could be explained by differences in subjective health status, with those self-
reporting diabetes also reporting a worse health status. Interestingly, differences
in glycated hemoglobin (HbA1c) levels did not drive the stronger effects for those
self-reporting.
Chapter 5 continued the investigation of the impact of self-reported diabetes
on employment probabilities, but this time in China. It further investigated how
a diabetes diagnosis affected diabetes-relevant health behaviours in a develop-
ing country. Because the relationships may be biased due to confounders not
previously taken into account, the study used two different econometric strate-
gies: marginal structural models (MSMs) and FE. Each controlled for a different
source of confounding, improving the robustness of the identified effects. The used
data consisted of six waves of the China Health and Nutrition Survey (CHNS),
covering a period from 1997 to 2011.
The results from Chapter 5 provided further evidence of a deterioration of
employment probabilities after a diabetes diagnosis, though this time only for
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women. They experienced a reduction in employment probabilities between 11
to 12 percentage points. For men, the MSM and FE models showed insignificant
relationships. These reductions for women were similar to those found in Mexico
(16–17% in China and 14% in Mexico) when the female employment rates in both
countries were taken into account. The results for behavioural risk factors also
suggested different effects for men and women. According to the results, men
were able to reduce their alcohol consumption, body mass index (BMI) levels,
waist circumference and daily calorie consumption, potentially reducing the risk
for diabetes complications (Wilding, 2014). For women, no strong evidence for
similar reductions was found. A similar picture remained when investigating the
effects over time using linear and non-linear specifications. On the one hand they
suggested maintained reductions in female employment probabilities over time
but no strong changes in risk factors. On the other hand, men were able to more
consistently reduce behavioural risk factors in the years following diagnosis while
not experiencing any labour market penalties. Overall, the findings suggested a
potential relationship of changes in risk factors with changes in labour market
outcomes.
Implications for policy making
The findings of this thesis indicate an important global economic burden of di-
abetes and have added first evidence on the effect of diabetes on labour market
outcomes in MICs. The thesis also showed that diabetes—at least as far as
labour market outcomes are concerned—did not similarly affect the population
unaware of their diabetes diagnosis as it did those who were aware. Additionally
it showed, that a diabetes diagnosis can elicit positive changes in behavioural
risk factors, though to different degrees for men and women. Further, the dis-
tributional analysis brought to light that the burden of diabetes appears to be
distributed unequally, disproportionally affecting the poor, those in the informal
labour market and women.
These findings may lead to several implications to reduce the economic burden
of diabetes in MICs.
Inequities in the economic burden of diabetes
An important finding of this thesis are the economic inequities in the burden of
diabetes. In Chapter 2, the review found a high out-of-pocket (OOP) burden
in LMICs, especially for those with no insurance coverage. Chapter 3 showed
that the adverse employment effects were concentrated among those in the in-
formal labour market and with fewer resources. This was further supported by
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findings from Chapter 4 that indicated a greater reduction in the probabilities
to work in the agricultural or self-employed sector, while for those working in
a non-independent wage job—that often entails greater contractual job security
and better access to health insurance—diabetes did not appear to elicit negative
effects. Chapter 5 found bigger adverse employment effects and more modestly
positive behavioural changes in women compared to men after they had received
a diabetes diagnosis. These gender inequities are also supported by the results for
Mexico, in particular by Chapter 4, where, taking into account the lower overall
employment rates for women in Mexico, the relative reduction in employment
probabilities was much greater for females than for males.
There may be several potential strategies how to reduce these inequalities.
In particular, these include tackling the observed differences by gender, better
prevention of diabetes, earlier diagnosis and better treatment of those diagnosed.
Gender
One of the main results of this thesis is the identification of women with diabetes
as a specific target group. Gender differences in the disease burden of diabetes
have come to the forefront only recently (Peters et al., 2015), but may hold one
of the keys to reducing the economic burden of diabetes. In particular, it ap-
pears that biological differences between men and women likely lead to greater
adverse effects of diabetes compared to men (Bertram et al., 2010; Peters et al.,
2015, 2014a,b) which could be driving the observed differences in the economic ef-
fects. Efforts to reduce the burden for females would include increasing awareness
among doctors about the higher risks for women to develop diabetes complica-
tions, as well as screening for cardiovascular risk factors in women at or before
a diabetes diagnosis. This would present an opportunity to prevent a further
escalation of the cardiovascular risk profile (Peters et al., 2015). Additionally,
weight reduction seems to be the single most important step to reduce the risk of
diabetes and ensuing complications in women (Peters et al., 2015). As this thesis
has shown, women in China were not able to achieve weight reductions to the
extent men did and therefore may need to be treated differently. Future work on
LMICs can provide important contributions to help develop effective strategies
to obtain this type of improvements in women’s health outcomes.
Moreover, reductions in socioeconomic inequities identified in this thesis may
also contribute to a reduction in the observed gender differences. If women have
fewer economic resources than men, are more likely to work in the informal labour
market and less likely to be insured (Galli et al., 2008) and therefore are more ad-
versely affected by diabetes, then interventions targeting the poor and uninsured
should specifically help women. Some of these interventions will be discussed
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below.
Prevention
Greater prevention of diabetes could help to reduce the observed inequities and
the individual economic burden of diabetes. Given the inequities found in this
thesis, such efforts may be particularly worthwhile if they focus on those dispro-
portionally affected by the adverse economic effects of diabetes.
One option is the introduction of national policies to affect food consumption.
There is already some real life evidence of such interventions with the goal of
reducing obesity in developing countries. In Mexico, a 10% tax on purchases of
sugar-sweetened beverages and ’junk food’ has been introduced in 2014. First
results have suggested a reduction in purchases of these goods after the introduc-
tion of the tax, with a steeper decline for those with lower income levels (Batis
et al., 2016; Colchero et al., 2016). If these changes in consumption actually lead
to a healthier diet and are large enough to cause reductions in obesity and dia-
betes prevalence has not been evaluated yet and remains to be seen. Other efforts
to prevent diabetes in LMICs include increasing the awareness of diabetes and
how to prevent it via population level campaigns, and increasing the accessibility
to sport courses and fitness equipment to foster physical activity (Cefalu et al.,
2016).
Another option is the identification of at risk groups and targeting them with
interventions to increase physical activity and dietary changes. These have shown
promising results across the globe, including in developing countries such as India
and China, where interventions have caused long term reductions in the risk of
developing diabetes (Cefalu et al., 2016). For example, for China a randomized
controlled trial provided long term lifestyle interventions to reduce the incidence
of diabetes and cardiovascular disease as well as to reduce mortality in people at
risk of developing type 2 diabetes. Over the active trial period of six years, the
diet and exercise intervention reduced the relative risk for diabetes incidence by
over 50% (Pan et al., 1997). A more recent evaluation of the long-term impact of
the interventions showed that over 20 years after the intervention had ended, the
incidence of diabetes was still over 40% lower in the intervention group. Further,
people that had received the intervention spend 3.6 years less with diabetes than
those in the control group (Li et al., 2008). However, the translation of these
interventions to real-world settings has been less successful, even in high-income
countries (Kahn et al., 2014; Wareham et al., 2016). For example, weight loss
has only been a small fraction of the reductions achieved in trials, likely often
too little to prevent diabetes. Kahn et al. (2014) argue that weight loss is noto-
riously difficult to maintain over a longer period of time, with trials often only
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capturing initial weight loss, but not the return to previous weight levels over
time. Therefore, prevention efforts based on lifestyle interventions or aiming at
weight loss may not yet be translatable into real life, as too little is known about
their cost-effectiveness and long-term effects to justify the use of limited resources
(Kahn et al., 2014). There are also questions about the cost-effectiveness of these
interventions if scaled to a population level and the challenge of finding qualified
staff to implement lifestyle interventions at the local level.
The evidence for pharmacological interventions mainly using metformin also in-
dicates a reduction in the risk of diabetes. However, Cefalu et al. (2016) mention
the potentially large heterogeneity in the benefit of pharmacological interventions
across ethnicities. More research on this subject will be needed to find out if suc-
cessful pharmacological interventions in one ethnicity can be translated to other
ethnicities. Nonetheless, Cefalu et al. (2016) argue that preventive metformin
treatment—which has been shown to reduce diabetes incidence in a number of
randomized controlled trials—in individuals with a high risk of progressing to
diabetes may be the best approach in countries with few economic resources.
Low-cost generic versions of metformin exist, are considered essential diabetes
medications in almost all LMICs (Bazargani et al., 2014), are effective in pre-
venting or delaying the onset of diabetes, and are safe (Rojas et al., 2013). They
therefore may present a relatively cost-effective intervention that could be applied
using existent healthcare infrastructure and pharmacies. It could be especially
effective in MICs, where the healthcare system infrastructure is much more de-
veloped than in low-income countries (LICs). Nonetheless, specific targeting of
populations most likely to benefit from pharmacological preventative treatment
will be needed, as the effects of metformin appear to be heterogeneous across age.
Further, pharmacological treatments may also exhibit different effects across pop-
ulations and ethnicities (Cefalu et al., 2016).
The identification of high-risk individuals that could be targeted with the men-
tioned interventions may pose an additional hurdle to successfully preventing
diabetes. Population level screening could be a way to identify people at risk.
Screening could also be carried out at the workplace or the community, and exist-
ing medical records could be used to identify people at an increased risk. Further,
there may be possibilities to promote risk self-assessments using online resources
through advertising and social media (Cefalu et al., 2016). However, scientific
evidence of the cost-effectiveness and feasibility of screening for high-risk individ-
uals in LMICs is non-existent, and if it were to happen may overwhelm healthcare
systems. It also carries the risk of further widening health inequities if the lower
income populations are less likely to attend screening efforts (Wareham et al.,
2016).
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Diagnosis
If prevention is not successful and people have developed diabetes, the earlier
diagnosis of diabetes to prevent further complications could be a viable option
to reduce the economic burden of diabetes. In Chapter 4, adverse labour market
outcomes were only observed for the self-reporting population with diabetes, sug-
gesting that the adverse impact manifested only after some time of living with
the disease and mainly after diagnosis. This is not surprising given the gradual
increase in blood glucose as diabetes progresses and the concomitant relatively
slow deterioration of health (Bertram et al., 2010). While earlier detection of dia-
betes via screening did not yield important improvements in disease outcomes in
the Addition-Trial in European HICs, this might be markedly different in MICs.
The large undiagnosed population found in Mexico in Chapter 4 as well as for
other LMICs in a recent study by Beagley et al. (2014), suggests that, compared
to HICs, in MICs more people with diabetes remain undiagnosed for an extended
period of time. Therefore, earlier detection may have a greater beneficial ef-
fect (Choukem et al., 2013), in particular, if it can prevent complications from
appearing within a person’s productive lifespan.
The results of Chapter 5 indicate that a diagnosis can introduce positive
changes in behavioural risk-factors that may be directly related to a reduced
economic burden of diabetes, suggesting that diagnosing those currently unaware
could have positive effects. Nonetheless, earlier detection would also increase
healthcare demands and costs, at least in the short term. Therefore, evidence is
needed that explores the trade-off between the costs generated by longer treat-
ment periods and a greater number of patients due to an earlier diagnosis and
potential reductions in healthcare expenditures and productivity losses as a re-
sult of lower complication rates at later stages (Engelgau et al., 2012). Evidence
on the cost-effectiveness of a population-based diabetes screening program was
provided by a recent study from Brazil, where over 22 million people over the age
of 40 were screened for diabetes, being the first trial evaluating an actual real-life
population-based diabetes screening program in a developing country (Toscano
et al., 2015). It was unclear if the program could be considered good value for
the healthcare system, as the cost-effectiveness of the findings depended strongly
on the underlying assumptions about how effective treatment would be in pre-
venting coronary heart disease and stroke. Given the results from this thesis,
cost-effectiveness might be greater from a societal perspective if an earlier diag-
nosis would prevent or decrease losses in productivity and productive lifespan.
Of course, early diagnosis may only be reasonable if the healthcare system is suf-
ficiently developed to allow all diagnosed cases access to appropriate treatment
options (Engelgau et al., 2012; Toscano et al., 2015).
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Apart from worse health in the population aware of its diabetes, another policy
relevant reason for the difference in the observed effects could be the psychological
effect of a diabetes diagnosis. Reductions in productivity may be the result of
increasing anxiety and depression as a result of becoming aware of the disease
and its potential consequences. Further, difficulties in adapting to the treatment
regime may cause additional stress. As discussed in Chapter 4, there is some
evidence that becoming aware of the disease leads to reductions in labour income
likely due to its psychological effects (Liu et al., 2014). If this is confirmed by other
studies, then strategies to provide better guidance and support at diagnosis and
thereafter to reduce the psychological burden of the disease could be worthwhile.
Treatment
Earlier diagnosis, however, will only be worthwhile if those diagnosed are able to
receive effective diabetes treatment. The adverse labour market effects found for
those with self-reported diabetes, and the increase in effect size over time after
diagnosis, suggest that currently this may not be the case and adverse health and
ensuing economic events often cannot be prevented. This may have several rea-
sons. The diagnosis could happen too late to prevent first complications from hav-
ing developed, making it increasingly difficult to prevent further complications.
Another reason could be the sub-optimal treatment of the disease, in particular
in the most adversely affected—likely socioeconomically disadvantaged—groups
identified in this thesis.
Therefore, an important step to improve outcomes would be the provision of
better quality in diabetes treatment, targeting the identified groups and tailoring
interventions according to their socioeconomic, physical and personal character-
istics (Cefalu et al., 2016). The existing evidence on diabetes treatment models
applicable in very resource constrained settings has recently been reviewed by
Esterson et al. (2014). While the evidence is still limited, the study provided
information on interventions that have had some success in improving diabetes
treatment for the poor. Further, it identified common characteristics of these suc-
cessful interventions: collaboration, education, standardization of guidelines and
algorithms, technological innovations, and resource optimization. The authors
recommended that initiatives to provide care to underserved populations should
be built on collaborations between academic institutions, hospitals, the private
sector and other organizations such as local governments. This should help to
achieve goals that would otherwise be difficult to reach for one stakeholder alone.
Further, programs should aim at providing appropriate education to doctors to
increase their ability to successfully treat people with diabetes. For very remote
communities, Esterson et al. (2014) suggested the use of peer-support programs,
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so that a few well educated community members or nurses could help their peers
with the challenges of diabetes management. Further, a need for standardized
guidelines and treatment algorithms was identified as a means for healthcare pro-
fessionals to improve and maintain their standards of care. Given that mobile
phones have already reached even very remote areas and are common in the de-
veloping world, interventions based on existent technologies could also improve
care and diabetes outcomes. They could facilitate communication between doc-
tors and their patients as well as tracking and controlling diabetes management
and outcome measures. Finally, resource optimization to use available and con-
strained resources more effectively, e.g. by transferring certain responsibilities
from doctors to nurses or from healthcare professionals to peers, could be an
option in very resource constrained settings (Esterson et al., 2014). Together,
the presented strategies could help in reaching and treating poorer parts of the
population.
A number of interventions have been implemented in LMICs to improve care
for people with diabetes. Focusing on China, Mexico and other MICs, some of
these will be mentioned here. Most of these interventions apply at least one of
the recommendations mentioned in the previous paragraph. For Mexico, a recent
randomized controlled trial tested the effects of providing better diabetes training
to physicians, as well as supporting them with nurses trained in diabetes care and
peer-support groups (Anzaldo-Campos et al., 2016). Further, the additional mon-
itoring and support of patients via the use of mobile phone technology was tested
in a second intervention group, given the common use of mobile phones in Mex-
ico. First results indicated a significant reduction in HbA1c and better diabetes
knowledge in both intervention groups compared to standard care. The use of
the mobile phone technology did not lead to statistically significant improvements
compared to the other intervention group. Other studies investigating the use of
mobile phone technology have, however, shown promising results (Singh et al.,
2016). Two randomized controlled trials investigated ways to improve diabetes
outcomes in Costa Rica and China, respectively (Goldhaber-Fiebert et al., 2003;
Sun et al., 2008). In Costa Rica, the application of a community-based nutri-
tion and exercise program led to reductions in weight, fasting glucose and HbA1c
levels. In Shanghai, China, more extensive diabetes education and the provision
of meal plans led to improvements in blood glucose, HbA1c levels, blood pres-
sure and waist-to-hip ratios compared to the group receiving standard diabetes
education. Unfortunately, so far information about the ultimate value of these
interventions in terms of their cost-effectiveness and long term effects is scarce,
partly because the investigation is still under way (Anzaldo-Campos et al., 2016)
or has not (yet) been evaluated (Singh et al., 2016).
Further, in MICs the provision of universal healthcare has been advocated as
170
a means to reduce health inequities by providing everyone with the ability to
access healthcare (Marmot et al., 2008). Mexico has been one of the countries
where the goal of universal healthcare has been almost accomplished through
the introduction of “Seguro Popular”, which provides those without prior health
insurance coverage with social security and access to diabetes treatment options
(Knaul et al., 2012; Rivera-Hernandez et al., 2016). However, evidence on the
impact of diabetes treatment and outcomes has shown that the availability of this
program has only led to very modest improvements, only finding a positive effect
on the use of pharmacological therapy. No effects were found on the monitoring
of blood glucose or adherence to exercise plans by people with diabetes (Rivera-
Hernandez et al., 2016). A likely reason for this, brought up by the authors,
was that many clinics were not prepared to provide specialized diabetes care
and medications, suggesting that barriers to accessing appropriate diabetes care
and education still existed. Hence, while public healthcare provision for those
previously uninsured can reduce inequities, such programs need to ensure that
their efforts are not sabotaged by the low quality of the offered services.
The overall disease burden and structural constraints
The mentioned strategies may be able to reduce the diabetes burden, however,
they mostly focus on diabetes without taking into account the overall disease bur-
den nor existing structural constraints existent in MICs that could significantly
limit the applicability and sustainability of interventions. They therefore tend to
represent temporary solutions aiming to address specific needs of people at risk
of or living with diabetes under the current circumstances, but may not help to
substantially reduce the burden of diabetes in the long term.
One constraint to the successful implementation of above mentioned interven-
tions is the wider disease burden, which may inhibit the healthcare system from
providing effective treatment for diabetes and other chronic diseases. However,
integrating diabetes care with the healthcare for other diseases may also present
a viable opportunity for healthcare systems in MICs.
Health systems in developing countries have been slow to adopt technologies to
reduce the burden of communicable diseases, maternal and perinatal conditions
as well as nutritional deficiencies (Gutiérrez-delgado et al., 2009). The main rea-
sons for this slow adoption are social and political instability limiting long-term
planning, a lack of resources to finance the introduction of health technologies,
and a dearth of qualified personnel in the public sector due to a lack of train-
ing and the greater attractiveness of the private sector and developed countries
(Gutiérrez-delgado et al., 2009). Therefore, many MICs face a double disease
burden with high rates of communicable and non-communicable diseases at the
171
same time (Gutiérrez-delgado et al., 2009). The treatment of non-communicable
diseases (NCDs) places additional pressure on health systems that did mainly de-
velop to provide acute care of infectious diseases based on single-visit treatments,
and are lacking the infrastructure, resources and experience for the treatment of
chronic diseases such as diabetes (Nulu, 2016). Policy makers in MICs there-
fore are forced to make decisions about the prioritization of treatments in an
effort to use the available resources in a cost-effective as well as equitable manner
(Gutiérrez-delgado et al., 2009), potentially limiting a systems ability to provide
effective diabetes care.
To improve treatment for diabetes under these circumstances, a greater inte-
gration of health services and control efforts for diabetes with the treatment of
communicable diseases and other NCDs could help to exploit synergies and inter-
actions between diseases. One such example presents the relationship of diabetes
with tuberculosis, with diabetes patients have a two- to threefold higher risk to
develop tuberculosis in many LMICs. Apart from the burden of an additional
disease, tuberculosis may also complicate glucose management in people with di-
abetes (Dooley et al., 2009). Therefore, instead of competing for resources, the
detection and treatment of both diseases may be integrated to reduce costs and
improve health outcomes (Marais et al., 2013; Remais et al., 2013). Because tu-
berculosis and other communicable diseases are more common in groups of lower
socioeconomic status with less access to high quality care, the double burden with
diabetes and the interplay between the diseases has the potential to even further
increase the already existing health and social inequities (Marais et al., 2013).
Similarly, diabetes is often accompanied by other NCDs that share risk factors
with diabetes and are further worsened by high blood glucose levels (Cheung et
al., 2012). In particular, hypertension often appears together with diabetes (Bar-
quera et al., 2013; Cheung et al., 2012), is very prevalent in MICs and one of the
major causes of mortality (Mills et al., 2016), offering another avenue for treat-
ment integration to improve health outcomes by better using existing resources.
Hence, focusing on ways to take advantage of the synergies presenting themselves
in the treatment of communicable and non-communicable diseases could provide
a way to reduce the overall disease burden, in particular, of more marginalized
populations, which could also reduce the existing inequities while limiting the
strain on healthcare budgets.
Studies have also consistently shown a relationship of early life health with later
life health outcomes, suggesting that bad health and nutritional status early in life
could increase the risk to develop diabetes and other diseases later (Currie et al.,
2013; Hanson et al., 2012). Therefore, efforts to improve maternal and early life
health outcomes of children will not only have short-term effects but likely help
to prevent adverse health outcomes later in life (Bygbjerg, 2012; Marais et al.,
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2013). As a result, investing in the treatment of infectious diseases, nutritional
deficiencies and maternal health could help to reduce the overall disease burden
now and in the future. Further, because the poor are likely most exposed to the
risk of adverse early life events, such efforts could help to reduce the economic
inequities found in this thesis.
However, while a greater integration of diabetes care with the care of other
diseases may be a viable way forward, such changes in the formal health-care
sectors will not be sufficient. Because of the feedback loops between poverty and
bad health, i.e. poor people are more likely to be sick which then further worsens
their economic situation, socioeconomic inequities themselves are drivers of the
disease burden (Di Cesare et al., 2013). Consequently, structural problems such
as an unequal distribution of power, financial resources, the access to education,
a healthy living environment, affordable housing as well as to high quality health-
care, need to be addressed. Only this will help to achieve lasting reductions in
inequalities and consequently also the disease burden due to both communicable
and non-communicable diseases (Di Cesare et al., 2013).
Discrimination of people with diabetes
Despite the proposed efforts to reduce inequities in the burden of diabetes, peo-
ple with diabetes may still face discrimination. The thesis has found considerable
adverse effects of diabetes on employment chances which may not only be ex-
plained by its health impact, but also by employers discriminating against people
with the disease. Once employers are aware of the employee’s diabetes, they may
decide to replace the employee with a healthy person as they suspect reductions
in productivity due to health problems or disease management at the workplace.
Little information exists regarding the importance of discrimination of employers
against people with diabetes in LMICs. For the USA, studies show that people
with diabetes were more likely to experience discharge, constructive discharge
or suspensions affecting their ability to retain their job (McMahon et al., 2005).
Further, working for smaller employers, being older and the ethnic background
affected the risk of experiencing discrimination due to diabetes in the workplace.
Similarly, a study for Switzerland found that people with diabetes were less likely
to be hired and diabetes related events—such as hypoglycemia—made it more
likely to experience job loss (Nebiker-Pedrotti et al., 2009). Even though we have
no information about the importance of discrimination for the employment ef-
fects found in this thesis, given the evidence from HICs it is likely that it plays
a considerable role. The adverse effects for the poor and informally employed
suggest that discrimination may play a more important role in manual occupa-
tions that value physical health to a greater extent than more brain based jobs
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in the formal sector. Additionally, informal jobs are not affected by job secu-
rity legislation (Loayza et al., 2011; Ulyssea, 2010), reducing the costs of lay-offs
and of hiring and training a new employees, making it easier to replace an ’un-
healthy’ with a ’healthy’ employee, further incentivising discrimination against
people with diabetes.
Unfortunately, simple remedies for this type of discrimination may not exist
in MICs. Because informal labour markets are a substantial part of transition
economies, legislative measures to reduce the incentives of discriminating against
people with diabetes may fall short—at least partly—as they would not be en-
forceable in the informal sector. Further, stricter protection legislation may have
counterproductive effects in MICs if they lead to reduced hirings of people with
diabetes or those at a higher risk to develop diabetes, such as overweight or obese
candidates (Muravyev, 2014). Companies may be inclined to demand health
check-ups prior to hiring to prevent the employment of personal with a higher
risk of adverse health outcomes. Therefore, measures to reduce discriminatory
behaviour by employers in MICs should also aim at reducing prejudices about
people with diabetes by increasing the knowledge about the disease, its treatment
the potential to prevent its adverse health consequences.
Overall it seems that for MICs, national policies to change food consumption
behaviours to prevent diabetes could currently be the best option to halt the es-
calation of the economic impact of diabetes and to reduce inequities. The results
of this thesis suggest that it should be a priority to design interventions that
address the existent inequities by preventing diabetes in those populations that
experience the worst economic consequences, i.e. the poor and more marginalised
groups of a country. One way to reduce the existing inequities using the existing
healthcare system would be the integration of the treatment of diabetes with al-
ready existing strategies to treat related communicable diseases that are common
in underserved populations. This would also reduce competition for resources to
treat different diseases, a problem facing many decision makers in very resource
constrained healthcare systems. The evidence base for the effectiveness of screen-
ing programs, preventative pharmacological treatment and lifestyle interventions
is less conclusive, potentially due to the social and economic structural constraints
existent in many MICs, preventing their successful implementation. Therefore,
the structural problems underlying the already existing social, economic as well
as health inequities will need to be addressed to achieve long term reductions in
the burden of diabetes. This also pertains to issues of discrimination of people
with diabetes at the workplace, currently being mostly unprotected from such
behaviour due to the large informal labour markets in MICs.
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Strengths and limitations
The strengths and limitations of each study and the used methodological approach
have been evaluated within each chapter. Additionally, the thesis overall has
strengths and limitations.
A strength of this thesis is the provision of a comprehensive overview and as-
sessment of the state of economic research on the impact of diabetes. It provides
other researchers guidance by identifying areas for future research and suggestions
on which methods to use. Further, the thesis itself fills some of the identified gaps
by investigating the impact of diabetes on labour market outcomes in MICs. A
strength of these analyses is the use of rigorous econometric approaches tak-
ing advantage of available and previously underexplored, high quality, household
data, allowing to investigate a variety of topics in the absence of experimental
data. One of the challenges was the choice of the most appropriate method to
establish a causal relationship. The main concern was that unobserved vari-
ables, measurement error as well as reverse causality may introduce bias into the
estimates. A variety of methods were used that each had advantages and disad-
vantages in terms of the underlying assumptions and the ability to account for
potential sources of bias. Their choice was mainly guided by the available data
and the best way of achieving a causal interpretation under the given circum-
stances. Nonetheless, regardless of the method used, results consistently showed
an adverse relationship of self-reported diabetes with employment probabilities,
suggesting a relatively robust and likely causal effect. The methods used also
improved upon previous approaches, providing more robust evidence and also
incorporated methods predominantly known in epidemiology.
A further strength is the provision of evidence on the potential of diabetes to
widen the economic inequities in developing countries, identifying the groups that
were disproportionally affected by the disease. Further, it has also advanced the
understanding of diabetes as a multifaceted condition by exploring effects over
time and for those who are aware and those who are unaware of their diabetes.
Finally, it provides evidence from different data sources and contexts and also
investigates the value of becoming aware of the disease through a diagnosis and
its ability to influence health behaviours.
The thesis has several limitations. Whilst the intention was to provide evidence
on the economics of diabetes in MICs, the thesis mostly investigates the economic
impact of diabetes. While this provided important information for researchers and
policy makers, the thesis did not investigate how to curb this economic diabetes
burden. Information about the best and most costs-effective interventions that
could be applied in MICs to lower the burden of diabetes is urgently needed as
information about who is affected most will not suffice to effectively reduce the
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burden. Research on how to implement interventions feasible in non-HIC settings
is therefore of paramount importance, but was beyond the scope of this thesis.
This leads to the next limitation. The thesis does not investigate in how far
healthcare systems in MICs need to change in order to better provide care. Be-
cause they often lack financial resources, do not efficiently use the available re-
sources, are designed to treat acute infectious diseases rather then affecting the
outcomes of long-lasting non-acute NCDs, and often provide unequal access to
their health services due to financial constraints of those seeking care, research
into how to better equip healthcare systems to confront the challenges of treating
NCDs is urgently needed (Guzman et al., 2010; Mills, 2014).
A further limitation is the geographical concentration of the thesis, as far as the
empirical, analytical chapters are concerned. While Mexico and China are among
the ten countries worldwide regarding the absolute size of their population with
diabetes, there are other large and small MICs currently facing similar challenges
(NCD Risk Factor Collaboration, 2016). It cannot be assumed that the evidence
provided in this thesis is perfectly representative of all other MICs. There is
hence a need to investigate the economic burden and potential solutions in other
countries, given their own specific context in terms of culture, the political system,
economic development and existing inequities.
Finally, while the thesis intended to provide a picture of the potential inequities
in the economic impact of diabetes for socioeconomic subgroups, it did not inves-
tigate in detail why these inequities exist and could only speculate on the reasons.
A better understanding of the underlying reasons will be essential for designing
adequate strategies to address these inequities. Further, whilst the thesis has
touched upon the potential reasons for the differences in employment effects be-
tween those self-reporting diabetes and those unaware, it has not provided an
in depth analysis of this phenomenon. A better identification of the underly-
ing reasons will be required to design interventions that can prevent the adverse
economic effects of diabetes.
Suggestions for future research
This thesis has shown the global economic impact of diabetes and its adverse
effect on labour market outcomes in Mexico and China. It identified the poor,
those in the informal economy and women as being most adversely affected by
the disease. It further found that, at least in China, it is men that appear to
make the most from a diabetes diagnosis in terms of positively changing their
health behaviours. Finally, it provided some indication that while self-reported
diabetes is related to adverse labour market effects, undiagnosed diabetes is not.
Without a greater understanding of the underlying reasons for these differences,
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it will be difficult to design policies that can help prevent the burden of diabetes
in MIC and reduce inequalities.
Several reasons for the observed gender differences in the impact of diabetes
have been discussed in this thesis, including biological reasons that increase the
risk of complications in women (Arnetz et al., 2014; Catalan et al., 2015; En-
gelmann et al., 2016; Peters et al., 2015, 2014a; Policardo et al., 2014; Roche
et al., 2013; Seghieri et al., 2016) and may also impair the ability of women to
lose weight (Penno et al., 2013), as well as differences in the access to appro-
priate healthcare (Penno et al., 2013). One strategy to further investigate these
differences would be the use of biomarker data in combination with information
on healthcare utilization as well as socioeconomic outcomes. This could then be
used to investigate potential heterogeneities in the relationship between diabetes
and overall metabolic health with labour market outcomes. Further, informa-
tion on healthcare usage could be used to investigate if differences in healthcare
access mediate the economic impact of diabetes. A potentially rich source of
information is provided by two Chinese household surveys, the China Health
and Nutrition Survey (CHNS) and the China Health and Retirement Longitu-
dinal Study (CHARLS). Both contain an extensive list of measured biomarkers
and socioeconomic variables that could help to investigate gender differences in
metabolic risk. Because biomarker data were only available for one wave in both
the CHNS and CHARLS, in the present studies they could not be used longi-
tudinally to predict future effects of diabetes. However, they will be able to be
used for this purpose in future waves. This information may also be used to
further explore differences in metabolic risk between people aware and unaware
of their diabetes. Also, studies measuring potential mediating variables—such
as knowledge, motivation, treatment, diabetes control and complications—would
help clarify the causal mechanisms through which diabetes affects economic and
other outcomes. Structural equation and mediation models could be useful with
such data.
Researchers should also try to confirm the results regarding the identified in-
equities, using different data and countries. Whether these relationships can be
confirmed or not, the underlying drivers of these inequities need to be explored
to design adequate policies. This could be done by identifying countries where
these inequities may not have been found, to isolate the causal determinants.
Further, strategies implemented currently or in the future in MICs that aim at
reducing these inequities, such as the implementation of universal health insur-
ance schemes, need to be evaluated in how far they are actually achieving this
goal in terms of diabetes. The same is true for population level interventions
such as taxes on foods or nutrients, as these are probably regressive and theo-
retically should reduce consumption in particular for those with lower levels of
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income (Mytton et al., 2012). This could then lead to a reduction in diabetes in-
cidence in these groups. However, depending on the price elasticities of the taxed
products, such taxes may only reduce the disposable income of the poor, lead-
ing to reductions in the consumption of other, potentially healthier foods. They
therefore may be seen as taxes on the poor, raising political and ethical dilem-
mas. Further, substitution effects with equally untaxed products may only cause
a shift in consumption towards other equally unhealthy, but untaxed products
(Mytton et al., 2012).
The population with diabetes in all countries, but especially in LMICs is only
partially observed. In other words, many people with diabetes are not aware
that they have the disease. This thesis has provided an investigation of the dif-
ferences between those who are aware and unaware in Chapter 4. It, however,
still remains unclear to what extent different factors such as health information
and actual health status are causing the observed heterogeneity in the economic
impact. Because increasingly household surveys are providing biomarker data in
combination with socioeconomic information, they should be used together with
quasi-experimental econometric techniques to investigate this topic. A regression-
discontinuity design may be used in a similar vein as in Zhao et al. (2013b), who
use cut-off values for hypertension to identify those newly diagnosed and the sub-
sequent effect of this diagnosis on health behaviours. A similar approach could
be used to explore the effects of a diabetes diagnosis and the entailed health
information on labour market outcomes, health behaviours and other economic
outcomes. Importantly, research should assess the heterogeneity of effects across
income groups, rural versus urban, education levels and between males and fe-
males. This would provide important information for designing interventions
to reduce the physiological and economic burden of diabetes while preventing a
widening of inequities.
Finally, there is a need to explore further economic downstream effects of the
economic impact of diabetes. If diabetes causes reductions in employment and
potentially also income, it is likely that these will cause not only problems for the
individual directly affected, but for the entire household as well. In MICs, where
social security is less extensive and comprehensive, adverse health shocks due to
diabetes could have consequences for children, spouses or other family members
living in affected households (Alam et al., 2014). The loss in labour income
due to diabetes needs to be compensated either by increasing the labour supply
of other household members or by reducing expenditures for other consumption
goods. Both could affect children directly, for example by reducing the time for
or the quality of education when tuition fees cannot be paid any more, and also
by having to substitute time for education with labour time. Similarly, spouses
may be forced to increase their labour supply, reducing the time they can care
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for their children. These effects have remained unexplored for diabetes but given
the scale of the diabetes epidemic may not be trivial.
Conclusion
Diabetes presents a major challenge for MICs, but evidence on its economic effects
has been scarce. This thesis has found that diabetes has an adverse economic
impact on individuals and puts a burden on healthcare systems. Because evidence
on the impact of diabetes on labour market outcomes was lacking in developing
countries, the thesis did focus particularly on this topic. Thereby, it not only
provided evidence of the adverse impact of diabetes on employment, but also
improved upon previously used econometric methods by using novel strategies
to identify a causal relationship. The thesis also identified potential inequities
in the impact of diabetes, pointing to larger adverse effects for the poor, those
in the informal labour market and women. But the thesis did not only focus on
the economic impact of diabetes, but also investigated the effects of a diabetes
diagnosis on health behaviours, unravelling evidence for differences in the ability
to change health behaviours between men and women.
These findings suggest that there is a need to reduce the economic impact of
diabetes in MICs. Considering the increasingly earlier onset of diabetes and the
ongoing increase in incidence in many countries, the non-trivial adverse economic
effects could otherwise hinder economic development and present a substantial
poverty risk. Strategies to combat the adverse diabetes effects need to be tailored
to the available resources within countries, target the most affected groups to
narrow inequities, also having in mind potential gender differences, structural
constraints and the overall disease burden. Finally, there is a large undiagnosed
population with diabetes in MICs that is likely to experience severe diabetes
complications if identified very late. Hence, ways to diagnose this population
earlier in order to prevent further deterioration of health may go a long way in
preventing and delaying the most catastrophic economic and health outcomes.
In conclusion, it is hoped that the research presented in this thesis contributes
to the knowledge on the economics of diabetes and helps to identify cost-effective
strategies to lower the health and economic consequences of diabetes. It has
demonstrated the economic burden currently caused by diabetes, in particular in
Mexico and China, and has identified groups that are particularly vulnerable to
the negative consequences of the disease and should be at the centre of efforts to
prevent the burden of diabetes.
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
DHS Armenia Cross-
section
2010 women
and men
15-49
6700
households
yes no yes diabetes
questions,
health ex-
penditures
http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-354.
cfm
DHS Bangladesh Cross-
section
2011 women
12-49 and
men 15-54
17141
households
yes no yes http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-349.
cfm
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
DHS Benin Cross-
section
2011-2012 women
12-49 and
men 15-64
17422
households
yes yes not yet diabetes
questions
http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-420.
cfm
LSMS Bosnia
and Herze-
govina
Cross-
section
2004 both sexes 2969
household
yes no yes Diabetes
question,
healthcare
expen-
ditures,
employ-
ment,
earnings
http:
//go.
worldbank.
org/
OLMHSTUX40
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
LSMS Bulgaria Cross-
section
2001,
2003, 2007
both sexes 4300
households
yes no yes diabetes
questions,
since when
diagnosed,
health
expen-
ditures,
earnings
http:
//econ.
worldbank.
org/
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
Cebu Lon-
gitudinal
Health and
Nutrition
Survey
Philippines Panel 5 1991-2005 Filipino
women
who gave
birth be-
tween May
1, 1983,
and April
30, 1984
2800
women
and 2260
children
no yes yes diabetes,
health, nu-
trition and
economic
data for
mothers
available
at least
since 1991,
for chil-
dren blood
samples
taken in
2005 and
were asked
for chronic
illnesses
http://
www.cpc.
unc.edu/
projects/
cebu/
datasets
CHNS China Panel Every 2
years since
1989
1989-2011 both sexes,
all ages
Around
16000
people
yes yes (next
wave 2013)
yes Diabetes
question,
biomark-
ers
http://
www.cpc.
unc.edu/
projects/
china
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
DHS Dominican
Republic
Cross-
section
2007 Women
15-49 and
men 15-59
32000
households
yes no yes Diabetes
question,
(earnings,
employ-
ment,
health
expen-
ditures,
wealth)
http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-291.
cfm
DHS Egypt Cross-
section
2008 Females
15-49 and
males
15-59
18968
households
yes no yes Diabetes
question,
socioe-
conomic
infor-
mation
(earnings,
employ-
ment,
health
expen-
ditures,
wealth)
http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-294.
cfm
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
DHS India Cross-
section
2005 women
15-49 and
men 15-54
109041
households
yes no yes diabetes
ques-
tion and
history,
earnings,
employ-
ment,
wealth
http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-264.
cfm
Indonesian
Fam-
ily Life
Survey
Indonesia Panel 4 1993,
1997,
2000, 2007
both sexes,
all ages
30000 peo-
ple
almost no yes diabetes
question
only in
last wave
http:
//www.
rand.org/
labour/
FLS/IFLS.
html
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
LSMS Iraq Cross-
section
2007 both sexes,
all ages
18144
households
yes no yes diabetes
questions,
comorbidi-
ties,health
expen-
ditures,
earnings,
employ-
ment,
wealth
http:
//go.
worldbank.
org/
HATUQJIMF0
DHS Lesotho Cross-
section
2009 Women
15-49 and
men 15-59
9391
households
yes no yes diabetes
questions,
earnings,
income,
wealth
http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-317.
cfm
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
LSMS Malawi From 2013
on partly
panel
structure
2004, 2010 both sexes 12271
households
in 2010
yes yes yes diabetes
questions,
health
expen-
ditures,
employ-
ment,
income
http:
//go.
worldbank.
org/
RMEFTSE8O0
MxFLS Mexico Panel 2 2002, 2005 both sexes,
all ages
35000 yes no yes diabetes
question,
labour
market
outcomes,
parental
diabetes
http:
//www.
ennvih-mxfls.
org/es/
ennvih.
php?
seccion=
1&
subseccion=
1&
session=
76719964140
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
Enquete
nationale
sur les
niveaux
de vie des
menages
Morocco Cross-
section
2007 ? 7200
households
yes no no infor-
mation
found
Diabetes
question
http:
//www.
hcp.ma/
Enquete-nationale-sur-les-niveaux-de-vie-des-menages_
a96.html
LSMS Nepal Cross-
section/Panel
3 1996,
2003, 2010
both sexes 6000
house-
holds,
Panel 1200
yes no yes diabetes
questions,
since when
diagnosed,
health
expen-
ditures,
earnings,
employ-
ment
http:
//go.
worldbank.
org/
LLAVNKC6E0
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
DHS Peru Cross-
section
2011 only fe-
males,
15-49
26182
households
yes no yes diabetes
questions,
income,
health
expen-
ditures,
employ-
ment,
wealth
http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-433.
cfm
DHS Senegal Cross-
section
2011 Women
15-49 and
men 15-59
7902
households
yes no yes diabetes
questions,
income,
health
expen-
ditures,
employ-
ment,
wealth
http:
//www.
measuredhs.
com/
what-we-do/
survey/
survey-display-365.
cfm
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
LSMS Serbia and
Montene-
gro
Panel 2 2002, 2003 both sexes 19725
persons
(2002),
8027
persons
(2003)
yes no yes Diabetes
question,
healthcare
expen-
ditures,
employ-
ment
http://
microdata.
worldbank.
org/
index.
php/
catalog/
80
South
African
National
Income
Dynamics
Study
(NIDS)
South
Africa
Cross-
section
2 2008, 2011 both sexes 7300
households
yes yes yes Diabetes
question,
taking
medica-
tion and
since when
diabetes,
income,
health
expen-
ditures,
labour
market
outcomes
http://
www.nids.
uct.ac.
za/home/
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
LSMS Tajikistan Cross-
section
2007 both sexes 4860
households
yes no yes diabetes
questions,
labour
market
outcomes,
health ex-
penditures
http:
//go.
worldbank.
org/
6TUMCB3K30
LSMS Tanzania Panel 2 1994, 2004 both sexes 900 house-
holds
no no yes diabetes
questions,
income,
employ-
ment,
health ex-
penditures
http:
//go.
worldbank.
org/
9F9RHLXM20
WHO
World
Health
Survey
Worldwide Cross-
section
2002 both sexes yes no not di-
rectly
Diabetes
question
http:
//www.
who.int/
healthinfo/
survey/
instruments/
en/index.
html
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Table A1: Household surveys from low- and middle-income countries including diabetes information as of 2014
Name Country Cross-
section /
Panel
Waves Years Population Sample
size
Nationally
Represen-
tative
Ongoing Data avail-
able
Interesting
content
URL
Russia
Longi-
tudinal
Monitor-
ing Survey
(RLMS)
Russia Panel 15 1994-2011 both sexes 4000-6000
households
yes yes yes diabetes
question,
time of
diagnosis,
health
expen-
ditures,
labour
market
outcomes
http://
www.cpc.
unc.edu/
projects/
rlms-hse
LSMS Living Standards Measurement Surveys DHS Demographic and Health Survey
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II Appendix to Chapter 2
What is endogeneity?
Endogeneity is a statistical problem that occurs in regression models if the as-
sumptions about the flow or direction of causality are incorrect. If endogeneity
is ignored, it could be that claims about causality between two variables or the
magnitude of the effect are false. In general, one can only be certain about a
causal relationship of the effect of x on y if the following three conditions are met
(Antonakis et al., 2012):
• y follows x temporally
• y changes as x changes (and this relationship is statistically significant)
• no other causes should eliminate the relation between x and y.
There are three major causes of endogeneity that violate the conditions above.
1. Omitted variablesWhen a regression is run to determine the causal effect
of variable x on variable y, but there are unobserved variables that affect
variables x or x and y simultaneously, the estimated effect of x on y will be
biased. For the case of type 2 diabetes and employment probabilities, there
is the danger that, e.g., personal traits like ambition, which are hard to ob-
serve, could influence the probability of developing type 2 diabetes through
their effect on a person’s lifestyle, but they could also simultaneously affect
the chances of employment through their influence on a person’s determi-
nation to find work or to perform well at work. If we are not able to control
for this, then our estimate of the effect of diabetes on employment prob-
abilities might, at least partially, represent the effect of personal traits on
employment probabilities. As a result, our estimate of the effect of diabetes
is biased and does not represent the true size of the relationship between
the two variables.
2. Simultaneity Simultaneity is present if our outcome variable y and our
variable of interest x influence each other simultaneously, so that y not only
is affected by x but x is also affected by y. In the case of type 2 diabetes
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and labour market outcomes, not only diabetes could influence employment
probabilities or work related income, but also resulting changes in lifestyle
due to employment or an increase in income could affect the probabilities
of developing diabetes. Due to an increase in income people could change
their diet or change towards a less active lifestyle which in turn would make
them more likely to develop type 2 diabetes.
3. Measurement error Measurement errors occur when the independent
variable x is imprecisely measured. Here this would be the case if peo-
ple in a survey did not remember if they have been diagnosed with type 2
diabetes and gave a wrong answer.
There are several solutions to the problem of endogeneity, but only using IV
techniques has the potential to deal with all three causes of endogeneity at once.
Endogeneity is a problem, because the variable of interest, here diabetes, is cor-
related with the error term of the estimated model, which includes all omitted
variables as well as the effect of y on x and if measurement error is present, the
true values. To do this, one needs to find a suitable instrument that needs to
fulfil the following conditions:
• it has to be causally related to the endogenous variable x and
• it should not be correlated to the dependent variable y other than through
its correlation with x.
This instrument is then used in a first regression to obtain predicted values of
the problematic endogenous regressor. Because the instrument is not correlated
with the error term, these predicted values of the endogenous variable will be
uncorrelated as well and can then be used in a second regression to predict the
dependent variable y. The estimated coefficients of this second stage can then be
regarded as consistent estimates.
In the case of type 2 diabetes and labour market outcomes, an instrument has
to predict the development of diabetes without being otherwise causally related
to any of the labour market outcomes, be it employment probabilities, wages or
some other measure of productivity. The instrument of choice so far has been
the family history of diabetes. It has been shown that a considerable part of the
risk of developing type 2 diabetes is hereditary (Hemminki et al., 2010; Herder
et al., 2011; The Interact Consortium, 2013). This fact is exploited when the
instrument is used and it is assumed that this is the only pathway through which
a family history of diabetes affects a person’s diabetes risk, and also that, e.g.,
parental diabetes does not affect the person’s labour market outcomes directly.
The most common estimation techniques for the estimation of IV regressions
are the linear IV model and the bivariate probit model. The latter is often
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deemed more apt for models where both the outcome as well as the instrumental
variable are binary, so either 0 or 1, which is the case for employment as an
outcome variable as well as diabetes family history as an instrument. Nonetheless,
there is some discussion in the econometrics literature regarding the best method
to estimate these cases, as it also has been argued that because the linear IV
technique does not depend on the assumption of normality of the error terms, in
contrast to the bivariate probit model, its results are more reliable in the case
of non-normality, but can sometimes lead to imprecise estimators which can no
longer be interpreted meaningfully (Chiburis et al., 2012). Both methods can be
found in the reviewed papers.
222
Country codes
Table A2: Country Codes
Country Country code Country Country code
35 developing
countries
LMIC Jamaica JAM
Argentina ARG Japan JPN
Australia AUS Latin America and
Caribbean
LAC
Bahamas BHS Mexico MEX
Barbados BRB Netherlands NLD
Belgium BEL Nicaragua NIC
Bolivia BOL Nigeria NGA
Brazil BRA Norway NOR
Canada CAN Pakistan PAK
Chile CHL Panama PAN
China CHN Paraguay PRY
Colombia COL Peru PER
Costa Rica CRI Serbia SRB
Cuba CUB Spain ESP
Czech Republic CZE Sudan SDN
Denmark DNK Sweden SWE
Dominican
Republic
DOM Switzerland CHE
Ecuador ECU Taiwan TWN
El Salvador SLV Thailand THA
Europe EUR The Bahamas,
Barbados,
Jamaica, Trinidad
and Tobago
CARICOM
France FRA Trinidad and
Tobago
TTO
Germany DEU United Arab
Emirates
ARE
Guatemala GTM United Kingdom GBR
Guyana GUY United States USA
Haiti HTI Uruguay URY
Honduras HND Venezuela VEN
Hong Kong HKG WHO African
Region
AFR
India IND
223
Table A2: Country Codes
Country Country code Country Country code
Iran, Islamic Rep. IRN
Ireland IRL
Israel ISR
Italy ITA
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Smith-
Spangler
et al.
(2012)
2002–
2003
35 LMIC 121051 General
pop.
Patient RB/M $ 3 at
50th per-
centile to
157 at
95th per-
centile
3.40 at
50th per-
centile to
178 at
95th per-
centile
Boutayeb
et al.
(2014)
NA Various
Arab
countries
NA General
pop.
Healthc.
system
SAM USD UDD
529j
Barceló
et al.
(2003)
2000 ARG 1250300 General
pop.
Societal SAM ARS 16547 1130 15416b 597a 904a 8145a 12330a
Davis
et al.
(2006)
2000–
2051
AUS 1294 General
pop.
Healthc.
system
SDS AUD 1514
(2000),
2282
(2051)
3496a
(2000)
3379a
(2000)
Barceló
et al.
(2003)
2000 BHS 12800 General
pop.
Societal SAM BSD 43 25.2 16 1605 2507 1009 1575
Abdulka-
dri et al.
(2009)
2001 BHS 10435 General
pop.
Societal SDS BSD 233 17 216b 836a 1310a 10789a 16914a
Abdulka-
dri et al.
(2009)
2001 BRB 28438 General
pop.
Societal SDS BBD 75 69.2 5 2455 2433 204 202
Barceló
et al.
(2003)
2000 BRB 23300 General
pop.
Societal SAM BBD 307 26 281b 1099a 1117a 11880a 12076a
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Jönsson
(2002)
1999 BEL 735
patients
General
pop.
Healthc.
system
SAM EUR 1561 3295 4704
Jönsson
(2002)
1999 7000
(overall)
General
pop.
Healthc.
system
SAM EUR 2834 Not pos-
sible be-
cause no
country
specific
estimate
Barceló
et al.
(2003)
2000 BOL 153900 General
pop.
Societal SAM BOB 901 338 563b 3435a 2199a 5717a 3659a
Barceló
et al.
(2003)
2000 BRA 4532600 General
pop.
Societal SAM BRL 54892 9598 45294b 1595a 2118a 1595a 9993a
Lau et al.
(2011)
2008–
2035
CAN 147498
with
diabetes
Four
Alberta
Health
and
Wellness
databases
Healthc.
system
SAM CAD 5934
(2007);
20032
(2035)
4563a 4023a
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Pohar
et al.
(2007b)
1993–
2001
CAN 57774
Saskatchewan
Canadi-
ans
(exclud-
ing
Indians)
Healthc.
system
SAM CAD large
urban:
3563
(1993),
3454
(2001),
small
urban:
3321
(1993),
3427
(2001),
rural:
3368
(1993),
3289
(2001)
large
urban:
2665
(1993),
3591
(2001),
small
urban:
3453
(1993),
3563
(2001),
rural:
3502
(1993),
3420
(2001)
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Pohar
et al.
(2007a)
2001 CAN 5284
(Indians)
+ 41630
(general
pop.)
with
diabetes,
11692
(Indians)
+ 98680
(general
pop.)
without
diabetes
Regis-
tered
Indians
according
to the
Indian
Act
Healthc.
system
RB/M CAD Excess
costs:
Indians
2227,
General
pop.
2378 (to-
tal costs
with di-
abetes:
3622 for
Indians/
3253 in
general
pop.,
controls:
1,395 for
Indians/
875 for
general
pop.)
Excess
costs:
Indians
2316,
General
pop.
2473:
( total
costs
with di-
abetes:
3766 for
Indians /
3382 in
general
pop.,
controls:
1450 for
Indians
/ 910 for
general
pop.)
Barceló
et al.
(2003)
2000 CHL 496500 General
pop.
Societal SAM CLP 5890 719 5171b 320601a 1447a 2307131a 10416a
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Wang
et al.
(2010)
2007 CHN 1478 T2D
patients
in these
Chinese
hospitals
Healthc.
system
Survey RMB 4564
(me-
dian),
7926
(mean)
1246
(me-
dian),
2164
(mean)
Wang
et al.
(2009b)
2007
and 2030
(projec-
tion)
CHN 2040 In-
patients
and out-
patients
with DM
in 20
hospitals
Societal Survey RMB 72916
(2007),
132472
(2030)
67946
(2007),
123187
(2030)
4982
(2007),
9058
(2030)
11555 3401 1586 467
Yang
et al.
(2012)
2009–
2010
CHN 1232 (di-
abetes),
1201 (no
diabetes)
General
pop.
Healthc.
system
RB/M RMB 4135
(3.38
times
greater
than
controls)
1136
(3.38
times
greater
than
controls)
Wang
et al.
(2009a)
2007 CHN 2054 T2D
patients
in these
Chinese
hospitals
Healthc.
system
Survey RMB 4800
(me-
dian),
10164
(mean)
1412
(me-
dian),
2991
(mean)
extcite-
Gonza-
lez2009b
32 years COL NA Average
Columbian
type 2
DM
patient
Societal SAM COP 5.3 1.8 3.5 611750 570 1187000 1106
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Barceló
et al.
(2003)
2000 COL 937700 General
pop.
Societal SAM COP 7737 1241 6496b 923826a 1323a 4836001a 6928a
Barceló
et al.
(2003)
2000 CRI 154900 General
pop.
Societal SAM CRC 1026 210 817b 192194a 1353a 749278a 5274a
Barceló
et al.
(2003)
2000 CUB 592400 General
pop.
Societal SAM CUP 1721 923 798b 1219a 1558a 1054a 1347a
Horak
(2009)
2007 CZE Insured
in health-
care
system
(63.1% of
pop.)
Healthc.
system
SAM CHK 190
Gyld-
mark
et al.
(2001)
1993 DNK 948 General
pop.
Societal WTP DKK 1128
(mean),
300
(median)
191
(mean),
51
(median)
Barceló
et al.
(2003)
2000 DOM 254100 General
pop.
Societal SAM DOP 1410 509 901b 14580a 2003a 25801a 3545a
Barceló
et al.
(2003)
2000 ECU 267300 General
pop.
Societal SAM USD 2830 1104 1727b 873a 4129a 1366a 6460a
Barceló
et al.
(2003)
2000 SLV 219400 General
pop.
Societal SAM SVC 1385 381 1004b 626a 1737a 1650a 4577a
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Honkasalo
et al.
(2014)
2005–
2010
FIN 1890
with
T2D
People
with
T2D in
two cities
in
Finland
Healthc.
system
SDS EUR 1038 1087
Ri-
cordeau
et al.
(2003)
1998,
2000
FRA 704423
(1998),
1145603
(2000)
with
diabetes
Metropoli-
tan
France
Healthc.
system
RB/M EUR 2784
(1998),
3268
(2000)
1529
(1998),
1655
(2000)
2107
(1998),
2241
(2000)
Jönsson
(2002)
1999 FRA 751
patients
General
pop.
Healthc.
system
SAM EUR 5478 3064 4214
Jönsson
(2002)
1999 DEU 809
patients
General
pop.
Healthc.
system
SAM EUR 1653 3576 4752
Köster
et al.
(2006)
2001 DEU 306736
(26971
with
diabetes)
General
pop.
Societal RB/M EUR Excess:
19364
(total:
40650)
Excess
2507
(total
5262)
Excess:
3329
(total:
6987)
Excess
1328
(total:
5019)
Excess:
1763
(total:
6664)
Köster
et al.
(2011)
2000–
2007
DEU 320000
(2000) to
275000
(2007)
AOK
Hessen
Healthc.
system
RB/M EUR 17299
(2000),
25614
(2007)
2400
(2000),
2605
(2007)
3493
(2007),
3218
(2000)
Martin
et al.
(2007)
1995–
2003
DEU 3268 Newly di-
agnosed
T2D
patients
Healthc.
system
SAM EUR 3210 4075
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Köster
et al.
(2012)
2000–
2009
DEU not
given,
only DM
patients
stated
(30472)
AOK
Hessen
Healthc.
system
RB/M EUR 21230
(2000),
26226
(2009)
2779
(2000),
2611
(2009)
3471
(2000),
3261
(2009)
Barceló
et al.
(2003)
2000 GTM 368700 General
pop.
Societal SAM GTQ 2535 878 1657b 6131a 2382a 11572a 4495a
Barceló
et al.
(2003)
2000 GUY 28400 General
pop.
Societal SAM GYD 141 80 62b 131041a 2800a 102135a 2182a
Barceló
et al.
(2003)
2000 HTI 79500 General
pop.
Societal SAM HTG 249 152 97b 12782a 1912a 8175a 1223a
Barceló
et al.
(2003)
2000 HND 193000 General
pop.
Societal SAM HNL 772 366 405b 8750a 1898a 9680a 2100a
Chan
et al.
(2007)
2004 HKG 147 T2D
patients
attending
the DM
outpa-
tient
clinic at
a public
hospital
Societal Survey USD 11638 2288 1817e 357e
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Ra-
machan-
dran
et al.
(2007)
1998,
2005
IND 556 with
T2D
(urban =
309, rural
= 247)
T2D
patients
in India
Patient Survey INR Median
values:
10000
(urban),
6260
(rural)
Median
values:
773 (ur-
ban), 484
(rural)
Tharkar
et al.
(2010)
2009 IND 718 Diabetes
patients
in
Chennai
city
Societal Survey INR 268 25391
(median)
1557
(median)
4970
(median)
305
(median)
Javan-
bakht
et al.
(2011)
2009 IRN 4500 Diabetes
patients
from
Tehran
and Fars
province
Societal Survey IRR 9611h 5187h 4420h 8358592 2142 8578816 2199
Es-
teghamati
et al.
(2009)
2004,
2005
IRN 710
(T2D),
904
(controls)
Pop. in
Teheran
Societal RB/M IRR 401
(Teheran);
2117h
(Iran)
327
(Teheran);
1727h
(Iran)
74
(Teheran),
390h
(Iran)
876622
(Teheran)
443
(Teheran)
200146
(Teheran)
101
(Teheran)
Nolan
et al.
(2006)
1999 IRL 701 T2D
patients
of four
Irish
hospitals
Healthc.
system
SAM EUR 2469 2867
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Chodick
et al.
(2005)
2001 ISR 24632 Insured
patients
in HMO
Healthc.
system
RB/M ILS 433 6002
(2001),
3926
(1999)
1950
(2001),
1275
(1999)
Lucioni
et al.
(2003)
1998 ITA 1263 T2D
patients
from
randomly
drawn
practices
across
Italy
Societal SAM EUR 8289d 7930 359 2991 4588 135ac 208ac
Bruno
et al.
(2012)
2003–
2004
ITA 33792
(dia-
betes)
and
863123
(no
diabetes)
Turin
pop.
Healthc.
system
RB/M EUR 2465
(3361
(dia-
betes),
896 (no
diabetes)
3328
(4537
(dia-
betes),
1210 (no
diabetes)
Mor-
sanutto
et al.
(2006)
2001–
2002
ITA 299 T2D
patients
who
visited a
diabeto-
logic
center in
Italy
(DC)
Healthc.
system
SAM EUR 1910 2823
234
Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
March-
esini
et al.
(2011)
2006 ITA 311979 People
with DM
at 22
local
health
districts
Healthc.
system
RB/M EUR 2589 3296
Abdulka-
dri et al.
(2009)
2001 JAM 186036 General
pop.
Societal SDS JMD 556 454 102 44647 2439 10046 549
Barceló
et al.
(2003)
2000 JAM 181400 General
pop.
Societal SAM JMD 1037 345 693a 32251a 1901a 64787a 3818a
Naka-
mura
et al.
(2008)
1990–
2001
JPN 4535
Community-
dwelling
in Shiga
Healthc.
system
SAM JPY 189060
(dia-
betes),
99900
(non-
diabetes)
1674 (di-
abetes),
884 for
(non-
diabetes)
Barceló
et al.
(2003)
2000 LAC Diabetes
preva-
lence of
15.2
million
Pop.
from all
countries
in Latin
America
and
Caribbean
Societal SAM USD 82304 13529 68774b 703a 887a 3576a 4512a
Barceló
et al.
(2003)
2000 MEX 3738000 General
pop.
Societal SAM MXN 30677 4006 26671b 4994a 1072a 33249a 7135a
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Arredondo
et al.
(2005)
2004,
2006
MEX 951417
esti-
mated
cases
All users
of health-
care in
public in-
stitutions
Societal SAM MXN 290d 229 61k 1472a 242a 386a 64a
Arredondo
et al.
(2011b)
2010 MEX Whole
pop.
Popula-
tion
demand-
ing
services
at
Mexican
health-
care
institu-
tions for
T2D
Societal SAM MXN 1066 470 596 4016a 485a 5090a 610a
Arredondo
et al.
(2007)
2005 MEX Whole
pop.
General
pop.
Patient SAM MXN 284 OOP
expen-
ditures
(52% of
overall
expendi-
tures)
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Arredondo
et al.
(2004)
2003,
2005
MEX Whole
pop.
General
pop.
using
public
health-
care
institu-
tions
Societal SAM MXN 532
(2005)
235
(2005)
297
(2005)
1467a
(2005)
263a
(2005)
1852a
(2005)
331a
(2005)
Ro-
dríguez
Bolaños
et al.
(2010)
2002,
2004
MEX 497 IMSS
insured
Healthc.
system
SDS MXN 661
(2004)
35622a
(2004)
4672a
(2004)
Redekop
et al.
(2002)
1998 NLD 1371
with
T2D
T2D
patients
in the
Nether-
lands
Societal SAM NLG 1014d 953 61 4023 2780 282a 195a
Linden
et al.
(2009)
2000–
2004
NLD 2.5
million
(641200
with
diabetes)
Dutch
people
with
diabetes
Healthc.
system
SDS EUR 571
(2000),
1063
(2004)
974
(2000),
1283
(2004)
1259
(2000),
1658
(2004)
Jönsson
(2002)
1999 NLD 909
patients
General
pop.
Healthc.
system
SAM EUR 671 1827 2761
Barceló
et al.
(2003)
2000 NIC 136100 General
pop.
Societal SAM NIO 442 292 150b 7922a 2145a 4082a 1105a
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Suleiman
et al.
(2006)
July
2003–
June
2004
NGA 35 Diabetes
patients
in out-
patient
clinic in
Nigeria
Patient SDS NGN 29366 662
Solli
et al.
(2010)
2005 NOR 4.6
million
from
register
data of
entire
pop.
General
pop.
Societal SDS NRK 319 242 76 20492a 2061a 5067a 650a
Khowaja
et al.
(2007)
2006 PAK 345 Diabetes
patients
in
Karachi
Societal Survey PKR 11580f 620f 840e 45e
Barceló
et al.
(2003)
2000 PAN 120500 General
pop.
Societal SAM PAB 926 222 704b 866a 1846a 2741a 5840a
Barceló
et al.
(2003)
2000 PRY 94300 General
pop.
Societal SAM PYG 738 244 495b 2661903a 2587a 5397747a 5245a
Barceló
et al.
(2003)
2000 PER 606800 General
pop.
Societal SAM PEN 5627 1533 4094b 2890a 2526a 7717a 6746a
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Leśniowska
et al.
(2014)
2009 POL Whole
pop.
All
Polish
diabetes
patients
Healthc.
system
SAM RSD 3396 1910 1486
Biorac
et al.
(2009)
2007 SRB 99 T2D
patients
in health
centre in
Svilajnac
Societal Survey RSD 7579h 47865 1610 5548 187
Bjegovic
et al.
(2007)
2002 SRB 360433
people
with
T2D in
Serbia
Serbian
T2D
patients
Healthc.
system
SAM RSD 280 12457a 761a
Mata
et al.
(2002)
1998 ESP 1004 Diabetes
patients
from 29
primary
health-
care
centres
Healthc.
system
SDS EUR 771 1488
Ballesta
et al.
(2006)
1999 ESP 517 People
with DM
in region
of Cadiz
Societal SDS EUR 2560 4690 1844 3379
239
Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Oliva
et al.
(2004)
2002 ESP 1675304
to
2010365
depend-
ing on
assumed
preva-
lence
Diabetes
patients
in
National
Health
System
Healthc.
system
SAM EUR 4010 (6%
prev.)–
4461 (5%
prev.)
1290 (6%
prev.)–
1476 (5%
prev.)
2155 (6%
prev.)–
2466 (5%
prev.)
Jönsson
(2002)
1999 ESP 1004
patients
General
pop.
Healthc.
system
SAM EUR 3679 1305 2453
Bastida
et al.
(2002b)
1998 ESP Whole
pop.
(exact
number
not
given)
Canary
Island
pop.
with
diabetes
Societal SDS Pts (pre
Euro)
75 47 28 78240 907 47928b 556b
Elrayah-
Eliadarous
et al.
(2010)
2005 SDN 822 Patients
with
T2D in
Khar-
toum
state in
Sudan
Patient Survey USD 438 456
Bolin
et al.
(2009)
1987 and
2005
SWE Whole
pop.
General
pop.
Societal SDS SEK 499
(1987),
1045
(2005)
223
(1987),
383
(2005)
276
(1987),
662
(2005)
12102
(1987),
12287
(2005)
1484
(1987),
1507
(2005)
15000a
(1987),
21253a
(2005)
1840a
(1987),
2606a
(2005)
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Norlund
et al.
(2001)
1993 SWE 70786
(1677
with
diabetes)
Southern
Sweden
Societal RB/M SEK 19411 2855 14777 2174
Wirhn
et al.
(2008)
2005 SWE 415990
(19226
with
diabetes)
Whole
Östergöt-
land
popula-
tion
Healthc.
system
RB/M EUR 18293 2243
Jönsson
(2002)
1999 SWE 773
patients
General
pop.
Healthc.
system
SAM SEK 929 24927 3319
Ringborg
et al.
(2008)
2004 SWE 8230 Diabetes
patients
in
Uppsala
county
Healthc.
system
SAM SEK 33210 3888
Schmitt-
Koopmann
et al.
(2004)
1998 CHE 1479 T2D
patients
from
randomly
drawn
practices
across
Switzer-
land
Healthc.
system
SDS CHF 561 3004 2030
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Lin et al.
(2004)
1998–
1999
TWN 20757185
(in 1998),
21089859
(in 1999)
People
with DM
in
National
Health
Insurance
Healthc.
system
SDS TWD 62617
(1998),
60775
(1999)
3499
(1998),
3396
(1999)
Chang
(2010)
2006–
2007
TWN 498 Diabetes
patients
in out-
patient
clinics in
northern
Taiwan
Societal WTP TWD 4003 68118 4004
Chi et al.
(2011)
TWN 16094 Elderly
with DM
in
Taiwan
Healthc.
system
SAM 51 111982 6338
Chatter-
jee et al.
(2011)
2008 THA 475 Diabetes
patients
treated
in
district
hospital
Societal Survey TWD 17638 1082 10569 649
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Barceló
et al.
(2003)
2000 TTO 71300 Pop.
from all
countries
in Latin
America
and
Caribbean
Societal SAM TTD 540 72 468b 3358a 1011a 21780a 6560a
Abdulka-
dri et al.
(2009)
2001 TTO 135093 General
pop.
Societal SDS TTD 852 227 625 5722 1677 15797 4628
Al-
Maskari
et al.
(2010)
2004 ARE 150 Diabetes
patients
in Al-Ain
District
Healthc.
system
Survey AED no com-
plication:
5906,
with
compli-
cations:
20774,
overall:
16115
no com-
plica-
tions:
2047,
with
compli-
cations:
7199,
overall:
5585
Jönsson
(2002)
1999 GBR 756
patients
General
pop.
Healthc.
system
SAM GBP 244 1558 3065
Dall
et al.
(2010)
2007 USA Diabetes
preva-
lence of
16.5
million
General
pop.
Societal SDS USD 167862 111257 56604 6414 6751 3263 3434
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Buescher
et al.
(2010)
1998 USA 127991 Medicaid
pop.
Healthc.
system
SDS USD 540 4098 4221
Dall
et al.
(2003)
2002 USA Diag-
nosed
DM
preva-
lence of
12.1
million
General
pop.
Societal SDS USD 161896 112947 48948 7601a 9346a 3294a 4050a
Druss
et al.
(2001)
1996 USA 23200 General
pop.
Societal Survey USD 78518 13768 4771 1097 1495 380ac 518ac
Durden
et al.
(2009)
2000,
2005
USA 21592
(2000),
127254
(2005)
Employ-
ees of
large,
privately-
insured
compa-
nies
Healthc.
system
RB/M USD 7365
(2000),
7327
(2005)
8349
(2000),
8306
(2005)
Trogdon
et al.
(2008)
2000–
2004
USA 3790 (di-
abetes),
42413
(no
diabetes)
General
pop.
Healthc.
system
RB/M USD 5035i 5708i
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Brandle
et al.
(2003)
2000 USA 1364 People
with
T2D
enrolled
in
managed
care
programs
Healthc.
system
SAM USD 3715
(median)
4747
(median)
O’Connell
et al.
(2012)
2005 USA 32052 American
Indians
in and
around
Phoenix,
Arizona
Healthc.
system
RB/M USD 5542 6282
Peele
et al.
(2002)
1996 USA 20937
with
diabetes
Em-
ployed
DM
patients
Healthc.
system
SAM USD 126 4430
(17.9%
OOP)
6039
(17.9%
OOP)
Rodbard
et al.
(2010)
2006 USA 3551 (di-
abetes),
8686 (no
diabetes)
General
pop.
Patient RB/M USD 233 264
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Honey-
cutt
et al.
(2009)
1998–
2003
USA 96873
(5289
had
diabetes)
General
pop.
Healthc.
system
SDS and
RB/M
USD 61958
(regres-
sion),
43452
(at-
tributable
fraction)
4240 (re-
gression),
2980 (at-
tributable
fraction)
4966(regression),
3490 (at-
tributable
fraction)
Ma-
ciejewski
et al.
(2004)
1998 USA 429918 USA
veterans
Healthc.
system
SAM USD 2214 3888a 5150a
Birn-
baum
et al.
(2003)
1997–
1998
USA 3759 (di-
abetes),
3759
(without
diabetes)
Em-
ployed
and
retired
women
Healthc.
system
RB/M USD 5.500 for
women
<age 65
per year,
25000 for
women
>= age
65 per
year,
233000
lifetime
costs
6680for
women
<age 65
per year,
30362 for
women
>= age
65 per
year,
282973
lifetime
costs
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Zhou
et al.
(2005)
10 year
follow up
USA 1223
with
T2D
People
with DM
in
Michigan
Healthc.
system
SAM USD 7100
(undis-
counted
per year
over 10
year
period)
9072
(undis-
counted
per year
over 10
year
period)
Dall
et al.
(2008)
2007 USA Diag-
nosed
DM
preva-
lence of
17.5
million
General
pop.
Societal SDS USD 185682 123788 62108 6649 7095 3328 3552
Tunceli
et al.
(2010)
2007 USA 256245
(T2D),
256223
(controls)
Non-
institutionalized
adults
Healthc.
system
SDS and
RB/M
USD Matching:
4217,
Dis-
ease at-
tributable:
3002
Matching:
4500,
Dis-
ease at-
tributable:
3204
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Condliffe
et al.
(2014)
2007 USA 7514
with
diabetes
USA
pop.
with
positive
health-
care
expendi-
tures in
survey
Healthc.
system
SAM USD 11167g 11917g
Ramsey
et al.
(2002)
1998 USA 8748
diabetes
patients,
8748
matched
controls
Employ-
ees of
large,
privately-
insured
compa-
nies
Employer RB/M USD 3842 5021 568 743
Lee et al.
(2006)
2000 USA 984 with
DM (540
white,
210
African
Ameri-
can, 234
Hispanic)
White,
African
Ameri-
cans and
Hispanics
in the
USA
Healthc.
system
SAM USD 6616
(6887 if
white,
6162 if
African
Amer-
ican,
5647 if
Hispanic)
8453
(8799 if
white,
7873 if
African
Amer-
ican,
7215 if
Hispanic)
Barceló
et al.
(2003)
2000 URY 119000 General
pop.
Societal SAM UYU 1202 147 1055b 9619a 1233a 69171a 8867a
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Table A3: COI study characteristics and cost estimates
Ref. Horizon Country Sample
size
Popula-
tion
Perspective Approach LCU Aggregate costs (mill. $) Per capita costs
Total Direct Indirect Direct
(LCU)
Direct ($) Indirect
(LCU)
Indirect
($)
Barceló
et al.
(2003)
2000 VEN 610800 General
pop.
Societal SAM VEF 4820 317 4503b 342a 518a 2100a 7373a
Kirigia
et al.
(2009)
2005 WHO
African
region
7020000 General
pop.
societal SAM USD 28610 9090 19520 876 983 10556 11845
T2D type 2 diabetes DM Diabetes Mellitus Healthc. System Healthcare system LCU Local currency unit Pop. Population Prev. Prevalence Ref. Reference RB/M regression based/matching SAM Sum-all medical
SDS Sum-diagnosis specific.
a Own calculation dividing presented aggregate cost estimate by number of people with diabetes in study.
b Total and direct cost estimates were presented in paper and indirect costs calculated, but not explicitly stated. We calculated indirect costs by deducting the presented direct costs estimate from the presented total
costs estimate to arrive at an indirect costs estimate.
c Calculated the number of people with diabetes by dividing the aggregated direct costs and the per capita direct costs estimate as presented in the study.
d Calculated total costs of diabetes for papers summing up direct and indirect costs.
e Calculated per capita indirect costs deducting direct from total cost estimate presented in study.
f Costs originally presented per visit, to arrive at yearly costs had to multiply costs per visit by number of visits per year.
g Per capita direct costs were presented for different groups of diabetics, calculated average costs for person with diabetes by summing up and weighting costs people with diabetes + hypertension, people with diabetes +
obesity, people with diabetes + obesity + hypertension.
h The study assumes sample would be nationally representative.
i Study only reported the adjusted incremental cost ratio of 2.39 compared to the average healthcare expenditures of people without diabetes of USA$3630. To calculate the incremental costs of a person with diabetes
we multiplied the average healthcare expenditures of people without diabetes by the given cost ratio .
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Table A4: COI study costing components
Ref. Country
(year of
cost data)
Hospital
Visits
Outpatient
Visits
Physician
Visits
Drugs laboratory Equipment Non-
medical
Other Costs Two main cost
contributors
Smith-Spangler et al.
(2012)
LMIC
(2002-2003)
No breakdown of costs provided
Kirigia et al. (2009) AFR (2000-
2005)
x x x x x x x x No exact information on
share in expenditures is
available
Davis et al. (2006) AUS (1993-
1996)
x x x x x x No exact information on
share in expenditures is
available
Lau et al. (2011) CAN (1995-
2007)
x x x Hospital, physician
Pohar et al. (2007b) CAN (1993-
2001)
x x x x x x Hospital, medication
Ohinmaa et al. (2004) CAN (1996) x x x x x x Hospital, medication
Dawson et al. (2002) CAN (1998) x x x x x No exact information on
share in expenditures is
available
Johnson et al. (2006) CAN (1992-
2001)
x x x x Hospital
Simpson et al. (2003) CAN (1991-
1996)
x x x x Hospital, prescription
drugs
Pohar et al. (2007a) CAN (1991-
2001)
x x x Hospital
Wang et al. (2010) CHN (2007) x x x x Complications, insulin
therapy
Wang et al. (2009b) CHN (2007) x x x Hospital, outpatient
visits
Yang et al. (2012) CHN (2009-
2010)
x x x x x x Hospital, medication
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Table A4: COI study costing components
Ref. Country
(year of
cost data)
Hospital
Visits
Outpatient
Visits
Physician
Visits
Drugs laboratory Equipment Non-
medical
Other Costs Two main cost
contributors
Wang et al. (2009a) CHN (2007) x x x x x x x No exact information
on share in
expenditures available
Camilo González et al.
(2009)
COL (2007) No breakdown of costs provided
Horak (2009) CZE (2007) x x x x x x Hospital, medication
Honkasalo et al. (2014) FIN (2005-
2010)
x x x x x x
Ricordeau et al. (2003) FRA
(1998,2000)
x x x x Hospital, medication
Köster et al. (2006) DEU (2001) x x x x x x x Hospital, medication
Köster et al. (2011) DEU (2000-
2007)
x x x x x x x x Hospital, other services
(medical devices,
remedies, professional
home nursing,
transportation)
Martin et al. (2007) DEU (1995-
2003)
x x x x x x No exact information
on share in
expenditures available
Köster et al. (2012) DEU (2000-
2009)
x x x x x x x x Hospital, medication
Jönsson (2002) EUR (1999) x x x x x x x Hospital, medication
Chan et al. (2007) HKG (2004) x x x x x x x x Hospital, outpatient
clinic visits
Ramachandran et al.
(2007)
IND (2005) x x x x x x Hospital/surgery,
medication
Tharkar et al. (2010) IND (2009) x x x x Hospital, medication
Javanbakht et al. (2011) IRN (2009) x x x x x x x x Complications,
medication
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Table A4: COI study costing components
Ref. Country
(year of
cost data)
Hospital
Visits
Outpatient
Visits
Physician
Visits
Drugs laboratory Equipment Non-
medical
Other Costs Two main cost
contributors
Esteghamati et al.
(2009)
IRN
(2004;2005)
x x x x x x x Hospital, medication
and devices
Nolan et al. (2006) IRL (1999-
2000)
x x x x x Hospital,
ambulatory/drug costs
Chodick et al. (2005) ISR (1999-
2001)
x x x x Medication and
lab/diagnostics
Lucioni et al. (2003) ITA (1999) x x x x x Hospital, drugs
Bruno et al. (2012) ITA (Au-
gust 2003-
July 2004)
x x x x Hospital, drugs
Morsanutto et al.
(2006)
ITA (Jan
2001-Aug
2002)
x x x x Hospital, drugs
Marchesini et al. (2011) ITA (1997-
2006)
x x x x x Hospital, drugs
Nakamura et al. (2008) JPN (1990-
2001)
No breakdown of costs provided
Barceló et al. (2003) LAC (2000) x x x x Medication,
complications
Arredondo et al. (2005) MEX (1989-
2003)
x x x x x No exact information
on share in
expenditures available
Arredondo et al.
(2011b)
MEX (1990-
2008)
x x x x x Medication,
complications
Arredondo et al. (2004) MEX (1989-
2002)
x x x x x Drugs, complications
Arredondo et al. (2007) MEX (2002-
2004)
x x x x x Drugs, complications
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Table A4: COI study costing components
Ref. Country
(year of
cost data)
Hospital
Visits
Outpatient
Visits
Physician
Visits
Drugs laboratory Equipment Non-
medical
Other Costs Two main cost
contributors
Rodríguez Bolaños
et al. (2010)
MEX (2002-
2004)
x x x x x x x Hospital, administrative
costs
Redekop et al. (2002) NLD (1998) x x x x x x x Hospital, medication
Linden et al. (2009) NLD (2000-
2004)
x x Hospital, medication
Suleiman et al. (2006) NGA (2003-
2004)
x x x x x x Drugs, diagnostic tests
Solli et al. (2010) NOR (2005) x x x x x x Drugs, medical devices
Khowaja et al. (2007) PAK (2006) x x x x Medicine cost,
laboratory costs
Leśniowska et al. (2014) POL (2005-
2009)
x x x x x x Medication, primary
care
Biorac et al. (2009) SRB (2007) x x x x x x Medication, medical
services (incl.
ambulatory and
hospital costs)
Bjegovic et al. (2007) SRB (2002) x x x x x No exact information
on share in
expenditures available
Mata et al. (2002) ESP (1998-
1999)
x x x x x x Drugs, hospital
Ballesta et al. (2006) ESP (1999) x x x x x x Medication, hospital
Oliva et al. (2004) ESP (2002) x x x Hospital, medication
Bastida et al. (2002b) ESP (1998) x x x x x Hospital, medication
Elrayah-Eliadarous
et al. (2010)
SDN (2005) x x x Outpatient clinic, drugs
Bolin et al. (2009) SWE (1987
and 2005)
x x x Hospital, drugs
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Table A4: COI study costing components
Ref. Country
(year of
cost data)
Hospital
Visits
Outpatient
Visits
Physician
Visits
Drugs laboratory Equipment Non-
medical
Other Costs Two main cost
contributors
Norlund et al. (2001) SWE (1992-
1993)
x x x x Hospital, home help
hours
Wirhn et al. (2008) SWE (2005) x x x Hospital, medication
Ringborg et al. (2008) SWE (2000-
2004)
x x x x x Hospital, outpatient
visits
Schmitt-Koopmann
et al. (2004)
CHE (1998-
1999)
x x x Hospital, medication
Lin et al. (2004) TWN
(1998-1999)
x x x x x No exact information
on share in
expenditures available
Chi et al. (2011) TWN
(2000)
x x Outpatient visits
Chatterjee et al. (2011) THA (2007-
2008)
x x x x x x Informal care,
hospitalizations
Abdulkadri et al. (2009) CARICOM
(2001)
x x x x x Medication and
lab/diagnostics
Al-Maskari et al. (2010) ARE (2004-
2005)
x x x x x Hospital (information
on other cost
components not
presented)
Dall et al. (2010) USA (2007) x x x x x x x x No exact information
on share in
expenditures available
Ramsey et al. (2002) USA (1998) x x x x x x x Inpatient, outpatient
Buescher et al. (2010) USA (1998) x x x x x x x x Physician visits,
hospital
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Table A4: COI study costing components
Ref. Country
(year of
cost data)
Hospital
Visits
Outpatient
Visits
Physician
Visits
Drugs laboratory Equipment Non-
medical
Other Costs Two main cost
contributors
Dall et al. (2003) USA (1998-
2000)
x x x x x x Institutional care
(nursing home stays,
hospital), outpatient
care
Druss et al. (2001) USA (1996) No breakdown of costs provided. Only self-reported healthcare cost estimate.
Durden et al. (2009) USA (2000,
2005)
x x x x x x Hospital, outpatient
services
Trogdon et al. (2008) USA (2000-
2004)
No breakdown of costs provided. Only self-reported healthcare cost estimate.
Brandle et al. (2003) USA (2000-
2001)
x x x x No exact information on
share in expenditures is
available
O’Connell et al. (2012) USA (2004-
2005)
x x x Hospital, medication
Peele et al. (2002) USA (1996) x x x x No exact information
on share in
expenditures available
Rodbard et al. (2010) USA (2006) No breakdown of costs provided.
Honeycutt et al. (2009) USA (1998-
2003)
x x x x x x No exact information
on share in
expenditures available
Maciejewski et al.
(2004)
USA (1998) x x Hospital
Birnbaum et al. (2003) USA (1997-
1998)
No breakdown of costs provided. Only self-reported healthcare cost estimate.
Zhou et al. (2005) USA (2000) x x x x x x No exact information
on share in
expenditures available
Dall et al. (2008) USA (2006) x x x Hospital, medication
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Table A4: COI study costing components
Ref. Country
(year of
cost data)
Hospital
Visits
Outpatient
Visits
Physician
Visits
Drugs laboratory Equipment Non-
medical
Other Costs Two main cost
contributors
Tunceli et al. (2010) USA (2006-
2007)
x x x Hospital, medication
Condliffe et al. (2014) USA (2004-
2007)
No breakdown of costs provided.
Lee et al. (2006) USA (2000) x x x x Medication, ambulatory
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III Appendix to Chapter 3
Linear IV estimates (1st and 2nd stage)
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Table A5: Impact of diabetes on employment probabilities (linear IV, 1st and 2nd stage)
linear IV male linear IV female
(1) (2) (3) (4)
Diabetes Employed Diabetes Employed
Age 25–34 −.001 (.005) 0.151∗∗∗ (.015) 0.003 (.005) 0.111∗∗∗ (.015)
Age 35–44 0.016∗ (.009) 0.154∗∗∗ (.019) 0.032∗∗∗ (.008) 0.198∗∗∗ (.017)
Age 45–54 0.081∗∗∗ (.014) 0.098∗∗∗ (.028) 0.108∗∗∗ (.014) 0.122∗∗∗ (.028)
Age 55–64 0.101∗∗∗ (.016) −.052 (.039) 0.198∗∗∗ (.021) 0.001 (.040)
Small city 0.001 (.010) −.010 (.019) −.005 (.011) 0.034∗∗ (.017)
City 0.014 (.014) −.041∗∗ (.020) −.009 (.013) 0.032∗ (.019)
Big city 0.008 (.008) 0.027∗ (.014) −.004 (.009) 0.093∗∗∗ (.013)
Central 0.011 (.011) 0.024 (.017) 0.015 (.011) −.035∗∗ (.017)
Westcentral −.002 (.010) 0.021 (.017) −.002 (.010) −.006 (.018)
Northeastcentral 0.007 (.012) 0.005 (.017) 0.009 (.012) −.051∗∗∗ (.017)
Northwestcentral −.006 (.009) −.033∗∗ (.017) 0.007 (.011) −.095∗∗∗ (.017)
Primary −.009 (.020) 0.060∗∗ (.027) 0.017 (.018) −.011 (.019)
Secondary −.003 (.020) 0.056∗ (.030) −.005 (.018) 0.052∗∗ (.021)
Highschool −.027 (.020) 0.045 (.031) −.008 (.020) 0.117∗∗∗ (.026)
College or university −.018 (.023) 0.057∗ (.032) −.028 (.020) 0.291∗∗∗ (.025)
Indigenous 0.009 (.010) 0.005 (.017) 0.012 (.013) −.006 (.018)
Married 0.015∗∗ (.007) 0.086∗∗∗ (.012) −.002 (.007) −.216∗∗∗ (.011)
Children (under 15) −.005∗∗ (.002) 0.010∗∗ (.004) 0.003 (.002) −.016∗∗∗ (.004)
Wealth 0.003 (.004) −.001 (.007) 0.003 (.004) 0.030∗∗∗ (.006)
Parental education 0.019∗∗ (.009) −.010 (.013) 0.014 (.009) −.001 (.011)
Diabetes father 0.068∗∗∗ (.020) 0.035∗∗ (.014)
Diabetes mother 0.043∗∗∗ (.016) 0.055∗∗∗ (.013)
Diabetes 0.098 (.215) 0.239 (.214)
Constant −.015 (.022) 0.607∗∗∗ (.036) −.020 (.021) 0.289∗∗∗ (.027)
R2 0.075 0.067 0.090 0.120
F stat (H0: weak instruements) 20.483 27.706
Sargan test (H0: valid instruments) 0.862 0.295
p value 0.353 0.587
Endogeneity (H0: Diabetes exogenous) 0.864 1.796
p value 0.353 0.180
N 6228 6286 8186 8243
Notes Robust standard errors in parentheses. Instruments: diabetes of mother, diabetes of father. Other control variables: age, region, urban, education, indigenous marital
status, children, wealth, parental education. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Results for older age groups
Table A6: Impact of diabetes on employment probabilities by age groups older
than 44 (probit)
45-54 55-64
(1) (2) (3) (4)
Males Females Males Females
Diabetes −.083∗ −.076∗∗ −.128∗∗ −.033
(.048) (.034) (.056) (.039)
Log likelihood −451.544 −764.722 −458.632 −392.174
N 1101 1399 770 847
Notes Average marginal effects; robust standard errors in parentheses. Other con-
trol variables: region, urban, education, indigenous, marital status, children, wealth,
parental education. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Instrumental variable analysis for age groups
The results of the bivariate probit models do not indicate endogeneity for the
older age group and for males in the younger age group (see Tables A7 and
A8), suggesting that particularly for males the results of the more efficient pro-
bit model (Table 11) show the true effect of diabetes on employment probabili-
ties. Only for females in the younger age group the test for endogeneity rejects
the assumption of exogeneity and the diabetes coefficient—surprisingly—shows
a strong positive effect of diabetes on female employment probabilities. Instru-
ment strength, however, is reduced significantly, which together with the very low
treatment probabilities questions the validity of the IV results for the sample of
the younger age group, as weak instruments possibly introduce a bias similar to
or stronger than the potential bias in the probit estimates (Staiger et al., 1997).
We therefore additionally apply a method proposed by Lewbel (2012), which uses
heteroscedasticity in the estimated models to construct additional instruments.
Instruments are generated by multiplying the heteroscedastic residuals from the
first-stage regressions with a subset of the included exogenous variables. Lew-
bel (2012) recommends the use of this method when traditional instruments are
not available or if it is suspected that the traditional instrument is too weak for
identification, which is the issue at hand. The approach has been widely used
over the last years both in health economics (Brown, 2014; Drichoutis et al.,
2011; Kelly et al., 2014; Schroeter et al., 2012) and in other economic disciplines
(Denny et al., 2013; Emran et al., 2012; Huang et al., 2009). Using this method
to construct additional instruments by using our age group dummies, we are able
to increase instrument strength significantly in the younger age group and the
overidentification test indicates validity of the instruments. The results of the
linear IV model with the additional instruments show exogeneity of diabetes for
males and females and do not indicate a significant positive effect of diabetes on
employment probabilities.
Apart from the results of the Lewbel approach, we also think that there are
theoretical reasons why diabetes is likely exogenous in the younger age group.
While we cannot distinguish between the types of diabetes with the data at hand,
it is likely that a relatively large proportion of the people reporting diabetes in
this age group have type 1 diabetes, which people tend to get at a younger age
(Maahs et al., 2010). The disease has a strong genetic component and it is very
unlikely that there are unobserved factors that affect the chances to develop type
1 diabetes and being employed at the same time, nor that employment status
would affect the development of type 1 diabetes. Therefore, for a large part of
the people reporting diabetes in the younger age group, endogeneity should not
present a problem because they have type 1 diabetes. Furthermore, it is also less
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likely that reverse causality is a problem for those having type 2 diabetes in this
age group, because any effects of being employed on developing type 2 diabetes
take time to develop. It would be reasonable to expect that if being employed
affected a person’s weight or any other diabetes risk factor, this would happen by
changing the person’s lifestyle due to changes in income or available leisure time,
or by reducing or increasing a person’s activity levels at work. Until these changes
are expressed in changes in weight or any other risk factor for diabetes and finally
cause a development of type 2 diabetes, a considerable time period of various
years has likely passed and people have reached an advanced age. We therefore
believe, that the risk of diabetes being affected by employment is much lower in
the younger age group based on the nature of the disease, compared to the older
age group. Hence we think that the assumption of exogeneity of diabetes in the
younger age group is valid—which is also supported by the Lewbel estimates—and
that the endogeneity indicated for younger females in the bivariate probit model
is likely the result of the low prevalence rates, and consequently the very low
treatment probabilities, together with weak instruments, making a meaningful
IV analysis difficult (Chiburis et al., 2012). We are therefore confident that we
can rely on our probit estimates for inference.
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Table A7: IV estimates for the age group 15–44
BP Lewbel IV
(1) (2) (3) (4)
Males Females Males Females
Diabetes 0.171∗∗∗ 0.496∗∗∗ 0.007 0.051
(.046) (.080) (.053) (.071)
R2 0.093 0.143
Score goodness-of-fit (H0=normality of errors) 9.56 14.25
p value 0.387 0.114
F stat (H0: weak instruments) 4.288a 10.835a 366.480 65.872
Sargan test (H0: valid instruments) 0.008a 0.044a 1.817 3.487
p value 0.930a 0.834a 0.611 0.322
Endogeneity (H0: Diabetes exogenous) 1.422 12.948 1.065 1.429
p value 0.233 0.000 0.302 0.232
N 4415 5997 4415 5997
Notes Average marginal effects for bivariate probit (BP); robust standard errors in parentheses. Instruments: diabetes
of mother, diabetes of father; for Lewbel additionally created age groups instruments. The models contain the age
categories 25–34 and 35–44 with 15–24 as the reference category. Other control variables: region, urban, education,
indigenous, marital status, children, wealth, parental education. a The test statistics are taken from the linear IV model
not presented here. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A8: IV estimates for the age group 45–64
BP Lewbel IV
(1) (2) (3) (4)
Males Females Males Females
Diabetes −.022 −.112 −.178 −.042
(.138) (.111) (.160) (.104)
R2 0.058 0.118
Score goodness-of-fit (H0=normality of errors) 7.00 11.10
p value 0.637 0.269
F stat. (H0: weak instruments) 15.408a 18.305a 12.534 18.897
Sargan test (H0: valid instruments) 2.717a 0.482a 4.397 1.688
p value 0.067a 0.487a 0.111 0.430
Endogeneity (H0: Diabetes exogenous) 0.688 0.574 0.082 0.024
p value 0.407 0.449 0.774 0.876
N 1871 2246 1871 2246
Notes Average marginal effects for bivariate probit (BP); robust standard errors in parentheses. Instruments:
diabetes of mother, diabetes of father; for Lewbel additionally created age groups instruments. The models
contain the age categories 55–64 with 45–54 as the reference category. Other control variables: region, urban,
education, indigenous, marital status, children, wealth, parental education. a The test statistics are taken from
the linear IV model not presented here. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Results for wealth quartiles
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Table A9: Impact of diabetes on employment probabilities by wealth quartile (probit)
1st 2nd 3rd 4th
(1) (2) (3) (4) (5) (6) (7) (8)
Males Females Males Females Males Females Males Females
Diabetes −.142∗ −.101∗∗∗ −.144∗∗ 0.028 −.082 −.026 −.040 −.053
(.077) (.029) (.060) (.048) (.053) (.044) (.046) (.048)
Log likelihood −776.619 −937.144 −672.633 −1092.280 −689.910 −1266.304 −703.495 −1144.588
N 1577 2039 1563 2052 1516 2143 1590 1974
Notes Average marginal effects; robust standard errors in parentheses. Other control variables: region, urban, education, indigenous, marital status, children,
wealth, parental education. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Instrumental variable analysis for wealth groups
To consider the possible endogeneity of diabetes in the upper and lower wealth
half, we again present the results of the bivariate probit and the Lewbel model.
The stratification into wealth groups significantly reduces instrument power as
well as sample size. For none of the wealth groups the bivariate probit model
indicates endogeneity (see Table A10 and Table A11 in the appendix). This
does not change even when using the Lewbel approach to increase instrument
strength. Accordingly, we do not find any indication of endogeneity of diabetes
in the wealth groups and rely on our probit estimates for inference.
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Table A10: IV results for lower wealth half
BP Lewbel IV
(1) (2) (3) (4)
Males Females Males Females
Diabetes −.354 −.064 −.142∗∗∗ −.054∗
(.241) (.139) (.050) (.032)
R2 0.071 0.099
Score goodness-of-fit (H0=normality of errors) NAa 7.41
p value NAa 0.594
F stat (H0: weak instruments) 6.322b 15.420b 2589.091 1311.647
Sargan test (H0: valid instruments) 0.342b 1.106b 4.169 2.804
p value 0.558b 0.293b 0.525 0.730
Endogeneity (H0: Diabetes exogenous) 1.190 0.016 0.005 0.156
p value 0.275 0.901 0.941 0.693
N 3169 4111 3169 4111
Notes Average marginal effects for bivariate probit (BP); robust standard errors in parentheses. Instruments: diabetes
of mother, diabetes of father; for Lewbel additionally created age groups instruments. Other control variables: region,
urban, education, indigenous, marital status, children, wealth, parental education. a The test statistics are taken
from the linear IV model not presented here. The command SCOREGOF failed to produce the test statistic for this
subsample. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A11: IV results for upper wealth half
BP Lewbel IV
(1) (2) (3) (4)
Males Females Males Females
Diabetes −.142 0.103 −.057 −.000
(.199) (.203) (.037) (.039)
R2 0.089 0.142
Score goodness-of-fit (H0=normality of errors) 11.40 12.92
p value 0.249 0.166
F stat (H0: weak instruments) 14.003a 13.215a 28673.088 1225.456
Sargan test (H0: valid instruments) 0.848a 0.019a 10.180 5.787
p value 0.357a 0.889a 0.070 0.327
Endogeneity (H0: Diabetes exogenous) 0.238 0.730 0.955 1.807
p value 0.626 0.393 0.329 0.179
N 3117 4132 3117 4132
Notes Average marginal effects for bivariate probit (BP); robust standard errors in parentheses. Instruments: diabetes
of mother, diabetes of father; for Lewbel additionally created age groups instruments. Other control variables: region,
urban, education, indigenous, marital status, children, wealth, parental education. a The test statistics are taken
from the linear IV model not presented here. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Multinomial logit and IV results for formal and informal
employment
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Table A12: Impact of diabetes on employment probabilities by employment status
(multinomial logit)
Males Females
(1) (2) (3) (4)
Informal Formal Informal Formal
Diabetes −.073∗∗ 0.031 −.044∗∗ 0.008
(.031) (.026) (.019) (.018)
Log likelihood −4997.064 −4997.064 −6267.941 −6267.941
N 6286 6286 8243 8243
Notes Average marginal effects. Base category is being unemployed. Other control variables:
region, urban, education, indigenous, marital status, children, wealth, parental education. ∗
p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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To consider the possible endogeneity of diabetes when estimating its effect
on formal and informal employment, we again present the results of the bivariate
probit and the Lewbel model. The stratification into formal and informal employ-
ment groups significantly reduces instrument power as well as sample size. For
none of the employment groups the bivariate probit model indicates endogeneity
(see Table A13 and Table A14 in the appendix). This does not change even when
using the Lewbel approach to increase instrument strength. Accordingly, we do
not find any indication of endogeneity of diabetes for the stratification into formal
and informal employment and rely on our probit estimates for inference.
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Table A13: IV results for informal employment
BP Lewbel IV
(1) (2) (3) (4)
Male Female Male Female
Diabetes −.046 0.069 −.048 −.037
(.123) (.130) (.030) (.025)
R2 0.103 0.088
Score goodness-of-fit (H0=normality of errors) 13.84 17.37
p value 0.128 0.043
F stat (H0: weak instruments) 13.565a 25.123a 5349.118 2536.362
Sargan test (H0: valid instruments) 0.551a 1.684a 4.067 4.063
p value 0.458a 0.194a 0.540 0.540
Endogeneity (H0: Diabetes exogenous) 0.025 1.152 1.128 0.722
p value 0.873 0.283 0.288 0.395
N 4604 6983 4604 6983
Notes Average marginal effects for bivariate probit (BP); robust standard errors in parentheses. Instruments:
diabetes of mother, diabetes of father; for Lewbel additionally created age groups instruments. The models
contain the age categories 55–64 with 45–54 as the reference category. Other control variables: region, urban,
education, indigenous, marital status, children, wealth, parental education. a The test statistics are taken from
the linear IV model not presented here. Base category is being unemployed. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A14: IV results for formal employment
BP Lewbel IV
(1) (2) (3) (4)
Male Female Male Female
Diabetes 0.098 −.103 −.022 0.003
(.195) (.069) (.049) (.021)
R2 0.256 0.262
Score goodness-of-fit (H0=normality of errors) 12.95 8.03
p value 0.165 0.531
F stat (H0: weak instruments) 8.518a 19.996a 2764.273 1647.887
Sargan test (H0: valid instruments) 1.111a 1.075a 9.286 6.741
p value 0.292a 0.300a 0.098 0.241
Endogeneity (H0: Diabetes exogenous) 0.516 1.833 1.602 0.318
p value 0.473 0.176 0.206 0.573
N 2204 5652 2204 5652
Notes Average marginal effects for bivariate probit (BP); robust standard errors in parentheses. Instruments:
diabetes of mother, diabetes of father; for Lewbel additionally created age groups instruments. The models
contain the age categories 55–64 with 45–54 as the reference category. Other control variables: region, urban,
education, indigenous, marital status, children, wealth, parental education. a The test statistics are taken from
the linear IV model not presented here. Base category is being unemployed. ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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IV Appendix to Chapter 4
Strategies to deal with inconsistent self-reporting over time
One of the key advantages of panel data is the repeated measurement giving more
than one data point for many of the individuals, thereby allowing to uncover
inconsistencies for those with at least two observations. While we are not aware
of any literature investigating the issue of inconsistencies in self-reported diabetes
over time, a study by Zajacova et al. (2010), on the consistency of a self-reported
cancer diagnosis over time in a USA population, found that 30% of those who
had reported a cancer diagnosis at an earlier point did report at a later point that
they never had received a cancer diagnosis. They also found that a more recent
diagnosis was reported with greater consistency possibly due to increasing recall
problems and/or reduced salience as time since diagnosis progresses.
We also find inconsistencies in the diabetes self-reports over the three waves of
the Mexican Family Life Survey (MxFLS) data, with between 10%–20% of those
reporting diabetes in one wave not doing so in one of the subsequent waves. In
order to reduce the amount of inconsistencies, we were interested in the validity
of diabetes self-reports. While we could not find a study assessing the validity of
self-reported diabetes in Mexico, a study from China has shown that specificity
of self-reported diabetes, i.e. those who self-report a diabetes diagnosis actually
have diabetes, was very high (>98% for China), while sensitivity, i.e. how many
people with diabetes, diagnosed or undiagnosed, actually self-report the disease,
was low (40% for China) (Yuan et al., 2015). This indicates that people who
report a diabetes diagnosis are likely to indeed have the condition while many of
those not reporting a diabetes diagnosis are unaware of their diabetes.
We assess the validity of self-reported diabetes in our data by using HbA1c
levels and the self-reports of diabetes related medicine use from wave three. We
find that 90% of those self-reporting a diabetes diagnosis had an HbA1c ≥ 6.5%
or did report taking diabetes medication, indicating relatively high specificity in
our data as well.
We used this information to infer the “true” diabetes status for those with
inconsistent reports. For those with two waves, we assumed that if a diabetes
diagnosis had been reported in a prior wave they also had diabetes in the ensuing
wave, even if then it was not reported. For people where we had data from all
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three waves, we used that additional information to make a decision on how to
deal with inconsistencies using the rules outlined in Table A15 in the appendix.
This approach should add more consistency to the self-reported diabetes in-
formation by using all available information. We tested if this approach was
supported by the HbA1c values provided in wave 3. Of those with inconsistencies
in their diabetes self-reports 95 were present in the biomarker sample (46 with
two and 49 with one self-report of diabetes). Using a t-test we compared the
mean HbA1c for the two groups and found a significantly (p<0.001) higher mean
HbA1c (9.7) for those with two self-reports compared to for those with only one
self-report of diabetes (7.0). Further, of those with one self-report, for only 30%
the HbA1c ≥ 6.5 compared to 87% of those with two self-reports. Based on these
results we are reassured that the way we have dealt with the inconsistencies in the
data minimizes misclassification of people into diabetes or no-diabetes and has
reduced some of the measurement error in the diabetes data. Unfortunately we
cannot use a similar method for dealing with inconsistencies in the self-reported
year of diabetes diagnosis, as it has only been reported once. Hence, the results
from duration analysis should be interpreted with care.
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Table A15: Inconsistencies in diabetes self-report in MxFLS
Diabetes self-report Assumption Number of
observations
replaced
2002 2005 2009
Yes Yes No Has diabetes
in 2009 as
well
19
Yes No Yes Has diabetes
in 2005 as
well
63
Yes No No Has no dia-
betes in 2002
either
66
No Yes No Has no dia-
betes in 2005
either
52
Yes No NA Has diabetes
in 2005 as
well
44
NA Yes No Has diabetes
in 2009 as
well
23
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V Appendix to Chapter 5
Attrition
Table A16: Attrition between waves
1997–2000 11.9%
2000–2004 13.0%
2004–2006 8.3%
2006–2009 16.2%
2009–2011 16.7%
Total 10.6%
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Missing data
Table A17: Number of imputed observations
Variable Missing Total Missing (%)
Employed 2333 47661 4.89
Smokes 3315 47661 6.96
Any alcohol consumption 3438 47661 7.21
Daily Kcal eaten (3-day average) 3599 47661 7.55
BMI 6092 47661 12.78
Waist circ. (cm) 6361 47661 13.35
Age 0 47661 0.00
Han ethnicity 0 47661 0.00
Rural area 0 47661 0.00
Married 2625 47661 5.51
Secondary education 254 47661 5.33
University education 254 47661 5.33
Any health insurance 253 47661 5.31
Urbanization Index 0 47661 0.00
Diabetes 0 47661 0.00
Per capita household income (Yuan (2011)) 552 47661 1.16
Years since diabetes diagnosis 333 47661 0.70
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Stabilized weights
Table A18: Summary of stabilized weights
Mean Min Max
Untruncated (men) 1.000515 0.281853 2.642838
Untruncated (women) 0.999907 0.451526 2.053581
Truncated 1 and 99 percentile (men) 0.999756 0.945491 1.057514
Truncated 1 and 99 percentile (women) 1.000001 0.960039 1.049472
Using overweight and obesity instead of BMI and waist circumference
Untruncated (men) 1.000516 0.232143 2.592925
Untruncated (women) 0.999857 0.251297 2.491703
Truncated 1 and 99 percentile (men) 0.999794 0.944632 1.058910
Truncated 1 and 99 percentile (women) 0.999782 0.932321 1.077095
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Duration groups results
Table A19: Analysis of the effect of time since diabetes diagnosis on employment
status and behavioural outcomes using marginal structural models
(duration groups)
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Male sample
0 0.088 −.031 0.049 −1.138∗∗ −.728 278.504
(.059) (.122) (.147) (.530) (1.927) (301.190)
1-2 0.024 −.049 −.102∗∗ −.485∗ −1.261 −133.527
(.034) (.042) (.040) (.260) (.876) (96.402)
3-4 −.033 −.091 −.082∗ −.665∗∗ −2.505∗∗∗ −160.612∗
(.042) (.056) (.045) (.309) (.814) (84.241)
5-6 −.110 −.116 −.090 −.917∗∗ −1.009 −156.064
(.068) (.080) (.056) (.384) (.980) (117.322)
7-8 0.044 −.191 −.146∗ −.833∗ −1.590 −260.923∗∗
(.076) (.134) (.079) (.467) (2.276) (130.336)
9-10 −.052 −.040 0.197 −2.198∗∗∗ −6.075∗∗ −386.292∗
(.117) (.140) (.181) (.765) (2.591) (199.311)
11-12 0.013 −.001 −.165 −.881 −3.505 40.936
(.120) (.132) (.125) (.708) (2.522) (174.858)
13-14 0.004
(.124)
Female sample
0 0.078 0.099 −1.210 −59.570
(.139) (1.021) (3.866) (157.723)
1-2 −.085∗∗ −.191 −.303 −32.947
(.040) (.352) (.724) (50.797)
3-4 −.202∗∗∗ −.411 0.591 −21.502
(.067) (.461) (1.232) (62.460)
5-6 −.070 −.475 −.187 −53.234
(.066) (.337) (1.055) (61.737)
7-8 −.180∗∗ −1.049∗∗ −1.787∗ −94.532
(.088) (.426) (1.057) (105.698)
9-10 −.329∗ −1.054 0.324 66.951
(.168) (.822) (2.538) (125.902)
11-12 −.119 −.554 −3.906 −29.022
(.120) (1.089) (2.464) (152.223)
13-14 −.117
(.154)
Notes The coefficients for outcomes 1–3 represent average marginal effects based on logistic regression models. All other
coefficients are from linear regression models. The smoking and alcohol models for females could not be estimated due to
too few non-zero observations. Similarly, apart from the employment models, the years 13-14 had to be omitted due to too
few observations for theses years. Other control variables: baseline values of age, age squared, region, urban, education,
Han ethnicity, marital status, urbanization index, time dummies, health insurance status, household expenditures, alcohol
consumption, smoking status, BMI, waist circumference and calorie consumption. N=16047 (male sample), N=16658 (female
sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A20: Analysis of the effect of time since diabetes diagnosis on employment
status and behavioural outcomes using fixed effects (duration groups)
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Male sample
0 0.151∗∗ −.005 0.027 0.064 2.200 −112.476
(.072) (.097) (.161) (.822) (2.257) (232.264)
1-2 0.040 −.029 −.137∗∗∗ −.598∗∗∗ −1.714∗∗ −228.738∗∗∗
(.038) (.038) (.042) (.230) (.784) (85.913)
3-4 0.010 −.007 −.066 −.706∗∗ −2.992∗∗∗ −113.409
(.044) (.051) (.050) (.296) (.797) (86.909)
5-6 −.118 −.026 −.093 −1.164∗∗∗ −2.191∗ −22.369
(.079) (.072) (.062) (.341) (1.309) (112.692)
7-8 0.126 −.147 −.262∗∗ −.750 −3.009 −302.744∗∗
(.078) (.120) (.116) (.493) (1.886) (131.910)
9-10 0.036 0.004 0.054 −2.123∗∗∗ −7.756∗∗∗ −228.356
(.141) (.138) (.145) (.788) (2.799) (184.833)
11-12 0.066 −.042 −.256∗ −1.604∗∗ −6.693∗∗ −195.061
(.180) (.156) (.141) (.742) (3.094) (160.761)
13-14 0.042 0.186 −.218 −1.389 −4.626∗∗∗ −167.675
(.183) (.126) (.140) (1.168) (1.190) (147.716)
Female sample
0 0.102 −.015∗∗ −.035 −.468 −4.036 −322.767∗
(.157) (.007) (.032) (.884) (3.229) (171.460)
1-2 −.104∗∗∗ −.031∗∗ −.019∗ −.419 −.727 −98.608∗
(.034) (.013) (.011) (.349) (.683) (56.443)
3-4 −.110∗∗ −.022 −.012 −.756∗∗ −.896 42.743
(.056) (.015) (.016) (.378) (1.000) (67.154)
5-6 −.095 −.049 0.007 −1.012∗∗∗ −2.293∗∗ −49.270
(.072) (.038) (.018) (.309) (1.021) (84.604)
7-8 −.219∗∗ 0.014 −.000 −1.385∗∗∗ −3.238∗∗∗ −76.316
(.090) (.032) (.013) (.391) (.962) (102.021)
9-10 −.261∗∗ 0.024 −.001 −.794 −.240 −12.562
(.124) (.035) (.025) (.572) (2.056) (134.903)
11-12 −.209∗ −.070 −.002 −.676 −4.068∗ −2.327
(.111) (.053) (.009) (.973) (2.462) (152.643)
13-14 −.178 −.026 −.001 −.001 0.056 −301.362∗∗∗
(.164) (.018) (.027) (.708) (2.411) (94.674)
Notes All estimates are beta coefficients from linear regression models. Other control variables: age squared, region, urban,
education, han, marital status, urbanization index, time dummies, health insurance status, household expenditures. N=23443
(male sample), N=23702 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗. p < 0.01
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Table A21: Analysis of the effect of time since diabetes diagnosis on employ-
ment status and behavioural outcomes using random effects (duration
groups)
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Male sample
0 0.123∗ −.034 0.051 0.381 3.652∗ 2.069
(.068) (.097) (.150) (.707) (2.075) (203.971)
1-2 −.005 −.067∗ −.142∗∗∗ −.276 −.392 −223.036∗∗∗
(.038) (.037) (.036) (.224) (.766) (78.475)
3-4 −.048 −.052 −.081∗ −.316 −1.318∗ −155.191∗∗
(.044) (.048) (.045) (.304) (.769) (72.913)
5-6 −.133∗ −.071 −.084 −.759∗∗ −.403 −75.706
(.076) (.069) (.058) (.344) (1.148) (104.001)
7-8 0.093 −.208∗ −.194∗ −.434 −1.172 −272.523∗∗
(.075) (.112) (.102) (.485) (1.703) (109.241)
9-10 −.018 −.028 0.122 −1.804∗∗ −5.786∗∗ −234.745
(.142) (.134) (.142) (.749) (2.609) (166.358)
11-12 0.012 −.071 −.209 −1.360∗ −5.108∗ −90.369
(.166) (.160) (.132) (.726) (2.790) (158.103)
13-14 0.008 0.206∗∗ −.152 −.985 −2.776∗∗ −14.049
(.157) (.093) (.142) (1.225) (1.122) (101.033)
Female sample
0 0.034 0.003 −.035∗∗ 0.097 −1.037 −145.397
(.145) (.025) (.017) (.842) (3.375) (139.781)
1-2 −.135∗∗∗ −.028∗∗∗ −.026∗∗∗ −.025 0.857 −44.182
(.031) (.011) (.004) (.337) (.631) (52.022)
3-4 −.169∗∗∗ −.018 −.015 −.379 0.901 −3.834
(.049) (.014) (.014) (.372) (1.005) (57.700)
5-6 −.129∗∗ −.038 −.005 −.612∗∗ −.317 −43.769
(.063) (.033) (.018) (.305) (.992) (69.632)
7-8 −.225∗∗∗ 0.024 −.018∗ −1.015∗∗∗ −1.357 −69.287
(.075) (.034) (.010) (.377) (.908) (105.179)
9-10 −.286∗∗ 0.026 −.018 −.515 1.421 98.605
(.111) (.042) (.024) (.572) (1.937) (127.672)
11-12 −.195∗ −.060 −.020∗∗∗ −.265 −2.043 31.945
(.117) (.043) (.005) (.948) (2.622) (137.113)
13-14 −.152 −.022∗ −.018 0.503 2.325 −301.291∗∗∗
(.152) (.013) (.026) (.773) (2.541) (91.369)
Notes All outcomes are beta coefficients from linear regression models.Other control variables: age, age squared, region, urban,
education, han, marital status, urbanization index, time dummies, health insurance status, household expenditures. N=23443
(male sample), N=23702 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Robustness checks
MSMs using truncated weights
Table A22: Analysis of the effect of a diabetes diagnosis on employment sta-
tus and behavioural outcomes using marginal structural models with
truncated stabilized weights at 1st and 99th percentile
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Diabetes
Male sample
Diabetes −.022 −.070∗∗ −.094∗∗∗ −.732∗∗∗ −1.637∗∗∗ −175.662∗∗∗
(.023) (.032) (.036) (.179) (.532) (51.574)
Female sample
Diabetes −.132∗∗∗ −.015∗ −.029∗∗ −.178 0.186 −47.980
(.029) (.008) (.012) (.248) (.638) (34.319)
Years since diagnosis
Male sample
Time since diagnosis −.006 −.010∗∗ −.016∗∗ −.133∗∗∗ −.326∗∗∗ −26.261∗∗∗
(.004) (.005) (.006) (.033) (.095) (9.160)
Female sample
Time since diagnosis −.019∗∗∗ −.002 −.004 −.044 −.016 −9.096
(.006) (.001) (.003) (.042) (.112) (5.681)
Notes The coefficients for outcomes 1–3 represent average marginal effects based on logistic regression models. All other coefficients are
from linear regression models. Robust standard errors in parentheses. Other control variables: baseline values of age, age squared, region,
urban, education, Han ethnicity, marital status, urbanization index, time dummies, health insurance status, household expenditures,
alcohol consumption, smoking status, BMI, waist circumference and calorie consumption. N=16047 (male sample), N=16658 (female
sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A23: Effect of time since diagnosis on employment status and behavioural
outcomes using MSM with truncated stabilized weights (1st and 99th
percentile; imputed), duration groups
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Male sample
0 0.089 −.047 0.031 −1.107∗∗ −.326 83.518
(.061) (.135) (.143) (.522) (1.909) (236.282)
1-2 −.002 −.072∗ −.121∗∗∗ −.472∗ −.962 −197.071∗∗
(.034) (.041) (.033) (.254) (.843) (82.739)
3-4 −.042 −.073 −.088∗∗ −.654∗∗ −2.113∗∗∗ −189.546∗∗
(.038) (.050) (.040) (.299) (.693) (77.787)
5-6 −.107∗ −.091 −.094∗ −1.022∗∗∗ −.954 −151.346
(.063) (.074) (.053) (.360) (1.013) (107.678)
7-8 0.054 −.222∗ −.127 −.863∗ −2.157 −264.374∗∗
(.063) (.118) (.078) (.462) (2.034) (115.620)
9-10 −.075 −.024 0.122 −2.270∗∗∗ −5.774∗∗ −289.988∗
(.117) (.136) (.148) (.700) (2.424) (174.301)
11-12 −.024 −.028 −.167 −.888 −3.275 −8.651
(.126) (.127) (.112) (.713) (2.467) (163.025)
13-14 −.053
(.142)
Female sample
0 0.068 0.541 0.219 −102.210
(.134) (1.136) (4.359) (139.467)
1-2 −.114∗∗∗ 0.130 0.472 −28.298
(.040) (.359) (.723) (53.113)
3-4 −.208∗∗∗ −.298 0.866 −31.300
(.064) (.457) (1.193) (61.496)
5-6 −.097 −.319 0.103 −60.088
(.063) (.347) (1.084) (66.056)
7-8 −.184∗∗ −.979∗∗ −1.522 −94.059
(.089) (.449) (1.074) (107.062)
9-10 −.344∗∗ −.975 0.637 71.060
(.168) (.827) (2.541) (133.178)
11-12 −.119 −.432 −3.355 −12.232
(.113) (1.070) (2.603) (141.560)
13-14 −.106
(.152)
Notes The coefficients for outcomes 1–3 represent average marginal effects based on logistic regression models. All other
coefficients are from linear regression models. Robust standard errors in parentheses. The smoking and alcohol models for
females could not be estimated due to too few non-zero observations. Similarly, apart from the employment models, the years
13-14 had to be omitted due to too few observations for theses years. Other control variables: baseline values of age, age
squared, region, urban, education, Han ethnicity, marital status, urbanization index, time dummies, health insurance status,
household expenditures, alcohol consumption, smoking status, BMI, waist circumference and calorie consumption. N=16047
(male sample), N=16658 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Results using non-imputed data
Table A24: Analysis of the effect of a diabetes diagnosis on employment status
and behavioural outcomes using MSM, FE and RE (no imputation)
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Marginal structural model
Male sample
Diabetes 0.049 −.054 −.118∗∗ −.601∗∗∗ −1.290 −205.746∗
(.043) (.040) (.053) (.229) (.859) (109.375)
Female sample
Diabetes −.087∗ −.026∗ 0.000 −.637 −1.043 −45.166
(.047) (.016) (.) (.402) (.865) (56.543)
Fixed effects
Male sample
Diabetes 0.024 −.004 −.103∗∗∗ −.844∗∗∗ −2.463∗∗∗ −152.316∗∗
(.030) (.033) (.036) (.169) (.508) (67.898)
Female sample
Diabetes −.110∗∗∗ −.024∗∗ −.015 −.634∗∗ −1.105∗ −81.340∗
(.034) (.012) (.012) (.288) (.636) (49.016)
Random effects
Male sample
Diabetes −.023 −.045 −.109∗∗∗ −.569∗∗∗ −1.163∗∗ −143.470∗∗∗
(.027) (.030) (.029) (.166) (.482) (51.625)
Female sample
Diabetes −.164∗∗∗ −.020∗∗ −.021∗∗∗ −.309 0.494 −59.269∗
(.026) (.009) (.005) (.269) (.583) (35.037)
Robust Hausman test of fixed effects vs. random effects
Male sample
Chi2 449.597 230.700 99.211 299.581 230.399 51.810
p-value <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
Female sample
Chi2 337.522 52.231 27.422 251.371 149.501 51.005
p-value <0.001 <0.001 0.017 <0.001 <0.001 <0.001
Notes The coefficients of the MSM for outcomes 1–3 represent average marginal effects based on logistic regression models. All
other coefficients are from linear regression models. Robust standard errors in parentheses. Other control variables for FE/RE:
age squared, region, urban, education, Han ethnicity, marital status, urbanization index, time dummies, health insurance status,
household expenditures. RE additionally controls for age. MSM controls for baseline values of the same variables as the
FE/RE models additionally to baseline values of age, alcohol consumption, smoking status, BMI, waist circumference and calorie
consumption. FE/RE: N=22135 (male sample), N=23143 (female sample), MSM: N=10006 (male sample), N=11471 (female
sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A25: Analysis of the effect of each year since diabetes diagnosis on em-
ployment status and behavioural outcomes using MSM, FE and RE
(non-imputed)
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Marginal structural model
Male sample
Time since diagnosis 0.019 −.019 −.036∗ −.203∗∗ −.550∗ −85.203∗∗
(.017) (.015) (.022) (.081) (.310) (38.378)
Female sample
Time since diagnosis −.028 −.008 0.000 −.338∗ −.579∗ −14.298
(.017) (.006) (.) (.178) (.333) (21.193)
Fixed effects
Male sample
Time since diagnosis −.001 0.003 −.016∗∗ −.158∗∗∗ −.516∗∗∗ −18.202
(.007) (.006) (.007) (.039) (.118) (12.059)
Female sample
Time since diagnosis −.023∗∗∗ −.002 −.001 −.103∗∗ −.177 −9.987
(.008) (.002) (.001) (.045) (.127) (7.788)
Random effects
Male sample
Time since diagnosis −.007 −.003 −.015∗∗∗ −.120∗∗∗ −.317∗∗∗ −20.749∗∗
(.006) (.006) (.006) (.038) (.101) (9.382)
Female sample
Time since diagnosis −.026∗∗∗ −.002 −.003∗∗∗ −.065 0.043 −7.041
(.006) (.002) (.001) (.044) (.124) (6.479)
Notes The coefficients of the MSM for outcomes 1–3 represent average marginal effects based on logistic regression models. All other
coefficients are from linear regression models. Robust standard errors in parentheses. Other control variables for FE/RE: age squared,
region, urban, education, Han ethnicity, marital status, urbanization index, time dummies, health insurance status, household
expenditures. RE additionally controls for age. MSM controls for baseline values of the same variables as the FE/RE models
additionally to baseline values of age, alcohol consumption, smoking status, BMI, waist circumference and calorie consumption.
FE/RE: N=22117 (male sample), N=23130 (female sample), MSM: N=10028 (male sample), N=11465 (female sample). ∗ p < 0.10,
∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A26: Analysis of the effect of time since diabetes diagnosis on employment
status and behavioural outcomes using marginal structural models
(duration groups) (non-imputed)
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Male sample
0 0.119∗ 0.053 0.010 −.942 0.596 459.443
(.070) (.170) (.156) (.589) (.934) (474.665)
1-2 0.026 −.055 −.137∗∗∗ −.571∗∗ −1.270 −182.199
(.044) (.046) (.043) (.273) (1.040) (121.087)
3-4 −.043 0.131 −1.013∗∗ −3.347 −782.090∗∗∗
(.153) (.156) (.450) (2.116) (177.206)
Female sample
0 0.123 −.136 −1.772 −101.086
(.188) (1.488) (5.608) (203.293)
1-2 −.083 −.613 −.685 −40.447
(.067) (.489) (1.026) (65.853)
3-4 −5.530∗ −8.510∗∗∗ 0.676
(3.260) (1.787) (257.875)
Notes The coefficients for outcomes 1–3 represent average marginal effects based on logistic regression models. All other
coefficients are from linear regression models. Robust standard errors in parentheses. The number of year groups is limited
due to too few observations for estimation within each group. Other control variables: baseline values of age, age squared,
region, urban, education, Han ethnicity, marital status, urbanization index, time dummies, health insurance status, household
expenditures, alcohol consumption, smoking status, BMI, waist circumference and calorie consumption. N=10028 (male
sample), N=11465 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A27: Analysis of the effect of time since diabetes diagnosis on employment
status and behavioural outcomes using fixed effects (duration groups)
(non-imputed)
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Male sample
0 0.126∗ −.013 0.081 −.013 1.444 −268.541
(.073) (.084) (.156) (.704) (1.883) (213.448)
1-2 0.046 −.019 −.135∗∗∗ −.817∗∗∗ −2.298∗∗∗ −225.905∗∗
(.039) (.039) (.042) (.199) (.637) (90.437)
3-4 0.013 0.035 −.052 −.786∗∗ −3.016∗∗∗ −107.317
(.046) (.054) (.055) (.325) (.819) (98.624)
5-6 −.134∗ 0.028 −.134∗∗ −1.159∗∗∗ −1.715 34.167
(.079) (.077) (.065) (.343) (1.178) (117.774)
7-8 0.162∗∗ −.138 −.270∗∗ −.692 −2.555 −305.553∗∗
(.078) (.117) (.117) (.429) (1.726) (133.202)
9-10 −.018 0.044 0.082 −1.938∗∗∗ −8.278∗∗∗ −196.802
(.136) (.123) (.131) (.667) (2.262) (201.492)
11-12 0.063 0.089 −.177∗∗ −1.743∗∗ −5.843∗∗ −22.708
(.178) (.134) (.082) (.736) (2.828) (140.771)
13-14 0.060 0.222∗∗ −.164 −1.508 −4.207∗∗∗ −119.852
(.194) (.113) (.111) (1.202) (1.063) (178.187)
Female sample
0 0.101 −.014∗∗ −.046 −.778 −3.920 −358.037∗∗
(.154) (.007) (.040) (.909) (3.420) (173.529)
1-2 −.100∗∗∗ −.029∗∗ −.023∗ −.329 −.558 −118.162∗∗
(.033) (.012) (.012) (.363) (.671) (56.839)
3-4 −.148∗∗ −.017 −.025∗ −.822∗ −.824 49.550
(.059) (.013) (.014) (.442) (1.148) (82.984)
5-6 −.122∗ −.043 0.002 −1.028∗∗∗ −1.616 −69.012
(.073) (.041) (.020) (.325) (1.016) (96.779)
7-8 −.235∗∗∗ 0.023 −.004 −1.327∗∗∗ −3.174∗∗∗ −90.185
(.090) (.027) (.008) (.390) (.978) (111.004)
9-10 −.247∗∗ 0.031 −.010 −.981 −.260 −64.808
(.118) (.039) (.009) (.621) (2.131) (134.146)
11-12 −.239∗∗ −.070 −.005 −.715 −3.440 −25.527
(.103) (.056) (.009) (1.021) (2.512) (173.367)
13-14 −.199 −.023 −.008 −.111 0.693 −366.259∗∗∗
(.166) (.018) (.009) (.665) (2.153) (87.213)
Notes Linear regression coefficients. Robust standard errors in parentheses. Other control variables: age squared, region, urban,
education, Han ethnicity, marital status, urbanization index, time dummies, health insurance status, household expenditures.
N=22117 (male sample), N=23130 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A28: Analysis of the effect of time since diabetes diagnosis on employ-
ment status and behavioural outcomes using random effects (duration
groups) (non-imputed)
(1) (2) (3) (4) (5) (6)
Employment Smoking Any alcohol BMI Waist (cm) Calories (kcal)
Male sample
0 0.094 −.043 0.065 0.148 2.276 −28.615
(.069) (.087) (.144) (.610) (1.683) (188.201)
1-2 −.008 −.053 −.144∗∗∗ −.533∗∗∗ −1.045 −203.986∗∗
(.038) (.038) (.036) (.195) (.658) (80.054)
3-4 −.041 −.007 −.070 −.493 −1.730∗∗ −140.623
(.045) (.051) (.051) (.336) (.809) (87.834)
5-6 −.159∗∗ −.012 −.120∗∗ −.866∗∗∗ −.330 −69.752
(.077) (.073) (.060) (.333) (1.054) (115.094)
7-8 0.114 −.213∗∗ −.215∗∗ −.473 −1.072 −243.936∗∗
(.074) (.108) (.097) (.431) (1.538) (105.320)
9-10 −.070 0.001 0.127 −1.803∗∗∗ −7.021∗∗∗ −173.366
(.134) (.118) (.132) (.620) (2.127) (167.349)
11-12 0.005 0.060 −.160 −1.446∗ −4.339 92.244
(.159) (.144) (.100) (.767) (2.681) (148.282)
13-14 0.029 0.234∗∗∗ −.118 −1.101 −2.531∗∗∗ 38.227
(.161) (.083) (.128) (1.263) (.931) (100.439)
Female sample
0 0.025 0.003 −.039∗∗ −.238 −1.178 −123.300
(.145) (.025) (.016) (.874) (3.554) (139.671)
1-2 −.142∗∗∗ −.028∗∗∗ −.028∗∗∗ 0.001 0.848 −66.418
(.031) (.010) (.004) (.349) (.622) (49.483)
3-4 −.195∗∗∗ −.020∗ −.028∗∗∗ −.481 1.064 43.196
(.052) (.012) (.005) (.433) (1.090) (68.580)
5-6 −.159∗∗ −.034 −.007 −.647∗∗ 0.445 −52.781
(.063) (.035) (.021) (.315) (.981) (77.715)
7-8 −.247∗∗∗ 0.029 −.022∗∗∗ −1.073∗∗∗ −1.501∗ −90.408
(.070) (.031) (.003) (.368) (.886) (116.975)
9-10 −.286∗∗∗ 0.029 −.024∗∗∗ −.748 1.422 124.263
(.099) (.046) (.003) (.605) (1.900) (156.687)
11-12 −.214∗ −.062 −.022∗∗∗ −.335 −1.482 49.789
(.114) (.046) (.005) (1.000) (2.752) (155.171)
13-14 −.176 −.022∗ −.024∗∗∗ 0.298 2.665 −332.344∗∗∗
(.153) (.012) (.006) (.755) (2.407) (99.899)
Notes Linear regression coefficients. Robust standard errors in parentheses. Other control variables: age, age squared, region,
urban, education, Han ethnicity, marital status, urbanization index, time dummies, health insurance status, household expenditures.
N=22117 (male sample), N=23130 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Overweight and obesity results
Table A29: Analysis of the effect of a diabetes diagnosis on overweight and obesity
using MSM, FE and RE
Males Females
(1) (2) (3) (4)
Overweight Obese Overweight Obese
Marginal structural model
Diabetes −.000 −.024 −.031 −.009
(.031) (.015) (.034) (.014)
Fixed Effects
Diabetes −.041 −.035 −.095∗∗∗ −.034
(.035) (.025) (.036) (.027)
Random Effects
Diabetes 0.014 −.006 −.070∗∗ 0.028
(.030) (.023) (.030) (.024)
Notes The coefficients for outcomes 1–3 represent average marginal effects
based on logistic regression models. All other coefficients are from linear
regression models. Robust standard errors in parentheses. Other control
variables for FE/RE: age squared, region, urban, education, Han ethnic-
ity, marital status, urbanization index, time dummies, health insurance
status, household expenditures. RE additionally controls for age. MSM
controls for baseline values of the same variables as the FE/RE models
additionally to baseline values of age, alcohol consumption, smoking sta-
tus, overweight status, obesity status and calorie consumption. FE/RE:
N=23443 (male sample), N=23702 (female sample). MSM: N=16047 (male
sample), N=16658 (female sample). ∗ p < 0.10, ∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Table A30: Analysis of the effect of time since diagnosis on overweight and obesity
using MSM, FE, RE
Males Females
(1) (2) (3) (4)
Overweight Obese Overweight Obese
Marginal structural model
Time since diagnosis −.001 −.005∗ −.003 −.003
(.005) (.003) (.005) (.002)
Fixed Effects
Time since diagnosis −.006 −.007∗ −.006 −.009∗
(.007) (.004) (.006) (.005)
Random Effects
Time since diagnosis 0.002 −.003 −.006 −.001
(.006) (.003) (.005) (.004)
Notes The coefficients for outcomes 1–3 represent average marginal effects based on
logistic regression models. All other coefficients are from linear regression models. Ro-
bust standard errors in parentheses. Other control variables for FE/RE: age squared,
region, urban, education, Han ethnicity, marital status, urbanization index, time dum-
mies, health insurance status, household expenditures. RE additionally controls for age.
MSM controls for baseline values of the same variables as the FE/RE models addition-
ally to baseline values of age, alcohol consumption, smoking status, overweight status,
obesity status and calorie consumption. FE/RE: N=23443 (male sample), N=23702 (fe-
male sample). MSM: N=16047 (male sample), N=16658 (female sample). ∗ p < 0.10,
∗∗ p < 0.05, ∗∗∗ p < 0.01.
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Figure A1: Analysis of the effect of time since diabetes diagnosis on overweight
and obesity (duration groups)
Marginal structural models
Fixed effects
Random effects
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